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Preface 
The decision to write the present work was prompted by the example of the laboratory 
manual entitled “Perfusion Techniques in Biochemistry”, written by Brian D. Ross and 
published by Clarendon Press, Oxford 1972. His book presents an excellent overview of 
organ perfusion techniques. Chapter 3 deals with techniques of liver perfusion, which was 
the pacemaker in the field those days, especially after Leon L. Miller had established the 
isolated perfused rat liver as a model, which he used to demonstrate the synthesis of 
serum proteins (other than immunoglobulins) by the isolated liver. Chapter 4 is devoted to 
the kidney and extends over 36 pages. Studies carried out in the Laboratory of Sir Hans 
Adolf Krebs demonstrated that the metabolic activity of the perfused kidney was higher 
than that seen in tissue slices, largely due to the dominant influence of ion transport upon 
energy metabolism in the organ. We and others later showed that certain metabolic 
substrates have a significant effect on ion transport in the kidney. 
 I worked on kidney perfusion over a period of 20 years, and struggled with its many 
problems. In the early period (1969-1975) I benefited from the enthusiastic encouragement 
of Klaus Hierholzer, the first director of the then new Institute of Clinical Physiology in 
Berlin, where I continued to work part time in parallel with my clinical education in Berlin 
until 1975. Hilmar Stolte greatly facilitated my start in Hannover and he provided a 
laboratory workplace in his Experimental Nephrology Unit. It was a period in which I learnt 
a lot. My thesis in Tübingen dealt with liver perfusion, my postdoctoral thesis at the 
Medical School in Hannover was devoted to kidney perfusion. My contacts with interna-
tional colleagues and members of the scientific community in Berlin, as well as in 
Hannover, were very stimulating. In Hannover, I enjoyed the support of Jens Bahlmann, 
who gave me access to his collection of reprints relating to kidney perfusion. During this 
period, Jan Brod and later on Karl Martin Koch headed the Department of Nephrology 
within the Center for Internal Medicine. 
 In 1988, I took sabbatical leave to work in Christian Bauer´s group at the Department of 
Physiology in Zürich on the synthesis of erythropoietin in the isolated perfused rat kidney. 
The Institute’s workshops were extraordinarily helpful in establishing the experimental 
setup, and I benefitted from a stimulating group of younger colleagues, including Armin 
Kurtz, Kai-Uwe Eckhardt and Holger Scholz.  
 After my retirement from clinical work, I was pleased to be able to avail of a guest 
position at the University Hospital of Münster and – with the support of Eberhard Schlatter 
and Giuliano Ciarimboli - I was able to set up a kidney perfusion system and resume 
experimental work. This led me to reflect on the experimental expertise I had acquired and 
to collect material that might be helpful to those beginning to work in the field of kidney 
perfusion. The Deutsche Forschungsgemeinschaft supported this work for years, bridging 
support was provided by the Ministry for Arts and Science of Lower Saxony, and in later 
years the Else Kroener-Fresenius Foundation supported the group. 
This laboratory manual does not aim to provide a comprehensive treatment of 
developments in the area of organ perfusion. Instead, the present work discusses a very 
subjective selection of topics to help readers to choose the most appropriate model for a 
given problem by describing the strengths and limitations of each of the available options. 
The Laboratory Manual by Brian D. Ross mentioned above is still worth reading. I am grate-
ful for the contribution of my friend Klaus Hinrich Neumann about technical niceties of 
tubular micropuncture in the isolated kidney and of Frank Schweda on the isolated 
perfused mouse kidney, who have now brought the kidney perfusion tradition that began 
with my sabbatical leave in Zurich to Regensburg.  
 The material for this handbook and all the results cited are the fruit of my collabora-
tions with many doctoral candidates and the stimulating scientific environment we created 
together. I will always remember the valuable assistance of Charlotte Mueller-Suur over 
the many years of my stay in Berlin. The exchange of ideas and views with the scientific 
community drawn to the Institut für Klinische Physiologie under the directorship of Klaus 
Hierholzer - with Eberhard Aulbert, Claus Behn, Petra Brandt, J.P. Brecht, Hans Ebel, 
Michael Fromm, Hans-Ulrich Gutsche, Ulrich Hegel, Roland Kirsten, Helge Lohfert, Roland 
Mueller-Suur and Michael Wiederholt - was a formative and enriching experience. Ingrid 
Krause became my first doctoral candidate, and I helped to supervise the work of Petra 
Brandt and Helge Lohfert.  
 While on a visit to the laboratory in Berlin, Hilmar Stolte encouraged me to come to 
Hannover, and there he gave me exactly the support I needed. I will never forget Iris Kilian 
for her skillful and sure hand in preparatory work generally, in the isolation of kidneys, in 
analytical work and especially in micro-analytical methods. Very special thanks are due to 
my longstanding technician and engineer, illustrator and friend Jörg-Dieter Biela, who gave 
me invaluable support in preparing Figures and in the development of the technical 
equipment. My first doctoral candidate in Hannover was Eberhard Schlatter, who was 
followed by Werner Meier, Eveline Assel and Christel Sonnenburg (co-supervised). She in 
turn was followed by Andreas Wiemeyer and Janosz Panzer (co-supervised), Josef Schlar-
mann, Horst Pagel and Christian Kellner (co-supervised), Gisela Wruck and Wulf-Peter 
Jesinghaus, Michael Hartwig, Hermann Thole, Harald Flohr, Harald Bertram and Uwe Jost (a 
particularly committed and valuable coworker), Mathias Bruno Zeh, Oliver Walter Johns 
and last but not least Giuliano Ciarimboli. Jeanette Alt won the respect of all as laboratory 
supervisor, and a large measure of the credit for the consistently high quality of the 
analytical work done in Hilmar Stolte´s group in Experimental Nephrology must go to her. 
 In summer 2006, Eberhard Schlatter arranged a meeting with former doctoral fellows, 
and encouraged and invited me to set up a new research group in Muenster. I accepted the 
invitation, which enabled me to supervise the doctoral work of Jens Klokkers, Christina 
Koeppen and Viktor Repp. In collaboration with Bayram Edemir and Eberhard Schlatter, a 
research proposal was submitted and accepted, and over a period of three years, we 
succeeded in throwing new light on the inability of the cell free perfused kidney to 
concentrate urine. In Münster, I have had support of two technicians, first Rita Schroeter 
and then Antje Stoeber, and I would like to thank both of them for their invaluable 
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Hans-Joachim Schurek    Lingen, Münster,  2017 
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Introduction 
A search for the term “kidney perfusion“ in the US National Library of Medicine´s 
database PubMed in Jan 2017 turned up a total of 14071 citations, “isolated perfused 
kidney” found 3422, and “isolated perfused rat kidney” (IPRK) 2213 entries. Some of these 
do not match the search profile, and mostly they are singular results. Very few publications 
deal with the methodology of perfusion, its background, possibilities, capabilities and 
limitations (162-164, 186, 223, 224), or with the choice of the most appropriate model for a 
specific question (246). An organ such as the kidney naturally functions best in a healthy 
organism. Once a kidney has been removed from its normal context, it is crucial to find the 
optimal compromise between the demands of the problem at issue and the experimental 
model to be adopted. An isolated kidney is, in effect, a “dying kidney”, although it may 
continue to function for between 1 and 4 hours, depending on one´s definition of normal. 
This of course holds to an even greater extent for fractionated experimental models, such 
as tissue slices, cell suspensions, isolated cell organelles (e.g., mitochondria, cell mem-
branes) and for the tissue cultures used as standard models in molecular biology. The basic 
reason for the progressive deterioration in function can be found in the stresses set up by 
the transition from perfusion by whole blood to the use of a more or less artificial perfusing 
medium. As Mephisto remarks in Goethe´s drama “Faust”, Studierzimmer II: “Blut ist ein 
ganz besondrer Saft”: “blood is a quite special juice”. Indeed, blood is a “liquid organ”, a 
highly complex cocktail that is steadily being reconditioned by the actions of other organs, 
and this complexity explains why all efforts to maintain kidney function in isolation are ulti-
mately doomed to failure. If we want to approach its fantastic properties, then we should 
leave an organ as the kidney within the body. Whether or not circulating micro-RNAs play 
any role in regulating kidney physiology only time can tell (296c).  
 
One vital but strangely neglected function of the blood in this context is its role in the 
maintenance of the integrity of the endothelium (166, 231), which no artificial perfusate so 
far developed can fully provide. Indeed, if this issue is the key to long-term viability of the 
isolated organ, it deserves to be analyzed in much greater detail, in particular with respect 
to the preservation of the endothelial glycocalyx (97, 204, 208) of glomerular and tubular 
capillaries. 
 
The following Figure provides a summary of the historical development of experimen-
tal models for the study of kidney function, most of which derive from in-vivo studies on 
experimental animals. To eliminate the impact of extrarenal factors, biochemists went on 
to develop in-vitro techniques based on the use of tissue slices of parenchymal organs like 
the liver and the kidney. These advances led to the discovery of a plethora of metabolic 
pathways, such as the Krebs cycle and the urea cycle, enzymes such as oxygenases, and 
much else. Initially, studies on respiration were carried out with the aid of simple mano-
metric methods, exemplified by the Warburg apparatus (124). Indeed, from our present-
day perspective, it is quite astonishing to recall how many seminal discoveries in bioche-
mistry were made with the manometric techniques pioneered by Otto Warburg. Equally 
fascinating are the contributions to a better understanding of kidney function made by the 
clearance techniques, hemodynamic studies and especially the classical micropuncture 
methods developed byphysiologists. Ussing in Copenhagen studied the function of epithe-
lial ion transport in frog skin and toad bladder, and the double-chamber he developed was 
 ʹ
a milestone in the history of transport physiology (149, 299). This technology made it 
possible, for the first time, to measure voltage-driven trans-epithelial sodium transport. 
When a countervailing electrical potential was applied, the current in the external circuit 
was equivalent in magnitude to the flow of ions transported across the membrane, quasi a 
short-circuit current. This breakthrough sparked the development of a set of tools for 
physiological studies on transporting epithelia, such as that of kidney tubuli, leading to 
measurement of the electric potential, to intracellular recordings, and the use of ion 
selective electrodes etc. These tools enabled researchers to characterize the different 
segments of the tubular epithelia in a nephron both in vivo and in vitro using isolated 
perfused tubules in their native state, as well as the influence of hormones and pharmaceu-
ticals such as diuretics. Another milestone was the invention of the patch-clamp technique 
by Sakmann and Neher, which generated a wealth of new insights (179, 180) by permitting 
functional analyses of membrane patches containing a single ion channel. This in turn led to 
the functional and genetic definition of individual channelopathies. Light microscopy, and 
more especially electron microscopy, provided fascinating visual images that reconciled 
ultrastructural morphology with functional findings. These advances gave pharmacologists 
unprecedented opportunities to study diverse aspects of drug actions and test new drugs in 
vitro. Comparison of results obtained in the isolated perfused liver with those from simple 
experimental models such as tissue slices made the disadvantages of the latter clear, and 
resulted in more precise analyses of metabolic pathways. Tubular ion transport in isolated 
perfused kidneys was found to require much higher levels of oxygen consumption than 
those observed in tissue slices, which support only a basal level of metabolism. In this sense 
the isolated perfused kidney takes an intermediate position between the unperturbed 
organ and the tissue slice in the canon of experimental models.  
 
In the meantime, research in nephrology has progressed to the molecular dimension, 
with the adoption of molecular biological and genetic methods. The ability to knockout 
genes in experimental animals or conversely to activate genes by knock-in techniques has 
opened up many new avenues to an understanding of mechanisms of pathogenesis and the 
biotechnological manufacture of new drugs, such as the synthesis of human erythropoietin 
in ovarian cell cultures of hamsters.  
  
Investigations of cell culture systems have become so dominant today that they now 
significantly shape modern nephrological research. It is now possible, for instance, to 
identify and express specific ion and water channels in the cell membrane. Moreover, 
knowledge of their molecular structures, functions and localization in the membrane con-
tinues to accumulate. Fascinating new insights into connecting bridges between cells (so-
called tight and leaky junctions) have emerged. What is true for ion and water channels 
applies equally to the characterization of transport molecules, ion pumps and signaling 
cascades that surpass the highest standards of control engineering. Many orphan diseases 
in clinical medicine have been dissected genetically and the mutations responsible for them 
are known, for example, the different types of Bartter syndrome, Gitelman syndrome, 
Fanconi syndrome and renal diabetes insipidus. And given the complexity of renal function, 
it is astounding that such a simple tool as a dialysis membrane suffices to detoxify the 
blood of a uremic patient.  
 
 ͵
As a young specialist in internal medicine, I treated many patients with acute renal 
insufficiency in the ICU of the Medizinische Hochschule Hannover. I was once interrupted 
by a visit from a well-known biochemist (Theodor Bücher) from Munich, who was inter-
ested in the technique of dialysis as it was practiced in those days. What surprised him 
most was the fact that, apart from physiological salts, the only metabolic substrate added 
to the dialysate was glucose. In his view, not to include the whole cocktail of substances 
found in normal blood was tantamount to a crime. However, I was able to reassure him by 
pointing out that only 5% of the circulating blood passes through the dialyzer membrane at 
any one time and that the organism is well able to cope with such small losses. Neverthe-
less, we nephrologists are all too well aware of the drawbacks of dialysis, in which essential 
substances are lost and physiological functions are irrevocably degraded. These deficits 
explain why renal transplantation remains the replacement of choice in the long-term. 
Ͷ
ͷ
1. Overview of experimental models of the kidney
ͳ
The scheme provides a historical overview of the development of experimental 
techniques in kidney research which have contributed to the present state of our know-
ledge of the organ´s function. The left side of the diagram focuses on studies of the kidney 
under in-vivo conditions, which provide information on renal function under almost normal 
conditions but have the disadvantage that systemic, extra-renal influences may adversely 
affect interpretation of the findings. The in-vitro techniques referred to cannot fully mimic 
normal renal function but are essential for the detailed analysis of cellular mechanisms. In 
particular, the development of the patch clamp technique, which allows for the electrophy-
siological investigation of single ion channels in membrane patches, has enabled molecular 
genetic characterization of so-called channelopathies. The isolated kidney represents an 
intermediate model: it excludes extrarenal influences, but it is in essence a dying organ, 
with limited function. This underlines the fact that the naturally functioning kidney in vivo is 
a highly efficient organ that regulates salt and water balance and acid-base balance, and 
eliminates waste products. It is also the target and the site of synthesis of hormones and 
metabolic substrates. The kidney acts on many other metabolic control circuits and allows 
us to adapt to life in multiple habitats.  
1.1. Historical aspects of the perfusion of isolated kidneys 
According to C. Jacobj (115), the earliest studies of isolated and artificially perfused kid-
neys are those reported by Carl Eduard Loebell in his 1849 doctoral dissertation in Marburg 
(153) and by Ernst Bidder in 1862 in his thesis submitted to the Imperial University of 
Dorpat (29), now Tartu in Estonia. Whereas Loebell´s thesis is written in Latin, which was 
still the language of science in his day, Bidder wrote his thesis in German, the new language 
of science those days. Bunge and Schmiedeberg subsequently demonstrated the synthesis 
of hippuric acid (47) in the isolated dog kidney in 1876. However, the techniques used in 
these investigations differed fundamentally from organ perfusion in its modern sense. 
In order to track down the site of hippuric acid synthesis, Bunge and Schmiedeberg first 
performed extensive preliminary experiments on frogs, and ultimately identified the kidney 
as the organ responsible for production of the compound. They then proceeded to remove 
the kidneys from a dog and, in the decisive experiment, they cannulated the vessels with 
glass tubes, and added as precursors benzoic acid and glycine to the defibrinated and 
filtered blood. The blood was then passed through the kidney via the glass cannulas under 
gravity from a carboy placed at a height of 1,75m. The detection of hippuric acid in the 
outflowing blood, within the kidney and in the urine confirmed their hypothesis that the 
substance was synthesized by the kidney. They referred to their experiments as “Durchlei-
tungsversuche”, or transit tests. These studies were carried out in the Institute of Experi-
mental Pharmacology at the University of Strasbourg, and led to the development of the 
remarkable perfusion apparatus designed by Jacobj.  
Carl Jacobj provided the first detailed description of the equipment in 1890 in a paper 
entitled “Apparat zur Durchblutung isolirter überlebender Organe”, which was published in 
the Archiv für experimentelle Pathologie und Pharmakologie (Vol 26) (see Figure 16.0.1./ 
16.0.2 in the Appendix) (115). In this paper, Jacobj pointed out that Carl Ludwig and his 
͸
coworkers in Leipzig had pioneered methods for the artificial perfusion of organs. The 
laboratory manual published by B.D. Ross includes a historical timetable (taken from a 
paper published in German by K. Skutul in 1908 of the Pharmacological Institute of the 
University of Kiev), which provides an overview of the chronology of the technical develop-
ments in the field (224, 277), s. Appendix to Chapter 16.  
A serious and perennial problem of these early studies, carried out with whole blood, 
was an unexplained vasoconstriction of the kidney. Descriptions of the first experimental 
systems always include the observation that, prior to its passage through the kidney, the 
arterial blood was bright red, while the blood leaving the kidney was dark blue, indicating 
that the rate of perfusion was extremely low. Alphonse Nizet, who had significant experi-
mental expertise himself, described this phenomenon in detail in his review of 1975 (186). 
Empirically, the addition of a functional lung in the extracorporeal circuit was shown to 
resolve the problem (14, 102, 103, 298). This led to the view that a vasoconstricting factor 
was eliminated by the lung and to the idea that deposition of destabilized lipoproteins in 
the kidney contributed to perfusion resistance by fat embolism (24). Nizet was convinced 
that erythrocytes are the source of this vasoconstrictor, which they released into the 
surrounding plasma, once they are outside of the vascular tree. This factor was also 
detectable in the aqueous hemofiltrate of hemodialysis patients (which also comes into 
contact with foreign surfaces during extracorporeal circulation!), and we were able to 
neutralize it by addition of verapamil to the perfusion solution (233, 234). For patients on 
dialysis (exposure to an extracorporeal circuit) it is not a problem, because they can inac-
tivate it in their lungs. Indeed, Nizet reported that the isolated kidney itself is able to 
neutralize the vasoconstrictive principle if freshly collected, unstirred donor blood is used, 
together with a mild method of oxygenation (e.g., via a membrane oxygenator) and recircu-
lation volumes of less than 15 times the weight of the kidney (186, 187, 189), and if the 
initial vasoconstriction is (optionally) suppressed pharmacologically. In a dog kidney per-
fused with whole blood (240) - a system that fulfilled all the criteria listed by Nizet - 
Schnermann et al. successfully demonstrated by micropuncture a feedback control of 
glomerular filtration rate. My colleagues and I were unable to detect such a feedback in the 
isolated, cell-free perfused rat kidney (unpublished results of Hans-Ulrich Gutsche and 
Reinhard Brunkhorst in my laboratory in Hannover, June 1979), see also Fig. 12.3.7. 
Vasoconstriction was not the primary reason for the introduction of cell-free perfusion 
solutions (with or without the addition of thoroughly washed erythrocytes) as  a semi-syn-
thetic medium – an approach which was first used by Schimassek in the isolated rat liver 
(232). Nevertheless, this procedure has had a positive effect on the maintenance of the 
isolated kidney. Historically, 1959 was a milestone, as Ch. Weiss published results (307) 
obtained with an isolated perfused rat kidney. Using a cell-free perfusate, he showed that 
the autoregulation of blood flow is detectable even in the absence of red cells. This refuted 
the then prevailing hypothesis proposed by Pappenheimer and Kinter, which postulated 
that autoregulation of flow in the kidney was the result of so-called plasma skimming (123, 
195). Up to this time, only larger mammals like the dog (186), the pig and the rabbit had 
been used as donors of experimentally isolated perfused kidneys. Ongoing miniaturization 
of analytical techniques then enabled researchers to use kidneys obtained from small 
mammals. Cell-free perfusion required the provision of sufficient dissolved oxygen to keep 
the organ alive, so the perfusate was either gassed with pure oxygen without bicarbonate, 
or gassed with 95% oxygen and 5% CO2 in the presence of bicarbonate as a buffer system. 
In renal perfusion, sodium bicarbonate has the advantage of facilitating trans-tubular 
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sodium-transport, unlike phosphate-based buffer systems without bicarbonate. One reason 
for this is that bicarbonate reabsorption enables the maintenance of a trans-epithelial 
chloride gradient (183), which itself serves as a driving force for the NaCl reabsorption – 
although this remains controversial (28).  
1.2. Oxygen supply – a critical parameter 
Perfusion without oxygen carriers (e.g. erythrocytes) is prone to cause tissue damage 
due to oxygen deficiency owing to the specific anatomy of renal vessels, especially in areas 
with a high susceptibility, such as S3-segments (proximal tubule) and in particular the 
medullary part of the thick ascending limb of Henle´s loop (7, 63). Here in the outer medul-
la, oxygen supply is at the brink of deficiency (259, 260, 263). Morphologist Manjeri Venka-
tachalam was the first to point to the particular vulnerability of the S3 segments of the 
proximal tubules to oxygen deficit, as they are localized within the interbundle area (300). 
Physiologist Christoph Weiss had shown earlier on that the oxygen consumption in the IPRK 
continues to rise in parallel with the perfusion flow rate, and interpreted this as an indica-
tion of inadequate oxygen supply (142, 306), while Dume, and Koch et al., speculated about 
a possible diffusion shunt for oxygen in 1966 (67).    
If it is mandatory to prevent oxygen deficiency, oxygen carriers (e.g. red cells) must be 
added (70). It is enough to add 5% of the volume as red cells if the solution is gassed with 
95% O2 and 5% CO2 (263). It is essential to wash erythrocytes several times (bovine, por-
cine, human or sheep) and thus to dilute the vasoconstrictive principle. Using whole blood 
as an admixture results in immediate vasoconstriction, even when blood has been drawn 
gently and carefully (s. above). This can be prevented ŽŶůǇďǇďůŽĐŬĂĚĞŽĨɲ-receptors (186, 
187, 189) or by calcium-channel blockers such as verapamil (253, 254). It is better to avoid 
this by using washed red blood cells. H. Schimassek first introduced the use of bovine 
erythrocytes for the perfusion of the isolated rat liver (232) because they were regarded as 
particularly stable. Interspecific differences in erythrocyte sizes (between rat, human, 
bovine) are of no practical consequence (209). The use of other oxygen carriers, such as 
fluorocarbon preparations (82) and ultrapure solutions of modified and polymerized 
hemoglobin has been discussed. However, there has been no real breakthrough in this 
area, despite multiple experiments over many years (personal communication W. Pfaller 
concerning stroma-free hemoglobin) (15, 16, 144, 147, 310, 311), though Baines has 
expressed a more optimistic view (15, 16). And work in this field continues (148)*.  
 Whether a relative deficiency of oxygen radical scavengers may contribute to 
functional defects of the IPRK is discussed in literature, i.e. to explain the enhanced 
glomerular leakiness for albumin (295) . 
*There is an interesting new way – not yet used in the IPRK - to enhance oxygen capacity by
using the extracellular macro-hemoglobin of the marine annelid worm Arenicola marina. 
This path has been developed by the French biologist Dr. Franck Zal and his company´s 
name is Hemarina. One may expect that this macro-hemoglobin will not be filtered at the 
glomerular capillaries and its large size may not significantly contribute to the colloid-
osmotic pressure (296b). 
ͺ
2. General principles of kidney perfusion
Attempts to perfuse the mammalian kidney with freshly drawn whole blood have
regularly failed, as discussed by Alphonse Nizet (186). Efforts to do so result in immediate 
vasoconstriction – even when the blood is drawn with extreme care, and regardless of 
whether defibrinated (103) or heparinized (46) blood is used. This phenomenon spurred 
the development of perfusion media composed of repeatedly washed erythrocytes and 
colloidal salt solutions (232). Perfusion without oxygen carriers like erythrocytes, even 
when the perfusate is gassed at high oxygen pressure, tends to result in tissue damage due 
to oxygen deficiency owing to the specific nature of the anatomy of renal vessels, especially 
in regions such as S3-segments (proximal tubule) and the medullary section of the thick 
ascending limb of Henle´s loop. This susceptibility arises from the special architecture of the 
renal vessels in the cortex and medulla. The tight contact between arteries and veins 
facilitates the shunt-diffusion of blood gases (134, 260, 263), especially when erythrocytes 
are omitted (263). Colloid-free perfusion media lead to a significant increase in the kidney 
volume, equivalent to a 30 to 50% increase in the initial weight, and the urinary volume 
reaches 50% of the glomerular filtration rate (251); see Chapter 10. 
There are four basic types of perfusion technique (Variant 1 - 4), whose advantages and 
drawbacks are discussed in detail below: 
2.1. Single-pass (once through) perfusion ȋͶǡʹ͵ͶǡʹͶ͸ǡʹͷͳǡʹͷ͸ǡʹͷ͹ǡ͵Ͳ͹Ȍ
2.2. Recirculation ȋͳ͵ǡ͵ʹǡ͵ͷǡͷͺǡͳͺͷǡͳͺ͸ǡʹͲͷǡʹʹ͵ǡʹ͵͹ǡʹͻ͵Ȍ
2.3. Recirculation and regeneration of the perfusate by dialysisȋʹͲǡͳ͸ͻǡ
ʹͶ͸ǡʹͷͳȌ
2.4. Reperfusion of an anatomically perfusion-fixed kidney.We estab-
lished this last variant as a model with which to analyze the physical properties of the 
glomerular filtration apparatus without having to perform laborious micropuncture 
experiments (50-53, 78, 266, 317). 
 The choice of procedure largely depends on the experimental question at hand. In the 
single pass perfusion technique (variant 1) the use of bovine serum albumin would be too 
expensive, except when using a mouse kidney. Variant 2 requires the smallest amount of 
albumin perfusate (60 to 100ml) and has become the most widely used technique. Variant 
3 requires a somewhat larger volume of perfusate as it makes use of a “dialung” or kidney-
lung” (dialyzer). Sterile filtration and/or online filtration (when recirculation is used) is/are 
equally important in all cases. In the first three methods, oxygen deficiency will arise in the 
absence of oxygen carriers (e.g., washed red cells), especially in the outer medulla and in 
the medullary rays of the renal cortex. In the following section, I discuss each of these 
methods in turn. 
ͻ
2.1. Single-pass perfusion (Variant 1) 
Oxygenation of the perfusate is carried out by aerating through sintered glass. This is 
possible when gelatin-based colloids (Haemaccel), hydroxyethyl-starch (HAES), dextran or 
pluronic (84) are used, but results in extreme foaming with BSA, which may also promote 
denaturation of the protein. We have used a combined system of recirculation, which is 
readily convertible to the single pass mode to enable analysis of metabolism and clearance 
of uremic middle molecules (233, 234). A membrane oxygenator is used to equilibrate the 
albumin-containing perfusate. Smyth et al. used a single-pass system with albumin either 
alone (280) or combined with Ficoll (279) and equilibrated the perfusate at a high flow-rate 
(2 L gas/min) by means of a capillary dialyzer. These authors provided no information on 
fluid loss by the hollow fibers. The dialyzer and other parts of the system were immersed in 
a water bath. This is critical for hygienic reasons. This has been practiced historically in 
peritoneal dialysis of man, but was later abandoned due to problems with contamination 
and replaced by dry temperature conditioning. It is better to use water bath jacketed glass 
coils upstream and downstream of the dialyzer. 
Perfusion without colloids is possible, but requires a different procedure compared to 
an isolated Langendorff preparation of a rat heart (66); it is essential to decapsulate the 
kidney and not to use ureteral catheters made of PE/PP10, which are too narrow. Cortell 
(59) points out that PE10 ureteral catheters are particularly unsuitable for the use especial-
ly at high diuresis rates (see Fig. 4.7.1.), as in the case of colloid-free perfusate (250, 251). A 
major advantage of the single pass mode is the constant supply of substrates, such as 
arginine as a constant source of NO, which is otherwise rapidly depleted in a pure recircula-
tion system especially at small volumes, if it is not replaced continuously (206, 207). If ery-
throcytes are added, an artificial lung, such as a glass-bulb (film-) oxygenator, membrane 
oxygenator or a dialyzer (dialung) as in mode 3, must be used for oxygenation where the 
aerated dialysate is used to equilibrate and regenerate the perfusate. In addition, the 
effects of the infusion/omission of peptide hormones such as arginine-vasopressin (by 
proportional infusion or withdrawal of hormones) can be analyzed more easily (305) than 
when Variant 2 is used.  
2.2. Recirculation (Variant 2) 
Variant 2 is the technique of choice if one is interested in following cumulative bioche-
mical or pharmacological effects over time. Examples include the study of metabolic pro-
cesses such as gluconeogenesis, the elimination or breakdown of drugs or the impact of 
hormones (23, 32, 58, 107, 108, 162, 164, 177, 185, 223, 225, 227, 237, 294). Membrane- 
or glass-bulb oxygenators were initially used as artificial lungs, but nowadays special capil-
lary dialyzers are preferred. Functionally the best colloid is albumin - bovine serum albumin 
(BSA) has the lowest viscosity at a given colloid osmotic pressure (COP), and therefore pro-
vides the highest perfusion flow rates at any defined perfusion pressure. Compared to 
other colloids albumin has a well-defined molecular weight. Bowman and Maack have best 
exploited the advantages of the recirculation method, as their apparatus is easy to set up 
and the functional results are comparable to those achieved with the method established 
by the Oxford Group of BD Ross and his followers. Urine was mostly reinfused, except in 
the case of clearance studies, and the withdrawal of perfusate and urine must be compen-
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sated for if the recirculating volume is very small. Pegg, however, has rightly pointed out 
that the urine contains particles that can block capillaries and enhance resistance to flow 
(196). Within 30 min after initiation of cell-free perfusion, detached fragments of tubular 
epithelia appear in the urine sediment (218), and this desquamation process has been 
verified by morphological studies (7, 263), thus confirming Pegg´s observations. These 
findings led to the inclusion of a filter between the perfusion pump and the kidney, which 
also removes particulates originating from the surgical procedure used to isolate the kidney 
from the animal.  
The recirculation mode is particularly suitable for biochemical and pharmacological 
studies because it facilitates the analysis of cumulative effects. Authors differ on whether 
BSA can be used in form of the crude Cohn faction V (23, 33, 162, 163) or should be 
defatted and dialyzed before use (55, 57). The former group finds the albumin-bound 
substances present in the Cohn V fraction useful, while the other group prefers tighter 
control over the composition of the perfusion medium. Moreover, the latter approach is 
generally thought to provide better functional stability of the preparation, as becomes 
apparent from continuous monitoring of multiple parameters such as flow, pressure, pO2 
and temperature. Indeed, it was the observation of a rapidly evolving acidosis in the iso-
lated rat liver – perhaps due to the HCO3 consumption for urea synthesis and/or a lactic aci-
dosis due to hypoxia – in small volumes of perfusate that led to the first use of dialysis (20).  
Fig. 2.1.: Urinary sediment from an IPRK perfused with washed human erythro-
cytes. The micrograph shows several human erythrocytes, one cell ghost and a larger 
tubular cell, which may be big enough to clog capillaries within the vascular bed. 
ͳͳ
2.3. Recirculation & regeneration of perfusate by dialysis (Var.  3) 
 This technique combines the advantages of the single-pass perfusion and recirculation 
modes, and my colleagues and I have used it particularly for physiological studies. In this case, 
the dialyzer also serves as the oxygenator, as the dialysate is aerated continuously via sintered 
glass frits in the mode of the single-pass perfusion. Cumulative effects reflected in changing 
concentrations of small metabolites, as seen in a pure recirculation system, are avoided. One 
disadvantage of this method is the greater technical effort required to compensate for the 
ultrafiltration implemented by the dialyzer. We used a level control of perfusate and automatic 
supply of dialysate that compensates for ultrafiltration and the removal of perfusate and urine 
samples. We routinely use a dialysate-to-perfusate ratio ŽĨшϮϬ͕ ŝ͘Ğ͕͘200-250ml perfusate to 
5000 ml of dialysate. This provides a quite stable composition of the perfusate as in a single 
pass perfusion mode and prevents the rapid loss of arginine as a source of nitric oxide (NO) 
(206, 207). Thus, the method is best suited for time-consuming micropuncture experiments 
(182, 184, 206, 207, 245, 248, 251, 266, 267, 291, 292). It also proved to be effective in other 
respects (106, 135, 136, 241, 242, 263, 267). So-called low-flux dialyzers with smaller pore size, 
which prevent the passage of albumin into the dialysate (unlike high-flux dialyzers which, 
however do not play a role in vivo due to the sealing capability of whole blood), are most 
appropriate in this context. Over the past 12 years, this technique has been applied to larger 
mammals like rabbits (3, 315), dogs (110) and pigs (89, 90). When Baumung and Peterlik (20) 
first used dialysis in liver perfusion they had to build their own dialyzer using cellophane tubes. 
But today´s mass produced dialyzers are affordable and durable, provided appropriate cleaning 
procedures are followed before reuse. 
2.4. Reperfusion of an anatomically perfusion-fixed kidney (Var.  4) 
By reperfusion of anatomically fixed kidneys, we were able to analyze the glomerular 
filter apparatus under conditions that are not applicable in vivo. For example, it was 
possible to analyze the permeability of albumin at acid pH near the protein´s isoelectric 
point or below, when the surface charge of albumin switches from negative to positive. The 
idea was triggered in response to the workload involved in the large numbers of micro-
puncture experiments required to analyze glomerular permeability for albumin in the isola-
ted perfused rat kidney (245, 248, 266, 292). The electric charge within the glomerular filter 
apparatus is preserved even in the perfusion fixed kidney. Reale et al. demonstrated the 
conservation of negative charge at the glomerular capillary membrane histochemically 
after perfusion fixation using glutaraldehyde (210-215). The aim was to obtain a prepara-
tion where GFR is high enough and identical to the urinary output. Therefore, we perfused 
kidneys for 15min at 100mmHg (effective perfusion pressure) with the addition of verapa-
mil (4.4 ђmole/l); beginning 2 min before fixation we increased the perfusion pressure to 
150mmHg and maintained it at that level during the fixation period. The fixation solution 
was a 1.25% glutaraldehyde, phosphate-buffered salt solution at pH 7.1 with 6% HAES as a 
colloid. Why the colloid additive? Our first fixation done without colloid but under normo-
thermia, revealed that the abrupt drop in the colloid-osmotic pressure to zero leads to a 
drastic increase of the perfusion resistance, thereby delaying and hampering the fixation. 
The addition of HAES (hydroxyethyl starch) improved fixation quality significantly and thus 
allowed us to establish this model (s.a. the morphological study: (263)). 
 ͳʹ
 The kidneys were stored together with their double-barreled aortic cannula at 4°C in a 
special designed custom-built acrylic glass box, until used for reperfusion days or even 
weeks later, s.a. Fig 5.4.1.- 5.4.4. (50-53, 78, 266, 317). 
3. Advantages and general limitations of in-vitro perfusion 
of the mammalian kidney 
Blood perfused organs in vivo are usually exposed to an oxygen pressure that barely 
exceeds 100mmHg. Hemoglobin, the oxygen-transporting pigment of erythrocytes is fully 
saturated at 100mmHg and the mechanisms that dispose of reactive oxygen species are 
designed to cope with this oxygen pressure (191). Conversely, the organism has strategies 
that help prevent or adapt to short- and long-term oxygen deficiency. The pressure ampli-
tude of oxygen in vivo is below 100mmHg; in vitro it is higher when a partial pressure of 
95% of oxygen is used for equilibration. The demonstration of a preglomerular arteriove-
nous shuntdiffusion leads to the assumption that peaks are smoothened so as to mitigate 
oxygen intoxication (72, 185, 260). If a kidney is subjected to cell-free perfusion in vitro, an 
adequate oxygen supply can be provided (within limits), if the perfusate is saturated with 
95-100% oxygen, but this leads to much higher amplitudes of the oxygen pressure than are 
attained in vivo. This is the only way to supply enough oxygen to the organ in dissolved 
form. An organ like the kidney is pervaded by a complex network of blood vessels, such as 
countercurrent exchanger within its vascular tree in cortex and medulla. There are areas 
which are particularly prone to injury owing to oxygen deficiency, despite the high level of 
oxygen in the venous perfusate. After a short period of time one can find morphological 
defects in S3-segments of the proximal tubule and the TAL-segments, which are distant 
from the vascular bundles of vasa recta (7, 263). The reason for the much higher depletion 
of oxygen in this area compared to the whole kidney is that the blood supply derived from 
the renal medulla is already low in oxygen, which has been extracted by shunt-diffusion in 
advance before. The addition of 5-10% of washed erythrocytes are sufficient to prevent 
these lesions at short term (hours, when equilibrated with 95% O2) (263). Whereas in vivo 
the whole kidney takes up only 8% of the oxygen supplied, in the cell-free perfused kidney 
at high partial pressure this figure reaches 50%. Furthermore, in the outer medulla, the 
oxygen extraction level in vivo is much higher - reaching approximately 80%. What then can 
be expected in vitro, even though a cell-free perfusate provides for significantly higher 
medullary perfusion than is attainable in vivo? Brezis derived the in vivo 80% oxygen 
extraction ratio based on the calculations of Julius J. Cohen (39, 56), so one can assume 
that oxygen deficiency is inevitable in vitro. Another feature of cell-free perfusion is that 
amplitude differences in pCO2 and pH between arterial and venous perfusate are 
considerably higher than in vivo, although they are significantly dampened if erythrocytes 
are present, due to their high transport capacity for CO2/HCO3 and the presence of carbonic 
anhydrase, plus the buffering capacity of hemoglobin and plasma proteins. This difference 
relative to the in vivo situation will at least result in a disruption of homeostasis, although 
the functional significance of this perturbation remains to be clarified. 
 
Under in vivo conditions, there is a significant increase in the colloid osmotic pressure 
COP along the filtering glomerular capillaries (Fig. 3.0.1). In vitro the perfusion rate is higher 
by a factor 4-15 (depending on the colloid) compared with the flow of plasma in vivo at a 
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comparable GFR. This means that there is little increase in COP along the capillaries and, 
unlike the case in vivo, at a starting COP of around 20mmHg there is no significant change 
within the post capillary vascular bed, as it occurs in vivo, which is important for the uptake 
of the reabsorbate (88, 312). This partly explains why the fractional sodium reabsorption 
and the reabsorption of fluid do not attain in vivo values. If, however, a higher concentra-
tion of albumin is used, mimicking the protein concentration expected in the postglomeru-
lar vascular bed surrounding early proximal tubules, the fractional sodium reabsorption is 
higher, but the GFR does not reach in vivo values nor the values seen in experiments with 
5g% albumin (34, 152, 251). At all events, the choice of a high COP for perfusion (7-7.5g % 
albumin) and acceptance of a reduced GFR is a good compromise with respect to main-
taining the stability of the preparation and is especially suitable for the recirculation mode. 
To compare the reabsorption capacity at a comparable GFR we used verapamil at a high 
COP (albumin >7,5g %) to dilate the vas afferens and thus the GFR could be enhanced to 
the level of an albumin 6g % experiment. This shows that the absolute (TNa) and the 
fractional sodium reabsorption is comparable at a high or normal COP. A high fractional 
sodium reabsorption can be reached in vitro only with reduced GFR, providing further 
evidence that the model does not reach the in vivo levels of efficiency and performance 
(see Tab. 11.1.1., Fig. 10.1.12, Fig. 10.1.19) (251). These deficits may be attributable to the 
fact that the in vivo oxygen supply is optimized and to the differences concerning the 
endothelial surface layer (204). 
What might account for the striking difference between the plasma flow in vivo and in 
vitro perfusion rate? It is in part due to the viscosity of the cell-free albumin solution, which 
is significantly lower than that of blood plasma or any other plasma substitute. The other 
major contributory factor is the lack of vasoactive hormones - catecholamines, angiotensin 
II or its precursor angiotensin I, which is produced by the action of renin on angioten-
sinogen - and it affects the perfusion of the kidney cortex as well as the medulla. Perfusion 
of the renal medulla in vivo is facilitated by a reduced dynamic hematocrit (318) and 
regulated by hormones such as arginine vasopressin (AVP) (319) and a complex variety of 
other factors (68) which may not play any significant role in the IPRK.  
The most effective and complex vasoactive hormone in the kidney seems to be the 
endothelin system (126). The latter has consequences for the concentrating ability of the 
IPRK. The high rate of perfusion of the medulla precludes the preservation and build-up of 
steep osmotic gradients between renal cortex and medulla. This, however, does not mean 
that the antidiuretic hormone AVP has no effect. Measured as free water reabsorption, it is 
possible to demonstrate the effect of AVP upon the incorporation of AQP2 into the luminal 
membrane of the collecting duct both physiologically and by fluorescence-labeled anti-
bodies (Fig. 3.2.). 
 ͳͶ
Definitions of Osmotic Clearance, Free Water Clearance and Free Water Reab-
sorption: 
   
Osmotic Clearance: CαUȀPήǚ  
 
The Free Water Clearance CH2O is the Free Water Reabsorption TH2O is  
calculated as follows: urine time volume calculated as follows: osmotic clearance and  
and osmotic clearance urine time volume 
 
 CH2O = ǚ  – Cosmol  TH2O = Cosmol – ǚ  
 
 
As shown below and in the chapter “Comparison of Results” the differences between 
the in vivo kidney and the isolated perfused kidney with respect to concentrating and 
diluting capacity result from the high perfusion rates within the renal medulla that accom-
pany cell free perfusion, which are incompatible with the build-up of an appreciable con-
centration gradient. By adding washed erythrocytes, U/Posmol gradients of at least a factor 
of 4 can be achieved, as Lieberthal showed in 1987 (145, 146). The fact that the capacity to 
concentrate and dilute urine is available, but cannot be realized due to the lack of the 
concentration gradient between cortex and medulla, is not reflected in terms of free water 
reabsorption or excretion. What might be the reason for the discrepancy between the 
concentrating capacity of the in-vivo kidney of the rat - which may reach a U/Posmol quotient 
of 10 - and the preparation of Lieberthal, which manages a ratio of 3-4 with a hematocrit of 
45% (with washed erythrocytes)? Most probably it is the difference of the rate of perfusion 
in the renal medulla, which is likely to be higher when a semisynthetic perfusate with 
albumin and washed erythrocytes is used instead of blood, which exhibits a much higher 
plasma viscosity. Fibrinogen, for instance, contributes with 0,3g/dl as much to viscosity as 
4g/dl albumin. Of course, vasoactive factors, such as catecholamines, prostaglandins and 
peptide hormones like angiotensin, endothelin (126), ADH etc., certainly make a contribu-
tion also (68, 319). Within the inner stripe of the outer medulla, the concentration of the 
receptors for angiotensin II and prostaglandin E2 are particularly high (38). 
 
We still know very little about whether and how e.g. endothelin acts as a highly potent 
vasoconstrictor in the isolated kidney. In principle, the endothelium itself synthesizes and 
secretes endothelin. Natriuretic endothelin receptors are found in highest densities in the 
area of collecting ducts (126). To me it seems noteworthy that the constancy of flow in the 
isolated kidney is higher when the perfusate contains only the standard eight amino acids 
rather than all 20 amino acids. We have not studied this issue systematically, either with 
endothelin antagonists or with receptor antagonists.   
ͳͷ
Fig. 3.0.1.:Idealized profile of the colloid-osmotic pressure COPalong the nephron.
Comparison of in-vivo results (solid line) with those for the cell free perfused isolated 
kidney using two different concentrations of albumin (5g and 7,2g/dl). Original drawings 
taken from (250) and based on published data (251). 
Fig. 3.0.1 shows the marked differences between in-vivo and ex-vivo perfusion schema-
tically represented by the course of the colloid osmotic pressure along the nephron. These 
differences first become manifest along the glomerular capillaries. In the rat, the COP 
increases sharply from 19.3 to 33.7mmHg at a filtration fraction of 30%, while in cell free 
ex-vivo perfusion the filtration fraction reaches less than 3%, whether perfusion is perfor-
med with a normal or enhanced BSA concentration. In the further course, the high 
postglomerular COP is more than sufficient to take up the reabsorbate from the proximal 
tubule in vivo. Cell-free in-vitro perfusion is unable to do so: the postglomerular COP is 
either too low - as in the case of “normal COP” of the perfusate with of 5g% albumin - or it 
is excessive at 7,2g% as specified in this scheme.  
In Fig. 3.0.2, the schematic representation is limited to the change in pressure along 
the glomerular capillaries. Under in vivo conditions, there is a variable hydropenia, whereby 
filtration equilibrium is reached after only half of the capillary length, in the second variant 
at the end of the route. In comparison, the in-vitro situation is much simpler and there is no 
need for complicated calculations. 
ͳ͸
Fig. 3.0.2.: Relative contributions of the driving forces of filtration at the single-
nephron level in vivo and in vitro. Only in the in-vivo case is equilibrium reached at 
normal or reduced extracellular space. In the in-vitro situation perfusion flow rates are ten 
times higher and the filtration fraction is an order of magnitude lower at comparable GFR. 
Accordingly, the COP changes dynamically along the capillaries in vivo, but not in the in-
vitro perfused preparation. This difference makes the IPRK ideal for the analysis of glome-
rular filtration dynamics with the aid of the micropuncture technique (181, 182, 184, 267). 
Pt: tubular pressure, ʋa: colloid-osmotic pressure, RPF: renal plasma flow or perfusion flow 
rate, FF: filtration-fraction. 
Finally, Fig. 3.0.3 depicts the salient parameters in three dimensions along the glome-
rular capillary length with the effective filtration pressure efp on the ordinate, the capillary 
length on the abscissa and the plasma - or perfusate - flow rate Yȩ  on the Z-axis. The condi-
tions prevailing in-vitro are depicted in the foreground, with high perfusion flow rates at 
essentially constant efp along the capillary length. In the background we see characteristics 
of the in-vivo condition, with plasma flows in the 70-120nl/min range. Here too, a variant in 
which the filtration equilibrium is already attained after half the capillary length is shown, 
together with further unrealistic variants.  
William J. Arendshorst from Chapel Hill has published a detailed discussion of issues 
relevant to filtration dynamics under in vivo conditions (9, 10).  
ͳ͹
Fig. 3.0.3.:Effect of changes ǚ ȋȀȌn the efp profile 
along the length of the glomerular capillaries. The effective ultrafiltration pressure efp 
hardly changes along the capillary length in the IPRK, in contrast to the in-vivo situation, 
where very clear changes in plasma flow are observed. In vivo, the plasma flow Yȩ  at the 
single nephron level in the rat ranges from 70 to a maximum of 120nl/min. In vitro, however, 
the perfusion flow rate is around 10 times higher (Z-axis), so that the tenfold lower filtration 
fraction implies that the entire filtration area is fully available even under physiologically very 
simple conditions. Filtration equilibrium is not reached by the end of the glomerular 
capillaries e.g. as observed in hydropenia in vivo; see also Fig. 3.0.1., 3.0.2. The diagram is 
taken from our own work (250).  
ͳͺ
3.1. Flow-constant versus pressure-constant perfusion 
For biochemical and pharmacological studies, the simpler flow-constant perfusion is of-
ten preferred and depending on the specific course of the perfusion resistance, increasing 
perfusion pressure will generally promote self-regulation. The higher albumin concentra-
tions used, as well as in-line filtration, contribute to the stability of this preparation, as do 
the lower GFR at a high albumin concentration and the associated reduction of the work-
load (33).  
Pressure-constant perfusion is the preferred variant for use in the analysis of hemody-
namics or hydrodynamics of the tubular system. For this purpose, it is, however, necessary 
to use a more sophisticated apparatus for pressure measurement within a double-barreled 
cannula and to provide for feedback regulation of the peristaltic pump and a damping of 
pulsatility by means of a surge tank and (optionally) electronic damping. A stable prepara-
tion is a prerequisite for micropuncture experiments and therefore we preferred to use the 
third perfusion mode (recirculation plus dialysis) for this purpose. We used a substrate-
enriched Krebs-Henseleit BSA solution with or without 5% erythrocytes, which is constantly 
regenerated and gassed over a larger volume of dialysate, essentially employing the dialy-
zer as “dialung or kidney-lung”. This permitted experiments to be carried out under ade-
quately stable conditions for periods of 2-3 hours (181, 182, 184, 251, 267).  
3.2. Concentrating and diluting capacity 
Whereas rat kidneys can concentrate urine by factor 4-10 relative to blood, this is not 
feasible by cell-free perfusion of the kidney, even when high doses of antidiuretic hormone 
(arginine-vasopressin) or (1-deamino)-D-Arg-vasopressin (dDAVP) have been used. This is 
largely due to relatively high in-vitro perfusion rate of the renal medulla. The in-vivo rate is 
much lower owing to the presence of erythrocytes, which have to negotiate the long vasa 
recta and also retard the flow rate because of the multiple branching, thus enabling the 
build-up of steep osmotic gradients. Another crucial factor may be the uptake of urea by 
transport proteins in the medullary collecting duct and in the cell membranes of erythro-
cytes, which probably contribute to the high accumulation of urea in the renal medulla. 
Erythrocytes can quickly take up urea via these transport proteins in a position-dependent 
manner and rapidly deliver it to the medulla (121, 228-230, 297). Since the discovery of 
urea transporters in individual sections of the loop of Henle (178, 229), the passive model 
of urine concentration propagated by Kokko and Rector (127) is no longer tenable. 
Thick ascending limbs known to be the core (or motor) of the concentrating mechanism 
are thought to suffer from oxygen deficiency especially in the interbundle region under cell 
free perfusion. These TAL-segments are found in cortical and mid-cortical nephrons, 
whereas TAL-segments of juxtamedullary nephrons surround vascular bundles directly and 
thus benefit from a radial oxygen diffusion and, if necessary, can increase their GFR 
accordingly. It should be noted that even those S3-segments of the proximal tubule, which 
lie in the interbundle area next to the affected TAL´s are damaged too (263).  
In terms of the attainable level of free water reabsorption or free water clearance, no 
significant differences from the in vivo situation are observed in the steady state phase 
during the first hour (publication in preparation). This argues that the function of the 
collecting ducts (CD) remains intact during this time. Fluorescence-labeled antibodies have 
ͳͻ
revealed the insertion of AQP2 into the luminal membrane of the collecting duct under AVP 
administration and its relocalization into the cytoplasm after AVP withdrawal (125, 262). 
Within 10 mins after starting single pass perfusion without AVP, osmolality of urine drops 
below the osmolality of the perfusate and the excretion of free water begins. Addition of 
AVP results very quickly (within 10 min) in a rebound in osmolality and Fig. 2c demonstrates 
that, at higher doses of the hormone, AQP2 is incorporated not only into the luminal 
membrane but also into basolateral membranes. The latter was detectable under in-vivo 
conditions only after considerable effort and required the use of additional stimuli, such as 
long-term treatment with aldosterone (64). Baines and Ross have pointed out that non-
oxidative metabolism of glucose plays an essential role in modulating the dilution capacity 
of the urine by the collecting ducts (17), a view discussed by Julius J. Cohen earlier on (54). 
Lieberthal et al. demonstrated the dominant role of erythrocytes in enabling a high concen-
trating ability in the isolated perfused kidney, when they added increasing amounts of 
washed bovine red cells up to 45% hematocrit (145, 146). Nonetheless, the highest 
concentration of urine attained in their experiments required blocking of prostaglandin 
synthesis in the presence of dDAVP, and amounted to 1200mosmol/l - not the 
3000mosmol/l seen in antidiuresis in vivo. 
The isolated kidney perfused by a cell-free medium can reach a U/Posmol of 0.5-0.6 as a 
minimum equivalent to a Uosmol of approximately 160mosmol/kg H2O. By addition of 
arginine-vasopressin (AVP) or desmopressin (dDAVP) a U/Posmol of 1.1 – 1.2 can be reached, 
while adding erythrocytes has a much greater effect, as discussed above. Specifically, it 
depends whether AVP is administered from the beginning of perfusion and subsequently 
withdrawn, or withdrawn immediately after the start of perfusion. We have studied these 
issues over the last few years and the data are being prepared for publication (262).  
ʹͲ
Fig 3.2.a, b, and c: Distribution of 
fluorescence-labeled AQP2 in the 
IPRK, a) After withdrawal of AVP 
(green) AQP2 becomes diffusely distri-
buted in the cytoplasm. b) Upon expo-
sure to physiological levels of AVP, it 
localizes predominantly in the luminal 
membrane and at an order of magni-
tude higher AVP dose (c), fluorescence 
is also detectable in basolateral mem-
branes. The data are from short-term 
experiments on the isolated perfused 
rat kidney (IPRK). Cell nuclei are labe-
led in blue.  
 These data were presented in 2011 at the 90th Congress of the “Deutsche Gesellschaft 
für Physiologie in Regensburg (262) and can be found in the PHD thesis of Jens Klokkers 
(125), doctorate to Dr. rer. nat. in the year 2010 in the Department of Biology at the 
Mathematics and Natural Sciences Faculty of the University of Münster. 
ʹͳ
3.3. The permeability of albumin in the IPRK and 
the “repaired defect” hypothesis 
In the initial experiments on the isolated rat kidney, carried out by Brian D. Ross and his 
group, they found an increased excretion of protein in the urine of the kidneys perfused 
with BSA, with levels of 3-5,3mg protein/ml urine at a quite low GFR of 150ђl/min·g kidney 
(wet weight), measured as clearance of creatinine (185). They went on to state that 
“proteinuria was somewhat high, but this is of limited significance since the rat kidney in 
vivo excretes injected bovine albumin” (150, 151). We have worked intensively on these 
issues (194, 244, 245, 248, 252, 266, 291, 292). The following figures illustrate our principle 
findings, which led to the “repaired defect” hypothesis (244). 
Fig. 3.3.1.: Albumin levels at the early 
proximal tubule in vivo and in vitro. 
Fluid was withdrawn from early proximal 
tubuli by micropuncture. Albumin levels 
in nl samples were estimated by staining 
and densitometric analysis of band areas 
after ultramicroscale-discelectrophoresis 
in microcaps (Joyce-Loebl two-beam 
microdensitometer). Control values were 
obtained from rat kidneys exposed in 
vivo during Inactin anesthesia. In-vitro 
values were measured in the isolated 
kidney perfused with two different con-
centrations of albumin (3 g% & 5 g%). 
The column on the right demonstrates a 
further increase of the albumin concen-
tration in the early proximal tubuli, after 
the pressure of the venous outflow had 
been increased to 20cm H2O.  
AlbuminEPT = early proximal tubuleǤ
Michael Weiner pointed to the fact that BSA is not identical to rat albumin. This cer-
tainly holds for the number of negative charges, while the size and shape of these mole-
cules are nearly identical (247). According to Peters, the BSA molecule carries 17 negative 
charges compared to 12 in rat albumin (203). If negative charges hinder glomerular pas-
sage, as one would expect, rat albumin should have an easier passage under in vitro con-
ditions than BSA. Thus, the effect tends to be underestimated. Another factor is that albu-
min acts as a transport molecule for lipids and water-soluble substrates, and exists in diffe-
rently charged states in vivo which may not be directly comparable to those of the mole-
cules as used in vitro. We have not performed a rigorous delipidation of albumin with acti-
vated carbon but subjected the protein to intensive dialysis. Aliquots were then stored at 
-20°C until use. Recently a functional test for albumin has been developed (s. chapter 9.8.).  
ʹʹ
In order to determine the precise timepoint of the increase in proteinuria during the 
in-vivo to in-vitro transition, we first measured the protein levels in urine collected from 
the animal´s metabolic cage. The second sample was obtained during anesthesia as 
ureteral urine from the kidney that was subsequently perfused. Immediately prior to the 
transition period, the urinary flow rate was increased by mannitol. Fig. 3.3.1 is modified, 
and is derived from the work of Horst Pagel in our laboratory in Hanover.  
Fig. 3.3.2.: Clearance-  Ȁ    
from in-vivo to in-vitro conditions. The initial values on the negative timescale were 
obtained from urine samples taken from the animal´s metabolic cage. The following values 
before zero time are for samples obtained during barbiturate anesthesia, and the values 
just before the transition were obtained following mannitol diuresis to raise the urine 
volume sufficiently to enable an early data recording after the transition to in-vitro 
perfusion (modified from Pagel (193, 194)). The clearance-quotient for total protein is 
higher than that for albumin in the early in-vitro phase. Shortly thereafter it equalizes, 
when the washout period ends and the albumin in the perfusate is the only remaining 
colloid.  
 The addition of 5% erythrocytes from the beginning reduces the clearance ratio for 
albumin by half, and this value remains stable over the further course of the experiment. In 
contrast, the clearance ratio continues to rise with time in the absence of erythrocytes. 
Swanson has shown, that even after later addition of red cells prevents any further increase 
in the clearance ratio (293). Hence, the question is how to explain this phenomenon. The 
study of this issue has led me to the hypothesis that in-vitro perfusion with cell free media 
unmasks membrane defects that facilitate the passage of albumin. The larger defects can 
be blocked by the passage of erythrocytes, while the smaller ones support the high residual 
excretion of albumin (244).
ʹ͵
Fig. 3.3.3.: Clearance ratio for 
albumin in the IPRK without and 
with addition of red cells. Signifi-
cant reduction of the clearance ratio 
at a comparable GFR, (group I and 
IV). The difference is even more ap-
parent in the collective with albumin 
and addition of globulin (group II and 
V) (193, 194).
The following figure comes from the 
study by Swanson (293) and is re-
produced by permission of the APS.  
Fig. 3.3.4.: Calculated concentration of albumin in the ultrafiltrate in three study 
groups. 
1. Perfusate with albumin and red cells (ARC)
2. Time-delayed addition of red blood cells (RBC) and
3. Albumin solution without red blood cells (A only)
ʹͶ
Only with a larger number of micropunc-
ture samples (n = 98) did it become clear 
that a skewed frequency distribution 
exists. Many findings were in the range 
of in vivo values, but approximately 16% 
of the samples lay in a significantly hig-
her range. This supports the assumption 
that only this small fraction of glomeruli 
exhibit significant leaks or defects, which 
are unmasked under the conditions im-
posed by cell-free perfusion, but are sea-
led by erythrocytes. In order to obtain 
valid data, micropuncture samples from 
early proximal tubules were collected un-
der pressure control using the “Berlin” 
system of a microperfusion pump com-
bined with a miniature pressure mea-
surement system (154), s.a. chapter 13.  
Fig. 3.3.5.: Frequency distribution of the concentration of albumin in early 
proximal micropuncture samples. The small insert are normal findings from in vivo 
studies in rats (69). In 17 of 22 samples values were below 1.5 mg%; in the other 5, levels of 
up to 3 mg% were recorded. Under the influence of angiotensin infusion, a rightward shift 
of the frequency distribution occurs, as it exists on the isolated perfused kidney without 
any infusion.  
 Infusion of angiotensin II into the IRPK does not increase the level of proteinuria (296). This 
could be a basis for the understanding of functional proteinuria during exercise, orthostasis, 
fever and congestive heart failure, all of which can be assigned to the so-called non-selective 
type of proteinuria and can be blocked by ACE inhibitors (30, 104, 248, 249, 258, 266).  
Is there a correlation between proteinuria and erythrocytes in the 
IPRK?  
 The “repaired defects” hypothesis, first formulated in 1986 based on the observation 
that cell free perfusion with BSA as a colloid immediately leads to bleaching of the kidney. 
However, microscopic examination revealed the presence of hematuria in the urine sedi-
ment for up to 60 minutes after the start of the perfusion. The decrease in the red cell 
number followed an exponential course (244). If red cells were added to a level of 5%, the 
hematuria leveled off at approximately 100 red cells/min during the second hour of 
perfusion – a factor of 100 higher than that seen in in-vivo studies of urine collected in the 
metabolic cage. Viktor Repp supplemented these test series in his thesis work (218) and 
demonstrated, that perfusion in the single-pass mode without a colloid led to even faster 
excretion of red blood cells compared to perfusions with BSA, presumably due to the 
higher glomerular filtration and urinary flow rates. If one calculates the total number of 
excreted erythrocytes, one gets a figure of 0.5-1.0·106 cells that find their way via the 
glomerular capillaries into the final urine (calculated from the area under the curve). 
Converted to 30.000 glomeruli per single kidney, this amounts to 17 to 34 red blood cells 
ʹͷ
per glomerulus that escape through the endothelium of glomerular capillaries via transient 
defects that are otherwise occluded by erythrocytes. What they left behind is the higher 
albumin permeability with BSA in the perfusate, which in turn can be reduced by adding 
sealing erythrocytes (see Figs. 3.3.3. and 3.3.4.). The remaining level of proteinuria is still 
much higher than in vivo. The added erythrocytes therefore occlude only larger defects (ш 
200nm). Under in vivo conditions, whole blood can seal defects in a variety of ways. Cellular 
elements, such as erythrocytes and leucocytes, can plug larger leaks, and are supplemented 
by platelets in combination with clotting factors, proteins like orosomucoid and the so-
called “sieve plugs”, which correspond to a functional lining of the fenestrations of the 
endothelium of the glomerular capillaries by glycocalyx. These “sieve plugs” are no longer 
discernible following conventional perfusion fixation and can be detected only with special 
procedures. They can also be disturbed functionally by hemodynamic perturbations such as 
the infusion of angiotensin II. This could explain many forms of functional proteinuria as 
well as forms of permanent or functional hematuria (glomerulopathy of thin basement 
membrane, higher basic hematuria in children relative to adults – due to a thinner basal 
membrane). Functional proteinurias induced by fever, orthostasis, load, stress or 
angiotensin II, are unselective proteinurias, and thus based on larger defects as they are 
needed for the passage of albumin. Experiments with dextrans of varying size have shown 
that there is a shift toward permeability to the larger dextran molecules upon infusion of 
angiotensin II (31).  
Fig.: 3.3.6.: Schematic representation of the “sieve plugs” from a review by Boerje 
Haraldsson (97). The function of orosomucoid was discovered by chance in studies with a 
preparation of human albumin, which was contaminated with orosomucoid (98). Repro-
duced by permission of the author and APS. 
Shedding of the glycocalyx of the endothelial cells of capillaries is a functional and 
reversible mechanism, induced by hemodynamic stress or other procedures, that has been 
discussed in a number of studies and reviews (85, 97, 166, 170, 204, 208, 217, 231, 301, 
302). An intact glycocalyx and the integrity of its functional surface layer seem to be 
essential for the physiological barrier function of the vascular endothelium of capillaries, 
and are even more important for glomerular capillaries due to their higher endoluminal 
perfusion pressure.  
ʹ͸
IPRK-based studies of the importance of negative charge on the 
glomerular basement membrane. 
The sieving characteristics for macromolecules in the IPRK undergo dynamic 
alterations, which differs significantly from the in vivo conditions. To grasp the significance 
of the negative charges on the penetration of negatively charged macromolecules we have 
used different perfusion techniques. Use of the polycation protamine chloride to neutralize 
negative charges leads to a strong vasoconstriction, which can be abrogated by verapamil. 
Whereas the baseline permeability for albumin in the IPRK is higher than that in vivo by 
factor 10-20, addition of protamine chloride causes a progressive further increase to 100 
times that observed in vivo (11, 12, 284, 285). When we repeated this study in the 
reperfused, anatomically fixed kidney, we saw only a slight increase in permeability. The 
complexing polycation causes no significant ultrastructural changes in the glomerular 
capillary wall once the collagen scaffold of the GBM has been crosslinked by fixing. Without 
this crosslinking, negative charges can be clustered by the polycation, leaving large 
uncharged regions between them (78). Using this model of the fixed and reperfused kidney, 
we were able to study perfusate with BSA at different pHs or perfusate supplemented with 
a chemically cationized albumin (317). The latter increased the permeability by a factor of 
2, while reducing the pH from 7.4 to 4.0 did so by a factor of 8. In the same study several 
different size classes of dextran were used, and protamine was found to increase 
permeability for the T110 molecular weight class alone -- by a factor of 2.5 (317). We 
published further findings using this model in the years 1999-2003 (50-53) to demonstrate 
the potency of such an experimental model.  
The data given by Swanson (293) regarding the increase of the clearance ratio for 
albumin over time when a cell-free perfusate is used and a stable situation by added red 
cells are qualitatively equivalent to our own experiences. This relates to the addition of 5% 
red cells. Thus, the otherwise morphologically detectable damage to TAL-segments and 
proximal S3 tubules is missing. Viktor Repp demonstrated in his thesis (218) that, during 
cell-free perfusion, epithelial cells or fragments of them could be detected in the sediment 
of the urine as early as 30 min after the start of perfusion. This is a reflection of hypoxic cell 
damage and the addition of red cells suppresses these defects. The minimum level of 
supplementation with red cell addition required to suppress cell damage is not yet known. 
We have never used less than 5%; however, it is conceivable that 2% is sufficient (see 
contribution of Frank Schweda chapter 14). At 5% red cells, the combination of reduced 
oxygen capacity and presumably much higher flow rates in the renal medulla may be 
sufficient to prevent hypoxic damage. An interesting contribution from the Oxford group 
demonstrated the high susceptibility of the proximal tubule to oxygen deficiency, when 
hypoxia is limited to prevent TAL-damage (70), see also Chapter 12.3.  
Whereas Boyce and Holdsworth (36) stated: “the demonstration that the glomerular 
filter in the IPK has a normal negative charge barrier indicates that the increased protein 
excretion in IPK systems cannot be attributed to abnormalities of this component of the 
filtration barrier”, another Australian group (295) discussed a relative deficiency of oxygen 
radical scavengers. Addition of mannitol, superoxide dismutase, catalase and a pretreat-
ment of the donor animal with allopurinol prevented the increase of the clearance-ratio for 
albumin as it was shown by Swanson only by the addition of red cells (scavenger function?), 
comparable to our own experience.
ʹ͹
4. Perfusion techniques
4.1. Perfusion medium
4.1.1. Salt solutions
The most common basic salt solution now used in kidney perfusion is the Krebs-
Henseleit type. Other formulations (Tyrode or Ringer solution and their variants) are solely 
of historical interest in this context; in particular, phosphate buffer has been entirely 
replaced by bicarbonate buffers, which require continuous input of 5-6% CO2. Table 1 gives 
the composition of the original Krebs-Henseleit, together with the substrate-enriched 
variant that we use. 
Table 4.1ǣ Compositions of the original Krebs-Henseleit salt solution and two 
modified versions ȋȀȌǤ ȗThe concentration of chloride, but not that of sodium, is 
reduced when substrates are added. Calcium concentrations are given as total calcium and as 
ionized Ca++. Measured levels of ionized calcium are usually lower than theoretically expec-
ted. When perfusate is dialyzed continuously, [Ca++] remains stable at a low level, even when 
the albumin concentration increases (depending on dialysis conditions, see Fig. 9.6.1.).  
Composition NaCl Na+ Cl* K(Cl) Ca(Cl2)/Ca2+ MgSO4 Mg(Cl2) NaHCO3 HCO3 NaH2PO4 KH2PO4 glucose urea 
Krebs-
Henseleit 118 4.7 2.52 1.64 24.88 1.18 5.55 
Modified 140 109 5 2.0 / 0.9 1 25-27 0.72 8.4 6 
Substrate-
enriched 140 105* 5 2.5/0.9 1 (0,8) 25-27 0.72 8.4 6 
4.1.2. Addition of substrates 
The addition of various metabolic substrates/intermediates of glycolysis or the Krebs 
cycle, of long- or short-chain fatty acids (such as butyrate) and amino acids enhances rates 
of tubular transport and increases oxygen consumption. Moreover, it functionally stabilizes 
the preparation, and this observation has led to the use of various substrate mixtures as 
supplements (25, 71, 256, 257, 264).  
Table 4.2ǣ Substrate additives. Recipe 1 (R1) has been used since 1972, and was first 
described in 1975 (257). Note that the glucose level was raised to 8,4mmol/l. R2 has been 
used since 1985 (263), ɲ-ketoglutarate and malate since 1986 (242), butyrate is used when 
required (246). 
R1 Glucose Pyruvate Lactate Glutamate Oxaloacetate 
mmol/l 8.4 2 2 2 1 
R2 Glucose Pyruvate Lactate Glutamate* Oxaloacetate Ketoglutarate Malate Butyrate Cystein Glutathione Carnitine 
mmol/l 8.4 0.3-2 2 1.6 1 1 1 1 0.5 0.5 0.1 
ȗHalve of the glutamate is contained in the amino acid mixture. Pyruvate, glutamate and
butyrate are added as sodium salts. Lactic, oxaloacetic, ketoglutaric and malic acids are 
added in their acidic forms, and upon dissociation the protons are exchanged for cations 
from sodium bicarbonate, thereby producing a high initial pCO2 in the dialysate (see 
preparation of perfusate). 
ʹͺ
Table 4.3.ǣSupplementation with amino acids. A 10% amino acid solution (Aminoplas-
mal AS10; Braun, Melsungen Germany) is added to a final concentration of 0.05-0.1% (0.5-
1ml in 100ml basic solution). In earlier experiments we added only eight amino acids (251) 
first used by DeMello and Maack (63) in 1976. Then in 1982 the Epstein group published 
their results with the full spectrum of amino acids (71). 
Recipe 1 is from Bowman and Maack (1972) with 6 amino acids (35). 
Recipe 2 is from DeMello and Maack (1976) with eight amino acids, which we also followed 
ȋ͸͵ǡʹͷͲǡʹͷͳȌ. 
Recipe 3 with all 20 amino acids was recommended by Epstein in 1982 ȋ͹ͳȌ. 
Recipe 4 is a modified version of R3, which we have used since 1982 (243, 263). The small 
amounts of citrate and acetate result from the use of the Genius System for batch 
preparation of the basic solution, which we adopted in 2007 (see 4.1.3.: Preparation of 
perfusate). 
R1 amino acids Met Arg Ala Gly Asp Ser 
mmol/l 0.5 1 2 2 3 2 
R2 amino acids Ile Met Arg Ala Gly Asp Pro Ser 
mmol/l 1 0.5 1 2 2 3 2 2 
R3 amino acids Ile Leu Lys Met Phe Thr Trp Val Arg His Ala Gly Asp Glu Pro Ser Tyr Cys Gln Asn 
mmol/l 0.3 0.4 1 0.33 0.32 0.24 0.07 0.33 0.5 0.24 2 2.3 0.2 0.5 0.31 1 0.2 0.5 2 0.2 
R4 amino acids Ile Leu Lys Met Phe Thr Trp Val Arg His Ala Gly Asp Glu Pro Ser Tyr 
mmol/l 0.38 0.68 0.67 0.3 0.28 0.35 0.08 0.53 0.66 0.2 1.18 1.6 0.42 0.49 0.48 0.22 0.02 
other citrate acetate 
substrates 0.05 0.66 
*For the production of the basic electrolyte solution, we used the Genius System for the
first time in 2007; thereby it came to the addition of citrate and acetate at a low concentra-
tion. 
 Glutamate, cysteine and glycine are precursors of glutathione, and their inclusion helps 
to maintain the starting level of reduced glutathione. However, only the addition of the full 
spectrum of physiological amino acids results in an overall improvement of functional 
parameters ȋ͹ͳȌ, albeit at the price of a reduction in glomerular filtration rate. 
Special note: The recipe successfully employed in our experiments during the years 1975 – 
1982/85 (see below) was based on the use of a batch of BSA obtained from Reheis/Armour 
in USA, sterile water supplied by the hospital’s pharmacy, and the sterile concentrated salt 
solutions used in intensive-care units (ICUs). This was supplemented with the eight amino 
acids used by Thomas Maack’s group ȋ͸͵Ȍ, a mixture of substrates (glucose, oxaloacetic 
acid, pyruvate, lactate and glutamate) that was first used during my time in Berlin (prior to 
1975) (257), and an amount of calcium calculated to be equivalent to a level of 1.25 mmol/l 
in the dialysate (see below). All tools and containers used during the preparation of the 
solution, such as pipettes and glass vessels, had previously been sterilized by dry heat. The 
tubing of the perfusion apparatus was sterilized with ethylene oxide and stored in sealed 
bags of paper/transparency foil. Metal and glass parts were sterilized by dry heat. This 
careful attention to detail paid off, and was essential for maintaining the stability of the 
preparation during the time-consuming micropuncture experiments (181, 182, 184, 245, 
250, 252, 266, 267, 290-292). 
ʹͻ
Composition of the perfusate during the period 1975-1982 
A. Dialysate for the preparation of the BSA stock solution (BSA powder was dissolved in 
dialysate, then dialyzed against it, and stored as 10% BSA in 100-ml aliquots) 
Na 140 mmol/l Cl 123 mmol/l 
K 5 mmol/l HCO3 25 mmol/l 
Ca 1.25 mmol/l HPO4 0.72 mmol/l 
Mg 0.6 mmol/l Neomycin-sulfate 10 mg/l 
B. Solutions for the perfusion & dialysis of the perfusate (final concentration) 
Perfusate (100-250ml) Dialysate (2000-5000ml) 
Na 140 mmol/l 140 mmol/l 
K 5 mmol/l 5 mmol/l 
Ca 2.5* mmol/l 1.25* mmol/l 
Mg 1 mmol/l 0,6 mmol/l 
Cl 104 mmol/l 104 mmol/l 
HCO3 25 mmol/l 25 mmol/l 
HPO4 0.72 mmol/l 0.72 mmol/l 
Urea  6 mmol/l 6 mmol/l 
Glucose 8.3 mmol/l 8.3 mmol/l 
Na-oxaloacetate 1 mmol/l 1 mmol/l 
Na-pyruvate 2 mmol/l 2 mmol/l 
Na-L-lactate 2 mmol/l 2 mmol/l 
Na-glutamate 2 mmol/l 2 mmol/l 
Methionine 0.5 mmol/l 0.5 mmol/l 
Alanine 2 mmol/l 2 mmol/l 
Serine 2 mmol/l 2 mmol/l 
Glycine 2 mmol/l 2 mmol/l 
Arginine 1 mmol/l 1 mmol/l 
Proline 2 mmol/l 2 mmol/l 
Isoleucine 1 mmol/l 1 mmol/l 
Aspartic acid 3 mmol/l 3 mmol/l 
*The free calcium concentration in the dialysate was constant, whereas the total calcium
concentration in the perfusate varies with albumin concentration and reaches a minimum 
of 1.25mmol/l in the albumin-free perfusate. The measured concentration of ionized 
calcium (Ca++) was 0.2-0.3mmol/l lower than that calculated on the basis of the added 
calcium salt. Chapter 9 describes the methods of measurement, and demonstrates the 
relationship between albumin and calcium under continuous dialysis (to regenerate the 
perfusate), which differs from the expected behavior (see Fig. 9.6.1.). The theoretically 
calculated concentration of calcium is also lower when measured in the dialysate with the 
appropriate ion-selective electrode (Radiometer ABL 505) at pH 7.4, as we recently (2014) 
ascertained. We used albumin at concentrations of between 2.5 and 7g/dl (and at 10g/dl in 
the non-filtering kidney variant). Differences in Na-concentration between perfusate and 
dialysate are due to the albumin concentration (which determines the volume of the 
protein-free distribution space). 
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4.1.3. Preparation of perfusate and dialysate 
 The solutions are made up by mixing prepared stock solutions or ampoules of sterile 
concentrates (clinical preparations) with sterile distilled water. When phosphate is added 
prior to aeration with CO2 (which lowers the pH), it should be added last – slowly, under 
constant stirring, and at its final dilution. Development of opalescence signals the precipita-
tion of calcium phosphate crystals, in which case the solution must be discarded. 
 For preparation of the large quantities (5-10 liters) needed for the single-pass variant 1 
or recirculation with regeneration by dialysis, we prefer the following approach: If the 
neighboring clinic has a Genius dialysis system (FMC), we prepare the salt solution for the 
perfusate in 90-l batches. Under aeration of the prepared batch with sterile (filtered) 
compressed air (supplied by a small compressor with a silicone adapter), we fill aliquots of 
5 or 10 liters into gas-tight glass bottles containing neomycin (50 or 100mg neomycin, 
freshly prepared in 1 or 2ml). Afterwards the glass containers are stored at 6°C in a 
refrigerator. The dry salt component is e.g. DS135/35 (135 Na, 35 mmol HCO3) and a liquid 
component HC 42 (4 mmol KCl, 1.25mmol CaCl2, and 0.5mmol MgCl2). During preparation 
of the batch, small amounts of acid (HCl, citric acid and acetic acid) introduced in the liquid 
component lead to the release of CO2 from the HCO3, and the pH falls below 7.0. Under 
these circumstances, the phosphate-free solution is stable for weeks and months. On the 
day of use, we enrich and acidify this basic solution by substrates as lactic, malic, 
oxaloacetic ĂŶĚɲ-ketoglutaric acids (further raising pCO2). Addition of magnesium chloride 
increases its concentration from 0.5 to 0.8 mmol, and potassium added e.g. as K-lactate (+1 
mmol/l) brings its level to 5 mmol/l. Supplementation with glucose raises its molarity from 
5.5 to 8.4 mmol/l. Then amino acids are added following the recipes given above together 
with e.g. AVP/dDAVP. Finally, phosphate is added at a low pH before sterile filtration under 
compressed air (2 bar). Even after that, the pCO2 remains high and equilibration is 
necessary to bring its down to the range of 40mmHg. We use a gas-mixing pump (Gigamax, 
Fa. Wösthoff Messtechnik GmbH, Bochum, FRG) to equilibrate the perfusate initially with 
pure oxygen, thereafter with 95% O2 and 5% CO2, sometimes 94% and 6%. The use of an 
interposed filter (e.g. from a transfusion tube system) to trap residual droplets of mineral 
oil emanating from the pump has proven to be effective and useful. Under these 
conditions, the measured HCO3 is in the range of 25-27mmol/l (reduced from 35mmol by 
the addition of substrates as sodium salts, resp. acids). For sterile filtration we use filtered 
air compressed to 2 bar, a pressure vessel of 10 liters capacity (stainless steel, Sartorius, 
Göttingen, FRG) and a membrane filter with a diameter of 142mm (cellulose acetate mem-
brane, pore size 0.2ђm), with or without an attachment for a 2 Liter container. For the 
single-pass mode, the standard system is adequate. For variants 2 and 3 the attachment is 
recommended. For use in mode 3 the dialysate is first passed from the 10 liter pressure 
vessel via the attached 2 liter overhead attachment. This approach is necessary because a 
residual volume of approximately 200 ml remains at the base of the 10-liter pressure vessel 
in which, a volume inadequate for the albumin perfusate (see Figs. 4.5.1., 4.5.2.). This 
residue can either be discarded or filled into the overhead attachment using a funnel, and 
filtered. Thereafter the empty 2-liter overhead is filled with the albumin perfusate and 
directly connected to the pressure source (see fig. 4.5.2.).  
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4.1.4. Albumin stock solution 
 For mode 2 or 3 experiments, albumin is prepared as a 10% stock solution by stirring 1 
kg of albumin (BSA) powder into 10 liters of dialysis fluid until fully dissolved (1 g albumin 
(BSA) powder in 10 ml dialysis fluid). This solution is further purified by dialysis (at constant 
volume) in a cooling chamber. We used a commercial low-flux dialyzer against 10-liter of 
dialysate for 6 to 8 hours, changing the dialysate every 2-4 hours. The purpose of this step 
is to remove/dilute out small albumin-bound substances, thereby contributing to a higher 
degree of standardization. Aliquots (100ml) of the purified solution are stored frozen at 
minus 20°C. Some authors, such as Bowman, Maack and Bekersky, prefer to retain these 
substances as metabolic fuels, and often dispense with the dialysis step (23, 33, 162, 163). 
In studies of fatty acid metabolism, removal of albumin-bound lipids by passage through 
activated charcoal has proved to be essential (57). In the case of mode 2 recirculation, we 
prepare an aliquot of diluent containing all additives (metabolic substrates, amino acids 
etc.) which is combined with the albumin stock solution before sterile filtration. For mode 
3, it is sufficient to mix the albumin stock with dialysate on final dilution and equilibrate the 
perfusate by dialysis. At a proportion of perfusate to dialysate of 1:20, dilution of the 
substrates is negligible, although one may adjust the additives to the final concentrations 
appropriate for perfusate and dialysate. In our early days, we used cellophane dialysis 
tubing (cuprophan) when preparing the albumin stock solution and dialyzed in a large 
beaker with a magnetic stirrer.  
4.1.5. Other colloid additives 
 To keep costs down, colloids other than albumin, such as gelatin derivatives (Haemac-
cel®, Gelifundol®), dextran, hydroxyethyl starch, Pluronic F108 or Ficoll 70, have been used 
for the single-pass mode. These colloids allow for aeration of the solution via a glass frit, 
which is not possible with albumin owing to foaming (although – undeterred -- Smyth has 
apparently used a dialyzer to aerate his albumin solution (280), as there was no mention of 
ultrafiltration in the paper). At comparable colloid osmotic pressure, albumin has the 
lowest viscosity (172) and enables the highest rates of perfusion and oxygenation to be 
achieved, while the GFR is higher than that attainable with other colloids at similar COP. 
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Table 4.4.: Overview of common colloids 
*Employed as the sole colloid or in combination with BSA
[e.g. BSA/Ficoll as used by Smyth (278)] 
Brand name Short name Chemical Manufacturer 
Haemaccel® Polygelin gelatin, cross-linked Delta Select 
Dextran Polysacharose Pharmacia 
Ficoll®, Histopaque®,
Polysucrose 
Copolymer 
sacharose-
epichlorhydrin- 
copolymer 
GE Healthcare 
Haes-steril® HAES hydroxy-ethyl-starch Fresenius Kabi 
Pluronic F108 PEG-PPG-PEG polyethylenglycol- 
polypropylenglycol- 
polyethylenglycol 
BASF, Sigma 
Wyandotte MI 
USA 
 The commercially produced colloids are not as homogeneous and their molecular 
weights not as sharply defined as that of albumin. Low and medium molecular-weight 
fractions of e.g. gelatin preparations are partly filtered and concentrated by absorption of 
fluid in the tubules during perfusion, which leads to a significant increase in viscosity in the 
distal tubule (verified by intratubular pressure measurements, unpublished). This in turn 
reduces GFR and may become functionally relevant when these substances are used as the 
sole colloid (257). Absorption of filtered colloids leads to changes (vacuolation) in the 
proximal tubule (266). Vacuolation occurs to a limited extent also with albumin (BSA), 
which is progressively filtered by a factor of 10-20 in the isolated kidney compared to the 
in-vivo conditions (244, 245, 248, 266, 291, 292). Brink (Nijmegen, Netherlands) measured 
the fractional clearance of Pluronic F108 in relation to the GFR and showed that the sieving 
coefficient increased to 0.58 at a low GFR, and was still raised considerably, at 0.33, when 
the GFR was normal at 1 ml/min (43). This corresponds to a significant amount of filtered 
colloid. Thus, urine viscosity increases by reabsorption of sodium and water, and thereby 
disturbs the hydrodynamics in the tubular system. One result is the regularly observed fall 
in GFR (<0.5 ml/min g kidney). 
In the pure recirculation mode, the volume necessary to fill the system depends on 
the type of oxygenator used and the volume of preperfusion solution required until the 
recirculation is closed. A minimal recirculation volume of 40 to 80 ml is needed (19, 35) 
when a glass oxygenator is used, for example. Note that arginine - as a source of NO - is 
very rapidly depleted, causing increased resistance to perfusion. This problem is less 
pronounced with larger volumes or when higher concentrations of albumin (>7g/dl) are 
used, and can be avoided by continuous regeneration of the perfusate by dialysis (mode 3). 
In any case, the preperfusion phase in the recirculation mode has mostly been driven by 
gravity (162, 163). In mode 3 we used 250-ml volumes of albumin perfusate (BSA 5g/dl) and 
5000 ml of dialysate. In the single-pass mode, the initial perfusion reduces the amount of 
perfusate to approximately 200 ml before the recirculation circuit is closed (e.g. 8 ml/min 
for 6 min, see Methods). The initial perfusion rate used is 8-10 ml/min in constant-flow 
mode, after that in constant-pressure mode at closed circuit. 
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 The dialysate is aerated via a glass frit; the dialyzer simultaneously serves as an 
oxygenator to equilibrate the perfusate (dialung). This method was first described for the 
perfusion of the isolated rat liver (20); Abraham (2) pointed out that Mayes & Felts 
independently described this 1966 (169). One should use only low flux dialyzers. High flux 
dialyzers exhibit a much higher albumin permeability. In dialysis patients, this does not 
matter, since the use of whole blood ensures that molecules the size of albumin are 
retained. During our early years in Hannover, we used the capillary-plate dialyzer 
(Hoeltzenbein) from Travenol, switching later to the cross flow dialyzer Secon 101 
produced in Göttingen. In the 6 years up to 2014 we used the low-flux Polysulfon hollow-
fiber dialyzer F4 from FMC (Fresenius Medical Care) and then turned to its successor model 
FX5. The filling volume of the F4 model was 50ml at 0.8m²; the FX5 model offers 54ml at 
1m² surface. Dialyzers with less surface and filling volume are welcome, but may be more 
expensive.  
4.1.6. Semisynthetic perfusate with oxygen carriers 
 In order to avoid oxygen deficiency during the perfusion of isolated kidneys, it is vital to 
add oxygen carriers. The reason why the kidneys of warm-blooded animals are so sensitive 
to oxygen deficiency lies in the nature of their vascular architecture, especially in the outer 
medulla. This is very different from e.g. the Langendorff heart preparation, which functions 
reasonably well even without colloids or oxygen carriers (66). On the one hand, the shunt 
diffusion of solutes, but also of blood gases, within the vascular bundles of the outer 
medulla between ascending and descending vasa recta permits the build-up of osmotic 
gradients between cortex and medulla. On the other hand, this leads to low oxygen 
pressure in the renal medulla and to trapping of CO2, a long known phenomenon. What 
was less clear is that shunt diffusion of blood gases also plays an important role in the renal 
cortex - especially between arteria and vena interlobularis, which represents the largest 
contact area between arteries and veins in the renal vasculature (190, 259-261). This fact 
no doubt favored the localization of erythropoietin synthesis in the renal cortex in the 
course of evolution, for reductions in oxygen pressure and capacity can be monitored quite 
efficiently there (128, 129, 134, 139) - in an organ whose metabolism quantitatively reflects 
the activity of the whole organism. 
 To improve the function of isolated kidneys of warm-blooded animals various options 
have been evaluated, including the use of the following oxygen carriers: 
4.1.6.1. Perfluorocarbon preparations 
ȋͺʹȌǢ
Ǥ
4.1.6.2. Stroma-free cross-linked hemoglobin preparationsȋͳ͸ǡͳͶͶǡͳͶͺǡ
͵ͳͲǡ͵ͳͳȌͳͲͳǦ
Ȃȋʹͻ͸Ȍ
4.1.6.3. Washed bovine or human erythrocytesȋͳͶͷǡʹ͵ʹǡʹ͸͵Ȍ
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Fig. 4.1.1.: Sagittal section of a rat kidney after perfusion with ultrasonically 
emulsified perfluorocarbon as perfusate. Labelling of the vascular tree with an 
inhomogeneous microsphere preparation (white). This was an early and unsuccessful 
attempt to exploit the high solubility of oxygen in perfluorocarbons (Berlin 1973). The 
problem was a rapid increase in resistance with decrease in perfusion flow rate. Franke has 
published data obtained with a different emulsifying technique (82) that uses high 
pressures and may yield more homogeneous microspheres, but this procedure has not 
found general acceptance. 
 The high hopes placed in emulsified perfluorocarbon microspheres and preparations of 
hemoglobin have not been realized (16, 82, 144, 147, 148, 283, 310, 311), and washed 
erythrocytes remain the oxygen carrier of choice. If a mixture of 95% oxygen and 5% CO2 is 
used for equilibration, the addition of 5(10) % red blood cells is sufficient to prevent oxygen 
deficiency at high perfusion rates. This type of semi-synthetic perfusate was introduced by 
H. Schimassek for perfusion of the isolated rat liver (232). In the isolated perfused rat 
kidney, the addition of 5-10% washed red cells (bovine or human) suppresses morpholo-
gical signs of oxygen deficiency that otherwise appear in the area of S3-segments of the 
proximal tubule and thick ascending limb (TAL) segments of Henle´s loop (263, 300), but 
does not provide the degree of functional stability seen in the in-vivo kidney. 
 The functional stability of the IPRK is crucial. When 5g% albumin (BSA) is used at a 
colloid osmotic pressure (COP) below 20mmHg and a perfusion pressure of 100mmHg, the 
GFR is as high as it is in vivo at 1ml/min per g kidney. Nevertheless, the functional stability 
of the preparation, measured in terms of the fractional Na reabsorption, progressively 
declines. When the albumin concentration is increased to 7g % - comparable to levels in the 
postglomerular capillaries of proximal tubules in vivo – the fractional Na-reabsorption is 
essentially unchanged, but the GFR falls by 50%. Thus the stability of one parameter may 
actually mask a loss of function (163). This finding also raises the basic question of why the 
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isolated perfused kidney fails to exhibit the functional stability of the in-vivo organ, even 
under supposedly optimized conditions. But it must be borne in mind that the in vivo 
conditions are far more complex and optimized in all respects (thanks to homeostasis, 
interactions with other organs, the highly complex perfusate cocktail provided by whole 
blood, “blood as a very peculiar liquid”, Goethe, Faust I, Studierzimmer II). The fact is that 
the isolated perfused kidney is a simplified model, and one must accept its intrinsic 
limitations. 
Why should erythrocytes be washed? 
The use of whole blood (with an anticoagulant such as heparin) for extracorporeal 
perfusion of the kidney leads to a drastic rise in perfusion resistance (46, 103, 186, 188). At 
constant pressure, perfusion comes to a virtual standstill due to vasoconstriction. The 
factor responsible is present in plasma, is released -- as Nizet surmised -- by the erythro-
ĐǇƚĞƐ͕ĂŶĚĐĂŶďĞĂŶƚĂŐŽŶŝǌĞĚďǇɲ-blockers or the calcium antagonist Verapamil®. The use 
of Verapamil enabled us to analyze the clearance of uremic middle molecules from the 
hemofiltrate of uremic dialysis patients. The vasoconstrictive factor is also present in 
uremic hemofiltrate (233, 234), and is perhaps released when blood comes into contact 
with artificial surfaces. 
 Therefore, it is advisable to use a semi-synthetic perfusate made up of washed 
erythrocytes and an Albumin-Krebs-Henseleit solution. After centrifugation, removal of the 
buffy-coat and blood plasma and three to five subsequent washes suffice to remove the 
factor, eliminating the risk of vasoconstriction. As wash solution, we use the final dialysate. 
Bovine erythrocytes are considered quite stable, but it is not always easy to obtain 
fresh preparations. We and others have also used human erythrocytes, which are 
comparable in size (7-8 ђm diameter) to rat erythrocytes (7.4ђm, (209)). A volume of 50 to 
100ml whole blood drawn by addition of 5000 U of heparin is enough for two experiments 
when a recirculation volume of 200-250ml is required. Human red cells from expired blood 
bags have successfully been used for (rat) liver perfusion, but for renal perfusion, the 
inevitable hemolysis is a complicating factor. It is known (173, 316) ƚŚĂƚ ɲ-tocopherol 
prevents hemolysis, but we ourselves have no personal experience with tocopherol, and 
whether it works for expired blood has not been studied. Nevertheless, experiments with 
expired blood have been carried out in larger animals, such as dogs (186, 188, 240) using ɲ-
adrenergic blocking, for example. In 1987, Lieberthal described the use of bovine erythro-
cytes, which he washed and prepared by a very complex process under sterile conditions. 
The results, however, showed that the effort was worthwhile, as Lieberthal was able to 
demonstrate the importance of the erythrocytes in the establishment of concentration 
gradients between the renal cortex and medulla. The maximum osmotic gradient (U/Posmol) 
attained in cell-free perfusions in the presence of antidiuretic hormone (AVP, ADH) was 1.2. 
Addition of the washed red cells to a hematocrit up to 45 % raised the U/P quotient to 3-4, 
though the maximum quotient of 4 was reached only under the influence of prostaglandin 
synthesis inhibitors (145, 146). In antidiuresis the rat kidney can reach a quotient of 10 in 
vivo, which corresponds to an osmolality of urine as high as 3000 mosmol/kg H2O. 
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Preparation of bovine erythrocytes (after Wilfred Lieberthal, (145, 146)). 
 The jugular vein of live cows was the source of bovine blood, which was drawn into the 
sterile bags used by blood banks, prefilled with sodium citrate and dextrose (Fenwall Labs., 
Travenol). The erythrocytes were processed within three days, and plasma, leucocytes and 
thrombocytes were separated off using sterile techniques (centrifugation at 3500g for 10 
min). The remaining cells were then passed through a filter (Pall) to remove residual 
leukocytes and platelets. The red cells were washed in a blood cell processor (IBM, model 
2991) with a solution containing 0.9% NaCl, 0.2 % glucose and 40mg of inorganic phosphate 
adjusted to pH 7.0. Every batch of erythrocytes was washed five times with 200ml of this 
solution. Finally, cells were resuspended in the same solution filled into sterile bags and 
stored at 4°C for maximum of 2 weeks. Tests revealed that leukocyte count had been 
reduced by 97.8% and platelets by 97.6%. Immediately prior to use in experiments, an 
adequate volume of erythrocytes was removed (under sterile conditions), washed 3 times 
(removing the supernatant (buffy coat) each time), and then brought to a hematocrit of 
45% with the albumin solution. 
Critical comment: While I have great admiration for the persistence and rigor shown by 
Wilfred Lieberthal in his approach to the preparation of bovine erythrocytes, I would argue 
that he should have used a Krebs-Henseleit bicarbonate solution for the final wash of all. 
During pretreatment with NaCl, the red cells lose bicarbonate and accumulate chloride 
(235). Subsequent mixing with the Albumin-Krebs-Henseleit (AKH) solution causes them to 
exchange their excess chloride for bicarbonate from the AKH solution, which in turn implies 
that the latter now contains correspondingly less NaHCO3. Our mode 3 recirculation with 
dialysis against a large volume avoids this problem. Otherwise, the time-consuming 
procedures used by Lieberthal are worthwhile, but they require appropriate resources and 
facilities offered by a blood bank with a blood cell processor for animal raw material. 
Extra note 
Dr. Jan Czogalla of Zurich has meanwhile located a source of fresh and defibrinated sheep 
blood in England. For details, see more at the end of the contribution of Frank Schweda, 
Chapter 14. 
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4.2.  Perfusion drive systems, measurement of flow and pressure 
4.2.1.  Hydrostatic pressure 
 The simplest drive system utilizes the difference in height between the perfusion 
reservoir and the kidney. Gas pressure also provides a driving force in the case of single-
pass perfusion, where the gas mixture is discharged through a water column or a regulated 
valve. 
 In the recirculation system, a roller pump is used to raise the pressure of the perfusate 
to the desired level. Fig 4.2.1 shows a system used by Brian D. Ross in the laboratory of Sir 
Hans-Adolf Krebs in which the oxygenator is accommodated in a tower placed on top of the 
temperature-controlled cabinet (185). Here, flow rate is measured either by the injection of 
gas bubbles and observation of their passage through a calibrated glass tube (see Fig. 
4.3.3.) or monitored with a rotameter (where the motions of a float of known density 
within a tapered tube reflect the flow rate). 
Fig 4.2.1: Perfusion 
cabinet for the IPRK. 
The photograph is taken 
from the laboratory ma-
nual by Brian Ross (224). 
The cabinet is extended 
in height especially for 
kidney perfusion. For the 
isolated rat liver, which is 
usually perfused via the 
vena portae at a signi-
ficantly lower pressure, 
the tower is dispensable. 
(reproduced with the 
author´s permission).  
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4.2.2. Gas pressure 
 The gas pressures required in the single-pass mode can be achieved with much less 
effort. The gas mixture (95% O2, 5% CO2) for oxygenation is injected at positive pressure via 
a glass frit into a closed glass container (e.g. a Woulff bottle) and discharged via a water 
column into a 2-m tall glass riser, allowing (within limits) a constant perfusion pressure to 
be maintained. In this arrangement, the perfusion pressure measured at the entrance to 
the perfusion cannula depends somewhat on the resistance of the perfusion cannula. One 
can use either a premixed gas (“Carbogen”: 95% O2 and 5% CO2) supplied by a pressurized 
cylinder via a pressure reducer, or a gas mixing pump (fig. 4.1.3.). The gas used should be 
filtered and humidified. 
Fig. 4.2.2.: Schematic diagram of a perfusion apparatus rigged for the “single pass 
mode” ȋʹͷ͸ǡʹͷ͹Ȍ. All components that are kept at a constant temperature are hatched. 1. 
Electromagnetic flow sensor; nowadays ultrasound-based sensors are available (see Chapt. 
9.2.). 2. Pressure transducer. 3. Kidney in tray. 4. Switching block. 5. O2-electrode. 6. CO2-
electrode. 7. Gas inlet (warmed and humidified). 8. Sampling port. 9. Connection to an 
alternative perfusate. 10. Air trap, 11. Reservoir (Woulff bottle). In this case, the perfusion 
cannula is fixed in the mesenteric artery and the pressure-measuring cannula is in the distal 
aorta. In those days, the flow rate was measured with an electromagnetic flow sensor (via 
the voltage induced by the ion current in the AC field). The gas outlet through a water 
column builds up the perfusion pressure.  
Pressure measurement: In the early days we used pressure transducers (strain gauges) 
from Statham Instruments Inc. (now Gulton-Statham, Rochester, USA), which were very 
expensive. Now we make use of the “single-use pressure transducers” employed in ICUs 
(intensive care units) with integrated preamplifier and calibration button. These are 
relatively cheap and robust, and re-use is common under laboratory conditions.  
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4.2.3. Flow measurement, peristaltic pumps. Flow constant or pressure 
constant perfusion 
 The use of a peristaltic pump provides more options for all perfusion variants (single-pass 
perfusion, recirculation and recirculation combined with dialysis). The simplest method, 
constant-flow perfusion, allows one to investigate the effect of vasoactive substances by 
recording the perfusion pressure. In this case, all other aspects of the physiological function 
of the organ are of secondary interest. Constant-pressure perfusion is technically complex, 
but more appropriate for the kidney. Ideally, the perfusion pressure is measured directly 
before the kidney. This can be done either as shown in Fig. 4.2.2., with the perfusion cannula 
placed in the mesenteric artery while the perfusion pressure is measured in the distal aorta 
(257), or by using a double-barreled cannula inserted into the distal aorta until just before the 
renal artery junction, in which case the pressure signal comes via the inner cannula of the 
double-barreled cannula (Fig. 4.2.2, 4.2.3 and 4.6.3-4.6.6 (251, 253, 254)). The pressure signal 
can either be passively recorded, or it may additionally be used to electronically control the 
pump for constant-pressure perfusion (161, 251). Pressure pulsations created by the peri-
staltic pump may be preferred (186) or can be compensated for by a buffering chamber 
(Windkessel) and/or electronically attenuated (RC attenuators). In older publications one 
sometimes comes across 2-valve pumps (see Jacobj (115) or Leon L. Miller (174)) which 
produce systemic pressure pulses, but also cause less hemolysis when blood or washed 
erythrocytes are used. Whether pulsatile perfusion is beneficial or not is still a matter of 
debate. 
 If the pump generates an analog signal that reflects its rotation speed (tachogenerator 
feedback), the rate of pump revolution can be recorded as the perfusion rate by means of a 
chart recorder as well as the pressure signal (repeater). The first apparatus of this type we 
used was developed by Joachim Lutz (159, 161) and manufactured by Apparatebau E. 
Jandke in Würzburg, Germany. In principle, analog-to-digital conversion can be used and 
data can be recorded by PC. However, we prefer analog recording on a multi-channel 
recorder (Rikadenki, Tokyo, Japan; Linseis, Selb, Germany). Recording of flow rates via the 
analog signal from the pump requires that no leakage occurs between perfusion cannula 
and renal artery. This can be evaluated at the point of venous outflow (gauging by ml) or 
from any difference between the calculated and the measured level of oxygen consump-
tion. The device currently used to control the peristaltic pump is shown in Figs. 5.1.05 and 
5.1.06. My coworker Jörg-Dieter Biela developed the apparatus in his own workshop. Fig. 
4.2.3 shows the modification of the apparatus, with peristaltic pump and feedback control 
via the output signal from the pressure transducer for constant-pressure operation. In this 
mode, it is easy to demonstrate the autoregulation of renal perfusion by pressure changes 
of 20mmHg via a step switch. In addition, constant-flow operation is possible with analog 
recording of flow and pressure. For measurement of arterial pO2, the bypass is opened by 
pushing the slide in the valve block (top right), while the extra flow is restricted by a 
preconstriction. Thanks to feedback control, the extra flow is detected and the pressure 
remains constant. In constant-pressure mode, protection against overshooting is no trivial 
matter. Electronics and hydraulics need to be well matched. In particular one should avoid 
small air bubbles in the hard-hose lead to the pressure transducer. The in-line filter must be 
well vented. In addition, the volume of the buffering chamber (Windkessel) can be critical. 
If it is removed from the circuit (clamped off), one can generate pulse amplitudes of 
ͶͲ
20mmHg or more. The best option would be to combine a two valve artificial ventricle (see 
Miller Fig. 4.3.1) with flow measurement by ultrasound.  
Fig. 4.2.3.: Schematic diagram of the perfusion apparatus with a peristaltic pump 
(246, 254). 1. Double-barreled cannula inserted in the aorta. 2. Ureteral catheter. 3. Vena 
cava. 4./5. pO2 and pCO2-electrode. 6. Inline filter (8ђm). 7. Servo-controlled peristaltic 
pump, feedback regulated by the pressure signal from 8. 8. Pressure transducer, connected 
to the inner barrel of the double-barreled cannula. 9. Pressure buffer. 10. Bypass for 
arterial gas measurement, 11. Kidney tray. 12. Valve block. 13. Reservoir (2 or 5 liters). The 
flow rate was recorded continuously based on the tachogenerator feedback from the 
peristaltic pump (preamplifier) (Rikadenki, Tokyo, Japan; Linseis, Selb, Germany). 
4.2.4. Other techniques of flow measurement 
In addition to the rotameter with its visual readout, flow rates can be measured 
electromagnetically and by means of ultrasound. In fact, the Transonic T106 flowmeter 
with cannulating flow probe SN22 (Transonic, Ithaca, NY, USA) allows one to use the 
ultrasonic transit-time method on cell-free media. Thus, one can also register the flow 
continuously, as with the technique in which the feedback signal is derived from the 
tachogenerator of the perfusion pump; however, in this case application to constant-
pressure perfusion requires a preamplifier. 
Ͷͳ
4.3. Temperature control 
4.3.1. Temperature controlled cabinet with a perspex sliding front door 
This type of temperature control became standard for biochemical and pharmacolo-
gical studies of the isolated perfused rat liver (174, 232). As the rat liver is normally 
perfused via vena portae only for simplification, a low perfusion pressure suffices. The 
system used for rat liver perfusion designed by Miller and his first publication on the 
synthesis of plasma proteins by the liver was a milestone (174). The renal perfusion system 
used by the Oxford research group led by Brian D. Ross was adapted to provide the higher 
perfusion pressure by constructing a tower on top of the cabinet to enable the glass 
oxygenator to be placed in an elevated position, and was used for metabolic studies (185). 
Fig. 4.3Ǥ1.: Perfusion Apparatus manufactured by Metalloglass Inc. based on 
Miller´s design for the rat liver (174). Air circulation within the cabinet is driven by a 
fan (fa), while a thermostat (th) and electric heating coils (ch) attached to the housing 
control the temperature. Note the two built-in filters (f) in the circuit (shown in detail in 
side view on the right). The filter membrane used was made of white silk (100-150 
mesh/inch). The other labeled components are: 1. Overflow with gas inlet to the glass 
oxygenator (get), 2. Gas inlet, humidifier (h), gas pressure measurement (gm), 3. Output of 
perfusate from the pump (p) via the filter (f) to the oxygenator (get), straight adapter (sa), 
second filter (f), inflow cannula (ic), watch glass (wg), outflow cannula (oc), liver platform 
(lp), thermostat (th), relay (r), gas return tube (grt), carbon dioxide trap (cdt). In the 
original, as shown in the next figure, a two-valve pump was used instead of a peristaltic 
pump. 
Ͷʹ
The major disadvantage of the cabinet with a sliding door is the fact that the door must 
be opened every time an intervention is necessary. The pump used in Miller’s original 
paper (174) was a two-valved, so-called Bluemle pump - a type which Jacobj had already 
employed in his apparatus in the year 1890 (115), though his was driven by a water-
powered motor (Figs. 16.0.2, 16.0.3). Later on, this sort of pump was used to minimize 
levels of hemolysis when necessary (76). 
Fig. 4.3.2.: Schematic representation of the original perfusion apparatus developed 
by Miller (174). Two-valve pump with eccentric rotor, connecting rod and a modified 
syringe (for volume displacement), which was connected to the valve chamber by a 
diaphragm. In this version, blood is drawn from the reservoir via a filter; the filter was no 
doubt later switched from the pre- to the post-pump position, as implemented in the 
modified version marketed by Metalloglass. When blood or purified erythrocytes are added 
to the perfusate, a two-valved pump causes a lower rate of hemolysis than a peristaltic 
pump. 
Ͷ͵
Fig. 4.3.3.: Schematic diagram of the perfusion circuit used by the Oxford Group 
(185, 224). The cabinet is omitted. The glass oxygenator was positioned high above the 
kidney to achieve a hydrostatic pressure of 120cm H2O (see Fig. 4.2.1.). The organ was 
placed on a suspended nylon mesh and hung on the glass cannula (see Fig. 4.6.2.). The 
venous outflow was directed to an oxygen electrode and a 2-ml graduated pipette was 
used as a bubble flowmeter. The pump flow rate in the oxygenator circuit was set to a 
higher value than that in the perfusion circuit to improve the oxygenation of the perfusate. 
Modified from Brian D. Ross (224), reproduced with the author´s permission.  
For details of the glass cannula used for perfusion of the kidney, see Figs. 4.6.1 and 
4.6.2; for the complete apparatus including the cabinet, see Fig. 4.2.1. A temperature-
controlled fan is also integrated, as shown in the previous diagrams of the Miller apparatus. 
ͶͶ
4.3.2. Temperature control by water jacketing 
 Physiological experiments designed to analyze the clearance of molecules and 
involving micropuncture of tubuli require easy access to the kidney. Therefore, water-
jacketing is now used for temperature control in parts of the circuit, such as the reservoir, 
oxygenator, glass tubes and double-barreled hoses. This principle is used for all four modes 
of perfusion from single-pass to recirculation techniques. For single-pass perfusion, we 
immersed the reservoir in a circulating water bath equipped with a thermostat for 
temperature control. An aliquot of the warm water was used to preheat the equilibrating 
gas mixture. Smaller thermostats are used to monitor the rest of the route to the kidney 
preparation, i.e. the glass tubes and hoses leading to the kidney and those in the 
recirculation systems, the jacketed oxygenator and/or the reservoir, which is also water-
jacketed. The kidney itself is placed in a tray made of stainless steel with temperature 
control by circulating water. Based on our experience, polypropylene couplings of the type 
used in compressed-air technology from Colder Products Company (St. Paul, MN. USA) 
connecting tubes and circulators have proved themselves in these roles. The couplings are 
available with and without a check valve, which opens after connection. With a connected 
counterpart, one can rinse and remove them easily. The use of water-bath disinfectants is 
recommended. 
4.4. Aeration 
4.4.1. Aeration via a glass frit 
 The simplest way to aerate the perfusate is via sintered glass frits in the single pass 
perfusion mode. In order to prevent evaporation losses, the gas mixture should be 
humidified. We pass the dry gas mixture through an air filter (e.g. 0,2ђm, Midisart 2000, 
Sartorius Stedim, Göttingen, Germany) in a closed bottle of sterile water with a glass frit, 
the moistened gas is then dried slightly over a jacketed glass coil to prevent moisture from 
entering the perfusate. From the perfusate reservoir, the gas flows either directly (if a 
perfusion pump is used) or via a pressurizing water column to set up the perfusion pressure 
(see Fig. 4.2.2.). One can also use the latter method to enhance the oxygen pressure in the 
perfusate. We use a gas-mixing pump, initially fed with 100% O2 to decrease the pCO2 to 
40mmHg and then with 95% O2 and 5% CO2, also 94/6% in case of need. Small droplets of 
mineral oil that might be emitted by the pump are trapped by a transfusion filter, 
preventing contamination of the dialysate or perfusate. To avoid foaming, perfusate with 
albumin as the colloid must be aerated indirectly, via an oxygenator or dialyzer. Foaming 
may cause denaturation of albumin. In Hannover up until about 1990, we scanned the level 
of the venous effluent capacitatively and returned it via a tube valve, almost free of foam, 
to the lower reservoir. To simplify the procedure we later returned it via a wide-lumen 
silicon tube, which may represent a backward step. We plan an analysis of this problem.
Ͷͷ
4.4.2. Glass oxygenators in recirculation technique 
Fig. 4.4.01.: Types of multibulb glass oxygenators after B.D. Ross(224). Leon L. Miller 
used Type a (174) see also Fig. 4.3.2. Hems in Oxford designed Type b with precisely 
calibrated dimensions (shown in Fig. 4.4.02). Type c uses a rotĂƟŶŐ disc to sƟr the medium; 
Nizet used a moĚŝĮed version of this type for the perfusion of isolated dog kidneys (186). 
With a ůŝƩle more eīort, the glass oxygenator can be water-jacketed for temperature 
control; this principle was Įrst described by Staib in 1968 (286). Bowman and Maack also 
used water-jackeƟŶŐ in their oxygenator (34, 35) and incorporated the reservoir for the 
perfusate at the boƩom (see Fig. 5.2.1.). Reproduced with the author’s permission.  
Ͷ͸
Fig. 4.4.02.: Details of the construc-
tion of the Hems oxygenator. One 
special feature is the upper part of the 
inflow section, which is designed as a 
conical entry bulb so that the thick-
ness of the liquid film is reduced in 
two steps, thereby wetting the entire 
circumference. The device has 4 to 5 
bulbs (105, 224). The measurements 
shown are external dimensions; the 
wall thickness is 2mm. The original 
glass tube was a heavyweight boro-
silicate glass of 22mm outer diameter. 
The lower part is designed to prevent 
frothing. The level of the overflow and 
gas inlet is critical in this respect. 
Reproduced with the author’s permis-
sion (224). 
The water jacketing of a glass oxy-
genator was first described by Staib 
(286), according to B.D. Ross (224). 
The following Figures show a glass oxygenator of our own design from the workshop in 
Hannover, with water-jacketing. This type would benefit from a conical entry bulb like that 
specified by Hems. Inlet and outlet for gases were each located in the middle of a bulb and 
directed downwards to prevent frothing. 
Ͷ͹
Fig. 4.4.03.: Jacketed glass oxygenator. The two screw connections on the left are in- 
and outlet for 38°C water, the two gas connections are on the front of the tube as shown, 
(on the left the inlet, on the right the outlet). On top and to the left side is the screw 
connection to the perfusion inflow; on the top right is the vent and the bulbous structure 
that facilitates wetting.  
Fig. 4.4.04.: Glass oxygenator with associated reservoir. Both are jacketed for tem-
perature control by means of a circulatory thermostat. On the left is an interrupted 
overflow outlet to which a valve can be attached to regulate the input of compressed air, 
on the right there is shown an uninterrupted overflow from the oxygenator to the reservoir 
(design by Schurek, unpublished). 
Ͷͺ
Fig. 4.4.05.: Reservoir attached to the oxygenator. The reservoir has two water bath 
connections sealed with screw caps. On the left is the connection to the base of the inner 
vessel, on the right, the connection to the venous effluent from the kidney, which should 
ideally be located higher up (see Fig. 5.3.2 for an improved version).  
4.4.3. Membrane oxygenators used in the recirculation technique 
Various types of membrane oxygenators have been described in the literature. At first, 
membrane oxygenators were not commercially available, so different laboratories deve-
loped several simple prototypes, such as tubing oxygenators, flat membrane oxygenators 
and capillary oxygenators. Four variants are shown here, the latter two of which (Figs. 
4.4.07, 4.4.08) we have used extensively. 
Ͷͻ
Fig. 4.4.06.: The silicone tube oxygenator after 
Folkman (79). The gas enters the tube which is 
wound around a glass rod, and is in direct contact 
with the perfusate, which is introduced via the side 
inlet. A glass frit at the bottom serves as a filter. The 
thin-walled silicone tube is not particularly robust 
and exhibits a pressure-dependent change in volume, 
and diffusion capacity is limited to small flow rates. 
Modified after Folkman. 
Fig. 4.4.07.: The silicone tube oxyge-
nator after Hamilton (96). The per-
fusate passes through a 5-meter sili-
cone tube with the following specifi-
cations: inner diameter 1.47mm, 
wall thickness 0.25mm. The tube 
(which is used only once) is inserted, 
loosely coiled, into a sample vessel 
(e.g. a mustard jar!) with a volume 
of about 500ml, and attached to 
appropriate connectors inserted in 
holes cut in the lid. Note that the gas 
inlet and outlet are far apart. The 
wall thickness used is a compromise, 
and was chosen to reduce the risk of buckling. In tests of effectiveness, a 12g rat liver was 
perfused with washed rat erythrocytes at flow rates of 10ml/min. Adequate oxygenation 
could be achieved at a hematocrit of 22% and a (gas) flow rate of 1.5 liters/min. A filling 
volume of 8-10ml for the silicone tubing is optimal. The oxygenator is equipped with only a 
single outlet directly to the liver, which is sufficient in one passage to provide oxygen and 
the pressure required for perfusion via the portal vein. 
 The Hamilton oxygenator is suitable for the perfusion of a mouse kidney, provided a 
separate oxygenator circuit is set up to achieve the higher perfusion pressure necessary. 
For the perfusion of a rat kidney, even higher perfusion flow rates are necessary (15-
45ml/min) and higher levels of oxygen uptake in the oxygenator circuit are required 
relative to the amount of perfusate supplied to the kidney. In addition, the dimensions of 
ͷͲ
the tube may need alteration. The main advantages of the Hamilton design are its simple 
construction, ease of use (no cleaning!) and low cost compared to the exorbitant prices 
charged for commercially available systems. A year earlier, Felts and Wayne had described 
a tube oxygenator (74) which was equipped with three parallel silicone tubes with thicker 
walls, which can withstand the arterial pressures encountered in the perfusion system of 
Mayes and Felts. These authors perfused the hepatic artery and portal vein separately 
(169). 
Fig. 4.4.08.: Membrane oxygenator after Röskenbleck & Niesel (221). This system, 
originally used as a thin-film dialyzer, was later also used as oxygenator, having been 
equipped for this purpose with a fiber glass-reinforced silicone membrane (Detakta, Ham-
burg, Germany), which was originally intended for use as an electrical insulator. In all, 18 
clamps are used to hold the outer glass slabs in place. Problems with the flow at the inlet 
and outlet (discharge block) led to search for an alternative solution (see Fig. 4.4.09). 
Eschweiler (Kiel, Germany) also supplied this type of membrane oxygenator, originally for 
use as a thin-film dialyzer.  
ͷͳ
Fig. 4.4.09.: Membrane oxygenator after Röskenbleck, modified after Schurek 
(unpublished). The grooved inner plates are from a RP6 dialyzer, formerly manufactured by 
Rhone-Poulenc (Hospal); the inner frame is covered by two layers of fiber glass-reinforced 
silicone membrane (Detakta, Hamburg, Germany) which form the interior compartment for 
the perfusate. A set of 18 clamps ensures that the outer stainless steel plates are tightly 
appressed to the grooved inner plates (torque wrench in the foreground). The gas flows 
between silicone membrane and grooved plate on both sides in countercurrent to the 
perfusate. The effective area for gas exchange is 2x400cm²; the filling volume with tube 
connections is 10-20ml, and can be reduced by using thinner sealing material and by 
counter-pressure (gas side).  
4.4.4. Capillary oxygenator 
Fig. 4.4.10.: Capillary oxygenator. As an alternative to the relatively large membrane 
oxygenator, Dr. Rintelen from the Enka company (now Membrana, 3M, Wuppertal, 
Germany) supplied us some time ago with an oxygenator made of test modules consisting 
of a bundle of polypropylen capillaries embedded in polyurethan with end caps for the 
perfusate and lateral connectors for gas inlet and gas outlet.  
After its first use, a cleaning procedure involving the use of formalin resulted in 
damage (bubble-like protuberances) to some of the capillaries. We subsequently cleaned 
the unit by rinsing with NaCl solution and demineralized water and then drying it.this 
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oxygenator is permeable to water vapor, dry gases should not be used. Each module 
contained 570 hollow fibers (lumen 280 ђm, wall thickness 50 ђm, 10 cm effective length) 
with a total surface area of 500 cm², and had an optimal filling volume of 6.2 ml including 
connecting caps. The efficiency approached that of the membrane oxygenator (Fig. 4.4.09). 
4.4.5. The dialyzer as a “kidney lung” 
The first dialyzer we used as a combined oxygenator/dialyzer was the capillary plate 
dialyzer, which was designed by Dr. Josef Hoeltzenbein in Münster (Germany), and manufac-
tured and sold by Travenol (251). This type of dialyzer was ideal due to its small filling volume of 
approx. 65ml, the restricted ultrafiltration rate and a surface area of 0.92m² (Type M1000). The 
perfusate is in contact with the capillary exchange surface over a distance of only 6 cm, but this 
is enough for adequate oxygenation because of the better blood-film geometry (see Fig. 4.4.11 
for a comparison between hollow fibers and capillary film). The dialysate distributes in diagonal 
countercurrent to the perfusate. We later switched to the Polysulfon low-flux capillary fiber 
dialyzer F4HPS from FMC (Fresenius Medical Care, Bad Homburg, Germany) because no plate 
dialyzer of comparable size (filling volume 51ml, surface area 0,8m²) is now on the market. 
Indeed the F4HPS itself has meanwhile been superseded by the type FX5 (54ml, 1m²). So-called 
high-flux dialyzers are not recommended because of their higher permeability; on the one 
hand, they have a higher ultrafiltration rate and, on the other, a higher permeability for 
albumin. The latter soon disappears under laboratory conditions if whole blood is used, i.e. the 
dialyzer attains its final, stable permeability only after being exposed to whole blood (219), 
probably because the larger pores are sealed by material present in whole blood. This 
phenomenon is also observed in the glomerular capillaries of the kidney (244, 245, 248-250, 
266). This example underlines the fact that not every type of dialyzer is suitable and that the 
permeability for albumin should be low. The Polysulfon dialyzer F4HPS was used repeatedly, 
thoroughly rinsed after use and stored with a filling of 3% formalin solution. Before reuse, the 
unit was intensively rinsed and dried in a stream of filtered compressed air. In addition, the 
dialyzer type FX5 prevents loss of albumin and incorporates a modified Polysulfon membrane 
(Helixone®). 
Fig. 4.4.11.: Comparison of the geometry of a hollow capillary fiber with that of the 
capillary film of a Hoeltzenbein dialyzer. Note that diffusion distances are shorter in 
the latter.   
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Fig. 4.4.12.: Hoeltzenbein- ȋTM  	Ȍ. Historical model 
M1000, once produced in Belgium by Travenol Laboratories Inc. The inlet for blood/ 
perfusate is on the front, the outlet on the rear face. Dialysate enters and exits via the 
Hansen couplings on the bottom and top, respectively. The surface area of the dialyzer 
membrane was 0.92 m2, the filling volume 65ml and the ultrafiltration coefficient was low. 
Dialysate flow was driven by a centrifugal pump at low pressure (Type 1022 Eheim GmbH, 
Delzisau, Germany), see Chapter 5.3. 
The use of capillary dialyzers as oxygenator, - gas instead of dialysis fluid 
Smyth described a single-pass system that used a capillary dialyzer as an oxygenator 
(279, 280), with a gas mixture of 95% O2 and 5% CO2 flowing through the dialysis compart-
ment external to the capillaries (2 liters/min). He used a dialyzer from Dow Cordis (C-DAK 
135sce). The letters SCE stand for saponified cellulose ester fibers, which are not as hydro-
phobic as modern synthetic fibers like Polysulfon. Hence, the more modern synthetic fibers 
available today may be more appropriate for this purpose. Dialyzers that are clinically used in 
pediatric wards offer less filling volume and surface area, but I prefer low-flux dialyzers. To 
prevent ultrafiltration of water from the perfusate, gas should emerge from the dialyzer 
against a higher than atmospheric pressure, e.g. into a water column of a defined height. 
Up to now we have used dialyzers as oxygenators only in our mode 3, where the 
perfusate was equilibrated and reconditioned by the dialysate. Systematic studies of the 
use of dialyzers as oxygenator with gas flow instead of dialysate are pending.
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4.5. Filtering 
4.5.1. Filtration of the perfusate 
 The aim here is the sterile filtration of the final perfusion solution immediately before 
addition to the perfusion apparatus. Fig. 4.5.1 demonstrates our set-up. 
Fig. 4.5.1Ǥ: Filtration-assembly 1. On the 
right is the 10 liter stainless-steel container. 
Filtration is driven by compressed (2 bar) and 
filtered air, which is passed through the steri-
lizing filter, and goes from there via a silicone 
tube directly into the glass reservoir (dialy-
sate). Immediately in front of it is the 2 liter 
filter attachment (filling port above), which is 
routinely used for filtration of albumin solu-
tion in step 2. But since the large 10-liter con-
tainer cannot be emptied completely, the 2-l 
vessel filter attachment can also be used to 
ƐƚĞƌŝůŝǌĞ ƚŚĞ у 200ml that remains, leaving 
only minimal amounts of residue in the filter 
(Sartorius, Göttingen, Germany). 
Fig. 4.5.2.: Filtration-assembly 2. 
The filtration attachment, mounted 
for filtration of 5 or 10liters of dialy-
sate (Step1). In the second step, 200-
ml volume remaining is optionally 
filled into the filter attachment via a 
funnel on top and filtered also. In the 
third step, compressed air is connec-
ted directly to the side connector of 
the 2-liter filter attachment, and the 
perfusate (albumin solution or other 
colloids) is filled in and filtered into a 
sterile glass bottle.  
After albumin filtration, the outlet 
and tap must be cleaned very tho-
roughly, as surface residues of dried 
albumin can cause problems (position 
behind the filter). 
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4.5.2. In-line filtration 
 For renal perfusion, in-line filtration has proven to be especially suitable for the 
recirculation mode (174, 227). During the isolation of the kidney, small particles may be 
detached, which then invade the arterial vascular bed and block capillaries. Experience has 
shown that GFR in the recirculation mode is more stable with in-line filtration than without 
a filter. Here, for cell-free perfusates a pore size of between 8 and 14ђm is selected. Specifi-
cally, we use a filter with a diameter of 42mm; the filter housing is made of stainless steel 
and was obtained from Sartorius (Göttingen, Germany). When washed red blood cells are 
used, the filter should be removed, placed in a bypass or covered with a polyester mesh 
(Leon L. Miller used white silk with a mesh count of 100-150/inch (174) when blood was the 
perfusate). Sterilization conditions for the filter membrane depend on the material used. 
Cellulose acetate, but not cellulose nitrate* or polyesther mesh, can be sterilized by dry 
heat at 132°C (oven). Zoltan Endre in Oxford used two different filters when using added 
red cells one from Pall (Pall Corp. Port Washington, NY, USA) and a transfusion filter from 
Fenwal (20-40ђm) (Fenwal Inc. Lake Zurich, Il., USA) (70). If urine is returned to the 
perfusate (in pure recirculation mode or when cell-free perfusate is used), which may be 
admissible for small recirculation volumes, one runs the risk of loading cellular debris into 
the perfusate. Within about 30 min the first cellular debris (218) appear in the urine sedi-
ment (which forms as a consequence of the relative lack of oxygen; see the first fig. 2.1), 
and may block capillaries and reduce both perfusion flow and the glomerular filtration rate.  
Fig. 4.5.3.: In-line fil-
ter. The cellulose nitrate 
filter (42mm diameter, 
pores 8ђm; Sartorius, 
Göttingen, Germany) on 
the left is inserted bet-
ween the perfusion 
pump and the glass hea-
ting coil with pressure 
buffer (Windkessel) and 
bubble trap. A screw-
vent connection can be 
seen at the front end of 
the filter. To vent the lo-
wer chamber, rotation of 
the filter is necessary du-
ring the preparation.  
ȗNote: Sterilization of cellulose nitrate filters by exposure to dry heat at 132°C (in direct
contravention of the recommendations of the manufacturer) alters the pore size, causing 
the filter to clog up within a short time. 
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 Pegg has pointed out that, in his experience, only the use of “0.2 micron filters” 
provided the stability of flow rate required for perfusion of isolated perfused rabbit kid-
neys! (Sterility problem?). In addition, a reinfusion of urine is associated with the risk that 
particles in the urine (tubular cell aggregates etc.) will enter the renal capillary bed and 
contribute to an increase in perfusion resistance (196-200). Our own observations show 
(218) that during cell-free perfusion cellular debris appears in the urine sediment within 
about 30 min after the start of perfusion; this phenomenon is not observed when the 
perfusate contains added erythrocytes. There is also a report (263) which describes the 
morphological damage that occurs in P3 proximal tubular segments and TAL segments 
during cell-free perfusion. An additional way to maintain stable flow rate in pure recircu-
lation and constant-pressure perfusion is to add verapamil, a calcium-channel blocker (99). 
This, however, leads to the loss of all autoregulation of the perfusion rate (see Fig.10.1.10).  
Fig. 4.5.4.: Temperature controlled glass coil with buffering ȋȌǡ
bubble trap, and return connection. Perfusate flows from left to right. The volume of the 
buffering chamber visible at the left end can be changed by adding an extension on top, as 
shown (s.a. Fig. 4.5.3.). On the right is a T-outlet that provides for the return of medium to 
the reservoir prior to the start of perfusion, which avoids “no flow” areas. Dimensions: 
overall length: 295mm, o.d. of glass tube 38mm, glass coil o.d. 6mm, i.d. 2.5mm. Glass 
screw thread standard GL 14 for water circulation thermostat.  
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4.6. Cannulation 
4.6.1. Arterial access to the kidney, perfusion cannulas 
 The original technique used by Weiss (307) was to intubate the right renal artery via 
the aorta (not via mesenteric artery, which is not shown in the original sketch). The arterial 
cannula was slipped into the renal artery through intubation of the distal aorta. The vena 
cava was intubated by a cannula with lateral perforations from caudal (L4) and ligated on 
the cranial side (L6).  
Fig. 4.6.1: Modified original sketch of the cannulation technique used by  
ȋ͵Ͳ͹ȌǤ Schematic diagram of the surgical field showing ligation points. The pressure 
measurement was performed just before the narrow end of the cannula. The sketch is 
modified and based on the original publication by Weiss, in which the mesenteric artery 
(along which later on the cannula was inserted into the renal artery) was not shown. Repro-
duced by permission of the APS.  
Fig. 4.6.2.: Technique for cannulation of 
the right renal artery with a glass can-
nula via mesenteric artery. This approach 
ideally requires that both vessels branch off at 
the same level (185), which is not always the 
case. The Figure is modified from the version 
in the handbook by Brian D. Ross (224). The 
dimensions of the glass cannula is 3.5mm 
(o.d.) and 2mm (i.d.), tapering to 1.3mm o.d. 
and 1mm i.d. at the tip, which permit 
intubation of the mesenteric artery of rats 
weighing 350 to 400g. Reproduced by permis-
sion of the author.  
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 To measure the effective perfusion pressure, we modified this technique in 1971 - 
perfusing via a cannula inserted in the mesenteric artery and measuring the perfusion 
pressure via the distal aorta (251, 256). Later on, we used this arrangement for constant-
pressure perfusion with feedback control of the perfusion pump. We then went on to 
develop the double-barreled cannula, with which only the distal aorta was intubated (253, 
254). Unaware of this technique, which was described in 1975 and 1976, 6 years later 
Loutzenhiser et al. (157) referred to the errors associated with indirect pressure measure-
ment prior to the stenosis of the cannula.  
Fig. 4.6.3.: Schematic diagram of the set-up used by Schurek 1969-1975 (256, 257). 
The cannula for perfusion is positioned in the mesenteric artery, the cannula for pressure 
sensing in the aorta. The venous cannula is mounted on the valve block on the right and is 
introduced from the cranial end into the vena cava inferior and ligated. By moving the 
piston in the valve block, the preconstricted arterial bypass is opened to the gas electrodes 
and the venous channel is now bypassed. The gas electrodes are always open to the 
atmosphere at one end, in order to avoid pressure fluctuations on their membranes. Note 
that the valve block was used only in the single pass mode. The current standard 
technique uses a double-barreled cannula inserted via the aorta from caudal end and was 
developed later (253, 254). This requires ligation of the suprarenal artery and smaller side 
branches of the aorta between the cannula and the right renal artery. Oil was introduced 
into the system only in connection with micro-puncture experiments in the single pass 
mode, and the urine receptacle was covered with a layer of oil only if volumes of urine 
were very low (rare). For the more recent system with valve block, see Figs. 8.2.10 - 8.2.12.  
ͷͻ
Fig. 4.6.4.: Schematic 
diagram of the standard 
cannula used in the aor-
tic position since 1974. 
The double-barreled can-
nula has a circumferential 
groove at the front which 
serves to anchor the 
binding thread. The ball-
lock pin fits into a magne-
tic recess in the block to 
facilitate cannulation of 
the aorta (253, 254). First 
description 1975.   
o.d., outer diameter;  
i.d., inner diameter. 
Fig. 4.6.5.: Detailed view of the aortic cannula. The cannula is mounted via a magnetic 
ball-and-socket joint (IBS Magnet, Berlin, Germany). The left port connects the inner 
cannula with the pressure transducer. The arterial bypass is clamped off with an alligator 
clip, which is opened for arterial pO2-measurements. The small protruding inner cannula 
serves as a pioneer for the intubation of the aorta. The stainless steel needles are firmly 
affixed to the acrylic block.  
͸Ͳ
Fig. 4.6.6.: Detailed view showing the inner cannula. The protruding inner cannula 
seen on the right extends all the way back to the angled connection that links it to the 
pressure transducer. The circulating perfusate is sealed off from contact with the pressure 
channel.  
4.6.2. Venous Cannulation 
Many authors avoid the venous cannulation altogether, and view it skeptically (162, 
163). However, it is necessary for the measurement of oxygen consumption, and our 
procedure allows it to be done without difficulty. After renal perfusion has been estab-
lished and flow rate and perfusion pressure is being continuously recorded by a chart 
recorder, we ligate the vena cava and can intubate it quite easily. The venous cannula can 
be pivoted near the venous opening and one can draw the vein over the cannula with two 
fine watchmaker’s tweezers and fix it. Then the open distal end of the vena cava can be 
closed with a ligature. In each phase, one can read on the continuous flow recording 
whether an obstruction arises etc. Fig. 4.6.3 shows the set-up we used until about 1975. 
For the technique used later on, see Figs. 8.2.04 and 8.2.11 and the last model in 8.2.12. 
͸ͳ
Fig 4.6.7.: Venous cannula with swivel. The vertical T-outlet of the venous cannula 
serves as a fulcrum and allows one to swivel it into the open cranial end of the vena cava. 
After fixing the cannula with the ligature, the distal end of the vena cava is also ligated. The 
effluent flows into the funnel below the kidney tray; on the right is a Luer-connector for 
venous sampling via a syringe. The outer diameter of the cannula is 3.2mm. The thin 
portion of the T-outlet is connected to the Tygon tubing for the pO2-pressure measure-
ment. For further details, see the Technical Appendix. 
4.6.3. Ureteral catheter 
It is crucial to select the proper ureteral catheter. In 1972 Cortell had pointed out (59) that 
the PE10 tube commonly used in rats with e.g. 50-100mm length is inadequate at higher 
urine flow rates, especially when low-molecular-weight fractions of colloids are filtered and 
enhance the viscosity of the urine. Two studies (34, 152) describe the phenomenon of 
“erratic behavior” of GFR in the IPRK at low colloid-osmotic pressure, i.e., a drop in the GFR 
instead of the expected increase. When the “appropriate” catheter is used, the GFR 
increases as the colloid-osmotic pressure falls, as one would expect on the basis of 
Starling´s concept (287). For perfusion with colloid-free media, it is necessary to remove 
the kidney capsule in order to avoid compression in the vascular tree and the tubules due 
to interstitial swelling. Under these conditions, the proximal tubular pressure reaches 
50mmHg without decapsulation at a GFR of approximately 0.5ml/min·g kidney; with decap-
sulation the corresponding values are 30mmHg and 1.2-1.6ml/min·g kidney under other-
wise comparable conditions (i.e. an effective arterial pressure of 90mmHg, see Fig. 4.7.1). A 
critical point is a bleeding into an already cannulated ureter, especially at low urine flow 
rates and because the obstruction may be discovered late. With a continuous recording of 
the perfusion flow rate, such a blockage may become apparent earlier (by flow depression). 
The tip of the ureteral catheter should not be thrust to the renal pelvis, as this can easily 
lead to hemorrhage. One way to reduce complications is to intubate the ureter with a 
bubble-free prefilled catheter. Some authors administer mannitol i.v. and intubate the 
expanded ureter under osmotic diuresis. 
͸ʹ
Fig. 4.6.8.: Front end of the ureteral catheter. 1. PE50 tubing, drawn out after heating 
to taper it. Note the considerably thinner wall and the taper. 2, 3. PE50 joined to PP10 with 
(2) or without (3) a spacer. The catheter is tied in front and secured with the ureter ligation 
thread. In the early years, we also tapered glass cannulas, extended with PE50 (s.a. Fig. 
4.7.0). 
 If the upper third of the ureter is intubated with a “dry” catheter, after the initial filling 
of the tip, one can observe that the urine front proceeds with each contraction of the 
ureter/kidney pelvis. This is somewhat dependent on the state of diuresis. To stimulate 
urinary flow some authors use mannitol or furosemide. Avoid the entry of air bubbles into a 
prefilled ureteral catheter.  
Hydrodynamics in the Nephron and the Colloid-Osmotic Pressure (COP) 
 In the early days we calculated the colloid-osmotic pressure using the formula of Landis 
and Pappenheimer (140) for albumin. These values are slightly higher than measured later 
on with a 20000 Dalton membrane (Osmomat 050, Fa. Gonotec, Berlin, Germany), see 
Chapter 9.7. Landis and Pappenheimer proposed the following empirical formula for colloid 
osmotic pressure due to albumin: 2.8c + 0.18c² + 0.0012c³, where c is the concentration of 
albumin in g/dl.  
͸͵
Fig. 4.6.9.: Pressure conditions in the glomerulus. Hydrodynamics of superficial 
nephrons plotted against the albumin concentration in the perfusate. Tubular free-flow 
pressure (ffp) and stop-flow pressure (sfp) are measured in the same early proximal tubule 
(250). We calculated the glomerular capillary pressure from sfp and the calculated colloid-
osmotic pressure (mean±SEM). Tubular pressures were measured by two different 
methods (141, 154) first by Gerd Schwietzer with the Landis technique (0% BSA) (141), and 
by Klaus Hinrich Neumann with the Berlin technique (154) (BSA=>2g %). See also results, 
Chapter 11.   
͸Ͷ
Fig. 4.7.0.: Characteristics of ureter catheters. The diagram provides an overview of 
catheter characteristics, which were investigated systematically using 0.9% NaCl-solution. The 
flow-dependent increase in pressure in various plastic tubes that are used as ureteral catheters 
serves as a measure of flow resistance. The PE10 catheter was the cause of the artefactual 
“erratic behavior” of GFR referred to above. As a standard catheter, we used either a 
combination of a short length of PP10 inserted in PE50 or PE50 with a glass tip. The thin PP10 
catheter was shorter than 10mm (PP = polypropylene, PE = polyethylene). The Figure is from 
the 1981 Habilitation (250). 
 We have used as standard catheter the combination PP10 short/PE50 longer or PE20 
short/PE50 longer or a glass tip and PE50 (same pressure profile). The thin PP10 catheter at 
the tip was less than 10mm long (PP = polypropylen, PE = polyethylene). The Fig. is from the 
habilitation thesis of 1981 (250). The PE10 tube has an i.d. of 0.011 inches and an o.d. of 
0.024 (i.e., 0.28mm i.d. and 0.61mm o.d.). The corresponding values for PE50 are 0,023 and 
0,038 inch (0.58mm and 0.97mm). The PE50 thermally on PP10 level and thus get an 
optimal ureteral catheter. Even better may be a rounded glass tip attached to PE50.  
Importance of the kidney capsule for the perfusion without colloids 
 In single pass mode, the kidney capsule should be removed on the ventral side before 
the start of perfusion when a colloid-free perfusate is used. The capsule facing the hilum is 
raised a little with fine watchmaker’s tweezers, and can then be easily cut away. In the rat 
kidney, there are no significant vascular connections to the capsule, unlike the case e.g. 
with the kidney of the cat (as venous drainage through the capsule). Fig. 4.7.1 demonstra-
tes the impact of the presence of an intact capsule upon GFR and the hydrostatic pressure 
͸ͷ
measured in early proximal tubules (so far unpublished); a first notice was given by Fülgraff 
(84b) in micropuncture experiments in vivo (furosemide diuresis). A prerequisite for the 
high GFR is a free urinary outflow (i.e. ureteral catheter with a sufficient bore (i.d)). Two 
papers in which a PE10 tube was used as a ureteral catheter reported a low GFR and 
referred to it as the “erratic behavior” of GFR (34, 152). This is incompatible with Starling´s 
concept (287) and has been shown to be an artifact* (245, 250, 251). The micropuncture 
data have been obtained by the Landis technique** (141) together with Gerd Schwietzer 
and by the technique from our Berlin laboratory*** (154) together with Klaus Hinrich 
Neumann.   
Fig. 4.7.1.: Isolated perfused kidney, single pass, colloid-free perfusate. The impact of 
decapsulation on colloid-free perfusion emerges from these data. The increased tubular 
pressure observed when the capsule is left intact limits the GFR; detaching the capsule 
causes the tubular pressure to fall and increases GFR. In our 1981 publication (251), decap-
sulation was not used systematically. This practice was prompted by the above findings and 
has been followed since then, with the result that initial perfusion rate and GFR are 
significantly higher (unpublished findings). For colloid-free perfusion, an effective perfusion 
pressure of 90mmHg is adequate (with colloid 100mmHg).  
* In vivo a ureter with peristalsis wins out over a PE10 catheter, as urine is actively
propulsed in the former. 
** Dr. Gerd Schwietzer performed the micropuncture experiments in the Hannover 
laboratory using the Landis technique (unpublished). At that time he was Prof. Karl-Heinz 
Gertz´s assistant at the Institute of Physiology (Hannover Medical School). 
*** Dr. Klaus Hinrich Neumann performed the micropuncture experiments in the Hannover 
Laboratory using the Berlin system of pressure measurement, see Chapter 13.0. 
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5. Material for the perfusion apparatus
5.1. Single-pass System 
 We designed the perfusion apparatus in such a way that the different perfusion 
techniques (single-pass mode, pure recirculation and recirculation with dialysis) can be 
carried out without major modifications. A thermostatic trough with immersion thermostat 
and circulation pump was large enough for both the 5-liter dialysate reservoir as well as 
providing for gas humidification. A ground-glass stopper attached to a plunger inserted in a 
500-ml Erlenmeyer flask was used as a glass frit to humidify the gas, which passes into a 
water bath-jacketed glass coil. In order to avoid the ingress of condensation, a second 
water bath jacketed glass coil was inserted downstream as an added drying measure. A 
glass riser (3-4cm in diameter, 200cm high) for the effluent gas was optionally incorporated 
to increase its partial pressure, which is adjusted by altering the immersion depth of the 
pipe (tube) in the water column; this can also be used as a hydrostatic pressure drive (s.a. 
fig. 4.2.2.). A typical gas mixture of 95% O2 and 5% CO2 does not result in the theoretical 
pO2 of e.g. 760mmHg - 47mmHg water vapor pressure = 713mmHg x 0.95 = 677mmHg, but 
to pressures of 450-600mmHg, depending on conditions, including the perfusion flow rate 
and the rate of (unavoidable) diffusion of oxygen from tubes.  
Fig. 5.1.01.: Control of temperature and gas humidification. A glass frit attached to a 
plunger is inserted into an Erlenmeyer flask filled with distilled water and moistens the gas, 
which is warmed up by passage through the water bath jacketed glass coil. In order to 
avoid percolation of condensation into the perfusate, a second water bath-jacketed glass 
coil is used to slightly dry the gas before it flows into the dialysate or to the membrane 
oxygenator.  
͸͹
Fig. 5.1.02.: 5-liter wide-mouth bottle 
with ground-glass  ȋ ;ͼȀͻͻȌ
attached to a plunger with four ports.
Triple-dip tube: Narrow central tube with 
an opening just above the bottom of the 
bottle (top left port- without screw-cap). 
Above the central tube is the next gas inlet 
tube, which in an upwardly open glass frit 
opens at the bottom (upper port on the 
right). Above the third wide glass tube, 
which has two lateral outlets directed 
downward for recycling of the medium – 
lower port on the left – and a further lower 
port for venting on the right. The glass 
tubes that are bent over the glass frit cause 
rotation of the medium to facilitate mixing 
(a magnetic stirrer that fits in the space 
between the glass frit and the bottom of 
the bottle can also be used for this pur-
pose). The system is suitable for the single 
pass-mode as well as the recirculation 
mode with dialysis (Glass-workshop MH-
Hannover modified in Münster).  
The inset shows details of the mixing 
nozzles for the recirculating dialysate 
positioned directly above the frit. 
͸ͺ
Fig. 5.1.03.: Temperature controlled bridge towards the recirculation pump versus 
perfusion pump, inlet and outlet ports for the circulating water are on the right, and on the 
left is the venting port. An additional middle glass tube allows the inlet and outlet for the 
circulation thermostat on one side only (the right). Overall length: 725mm, outer glass tube 
diameter 38mm, inner tube: o.d. 6mm, i.d. 2.5mm. 
Fig. 5.1.04.: Recirculation pump (also usable in single pass mode, reducing stagnant 
liquid columns, and providing an additional stirring effect in the reservoir). On the right is 
the perfusion pump that supplies the kidney. The pump provides tachogenerator feedback 
(speed sensor) as an analog output so that the rotation rate (which is documented by a 
chart recorder) serves as a proxy for the flow rate. Since this signal is also used for feedback 
control, a booster amplifier is required to drive the recorder. The recirculation pump 
(dialyzer) is operated with two pump hoses in mode 3, one for the dialysate, the other for 
the perfusate. The flow rates (proportion) can be set differently by appropriate selection of 
tubing with the same wall thickness but different inner diameters. 
͸ͻ
Fig. 5.1.05.: Control unit for the perfusion pump for use in constant-flow or 
constant-pressure mode. The slots on the left send analog data on pressure and flow to 
the chart recorder, the next slot to the right serves for the zero calibration of the pressure 
transducer. The third slot is the connection to the roller pump. We use the tachogenerator 
(speed sensor) signal from the roller pump to regulate the constant pressure mode and to 
deliver the analog data on the flow rate to the chart recorder. Here, the pressure can be 
changed in steps of e.g. 20mmHg or continuously, or the pumping mode can be switched to 
constant flow perfusion. The following two modules are indicators for flow and pressure. 
The first of these slots provides a digital display of pressure and flow. The second slot 
displays pressure and flow rates without damping on the vertical LEDs, providing visual 
readout of pulse rate and amplitude.  
Steady-state infusion of hormones or pharmaceuticals 
 Joachim Lutz in Würzburg developed a system that allows the tachogenerator feedback 
signal from the perfusion pump (after appropriate amplification) to drive an infusion pump 
that responds proportionately to the flow (160). If a vasoactive substance is infused and the 
flow rate decreases, the rate of infusion of the substance is proportionately reduced. Thus 
the final concentration in the perfusate remains the same, and a steady state is easily 
achieved. We have implemented the system in our control unit (s. fig. 5.1.0.6). 
͹Ͳ
Fig. 5.1.06.: Detailed image to 
top. The unit on the right in-
cludes the circuitry that drives 
two infusion pumps proportio-
nately to the perfusion rate. This 
enables the concentration of 
infused vasoactive hormones, 
for example, to be held constant 
during pressure-constant opera-
tion at varying flow rate. This 
has been used, inter alia, in col-
laboration with my colleague 
Armin Kurtz, and in the studies 
of the effect of angiotensin II 
done with Hermann Thole (136, 
296). 
Fig. 5.1.07.: Pressure transdu-
cer with preamplifier and 
manual calibration*. 
This disposable system, deve-
loped for ICU´s, is also suitable 
for continuous use in clinical 
research laboratories. 
*The small blue rectangle is the
calibration button for 
100 mmHg.  
Fig. 5.1.08.: In-line filter. (s.a. 
fig. 5.1.10, membranes with 8-
12ђm pore size). Optional in the 
single pass mode, essential for 
the recirculation mode, but not 
suitable for situations in which 
red cells are used. For this last 
case, Endre has reported the 
successful use of Pall/ Fenwall 
(20-40ђm) transfusion filters 
(70). Leon L. Miller used white 
silk with a mesh size of 100-
150/inch for the perfusion of the 
isolated liver (174).  
͹ͳ
Fig. 5.1.09.: A close-up view of the components below the level of the perfusion 
stage (right). A magnetic stirrer is placed below the cross; when recirculation is used, the 
cross marks the position of the temperature controlled reservoir for the perfusate which is 
stirred with a magnetic rod. We use polypropylen-couplings employed in compressed air 
technologies (Colder Products Company, St. Paul, MN. USA) to connect tubes, both in the 
perfusion circuit and in the circulation system used to maintain system temperature. These 
are available with and without check valves.  
Fig. 5.1.10.: -exten-
sionǤ The pressure buffer can be 
varied in height or fully clamped 
off, e.g. to achieve a pulsatility of 
flow and pressure. On the left is 
an in-line filter with a vent port 
(Sartorius, Göttingen, Germany).  
͹ʹ
Fig. 5.1.11.: Perfusion  ȋ version for micropuncture experimentsȌǤ
The platform is placed in a drip tray, and equipped with mounting brackets for the kidney 
tray. Below and in front of the kidney tray is the aperture for insertion of the collecting 
funnel and opposite it is the mounting bracket for the perfusion cannula, (the perfusion 
“gun”). After the start of perfusion we lower the scissor lift on which the operation table 
rests, the remaining connections to the animal are severed and the temperature-controlled 
table is removed together with the donor animal.
Fig. 5.1.12.: -
ted kidney tray made of 
stainless steel. The insert hol-
der permits loading from 
above, so that the kidney can 
be placed in the kidney tray 
with the renal hilum projecting 
from the opening in the front 
wall. The tray on the left has a 
suction tube laser-welded to 
the sidewall. For details and 
dimension, see Fig. 15.0.8 at 
the Appendix. 
͹͵
Fig. 5.1.13.: Constant-temperature flow cell for the oxygen electrode.A small roller 
pump drives the aliquot used for the measurement through the flow cell at a rate of 3-4 
ml/min. The venous pO2 is monitored continuously, arterial pO2 is measured intermittently. 
In the single pass mode the fluid is discarded, otherwise it is recirculated. The connection 
upstream of the flow cell is open to the atmosphere. For arterial measurements, the valve 
bar is displaced electro-pneumatically and opens the preconstricted arterial bypass. Under 
constant-pressure perfusion the flow rate increases to the same extent as in the bypass. 
For micropuncture experiments the flow cell was rearranged backwards. The electro-
pneumatic actuator allows vibration-free switching from venous monitoring to short 
periods of arterial measurement even during micropuncture.  
Fig. 5.1.14.: Small roller pump. 
This is used to supply the flow cell 
(at 3 - 4ml/min) during  pO2-mea-
surement. 
͹Ͷ
Setup for the calibration of the oxygen macro electrode 
Fig. 5.1.15.: Calibration of the O2-electrode. The sketch on the right is the original 
drawing of the mixing chamber used for blood gas equilibration in an Astrup pH-meter, 
which we repurposed for calibration of the O2-electrode. Below left is a schematic 
depiction of the double-walled 
glass cylinders used for 
equilibration of O2 and N2. The 
glass (circulation thermostat) 
chambers are connected in 
series; the cylinders vent via 
the connections on the top, as 
shown on the left below. In 
the coils the gases absorb 
moisture and flow into the 
mixing chamber shown above, 
and from there via a four-way 
valve to the O2-electrode. The 
Astrup design provided an 
optimal solution to the prob-
lem of saturating the gases. The dry gas flows into the cylinder from below, rises in the 
lower small tube, is deflected and emerges from the aperture at the bottom into the 
aqueous phase in the form of small gas 
bubbles that rise to the surface, 
emerging from the water and then 
pass, warmed and moisture, via the 
inner double-lumen connecting tube 
into the mixing chamber. The outer 
tube transports the temperature 
controlled circulating water. Repli-
cating these glass parts is a challenge 
for every glassblower. A zero 
calibration of the O2-electrode can also 
be achieved with a thiosulfate 
solution. 
(Na2S2O3). 
͹ͷ
Fig. 5.1.16.: Effluent reservoir with inlet tube.On the left the perfusion pump, the in-
line filter and the jacketed glass coil. The (bronze-colored) feedback-controlled infusion 
pump is mounted on top. On the bottom left are control modules for the magnetic stirrer 
that mixes perfusate with the test infusion and for the peristaltic pump for the gas pressure 
measurement (pO2). 
͹͸
5.2. Recirculation system 
 The different systems available are adapted to specific requirements. Thus, the system 
favored by Maack for hormone studies is well established, but the version shown in Figure 
5.2.1 is not suitable for use under the well-controlled conditions necessary for 
micropuncture studies, and was later modified accordingly (63). 
Fig 5.2.1.: Recirculation system used by Maack and Bowman. This demonstrates 
Thomas Maack´s preferred - and in his opinion very simple - IPRK system, which was 
described in a paper from 1972 (35) and whose advantages and limitations were later 
discussed in detail (162, 163). (Copyright permission APS). The detailed modified figure on 
the right is from a later work of Bowman (33).  
 Maack asserts that a trained experimenter should be able to connect his system to the 
"wash out" bottle within 10-minutes! After washing, the recirculation circuit is closed and 
the kidney is suspended in the constant-temperature oxygenator. He registered pressure 
and flow rate visually, and took samples via the four-way valve upstream and downstream 
of the kidney. Oxygenator and reservoir form a unit. The original recirculation apparatus 
used by the Oxford Group (described in chapter 4 (Fig. 4.3.3)) has a separate reservoir.  
 The apparatus we used is shown schematically in Fig. 5.2.2. Unlike the single-pass 
system, this requires a perfusate reservoir, which is placed on a magnetic stirrer. Fig. 5.2.2 
shows the variant we last used, jacketed for water circulation and with a filling volume of 
150-200ml. When erythrocytes are used at a volume fraction of 5-10%, a magnetic stirrer 
prevents sedimentation of the cells. The recirculation pump drives the perfusate at a flow 
rate of 100ml/min (up to 200ml/min with cell free medium) via the membrane oxygenator. 
The aliquot for the kidney preparation (20-40ml/min) is diverted from the perfusion line 
and pumped via an obligatory filter to the kidney; for cell-free perfusate 8-12ђm filter 
porosity is sufficient, otherwise larger pores are needed, i.e. a polyester mesh or white silk 
as used by Leon L. Miller (174) or without a filter.  
͹͹
This apparatus enables perfusion in either flow- or pressure-constant mode. The 
perfusion pressure is measured at the tip of the double-barreled cannula and recorded as 
an analog signal, and the flow rate is measured via the tachogenerator feedback (speed 
sensor) from the perfusion pump 5. The degree of functional stability provided by the 
recirculation system is less than that attainable when the perfusate is regenerated by 
dialysis (see also Table 10.1., Chapter 10.2). 
Fig. 5.2.2.: Schematic diagram of the basic recirculation unit ȋʹͶ͸ȌǤ 1. Double-bar-
reled cannula, shown here with a third port (e.g. for injection of a Lissamine Green bolus to 
estimate tubular passage times), 2. Ureter catheter. 3. Venous cannula, which protrudes 
through the vena cava into the renal vein. 4. Jacketed reservoir, connected to a tempera-
ture controlled water bath. 5. Feedback regulated peristaltic pump with a tachogenerator 
feedback for analog recording of the flow rate, 6. In-line filter, 8-ђm porosity. 7. Adjustable 
buffering chamber (Windkessel), variable volume. 8. Pressure transducer. Originally a Stat-
ham element was used, but this has been superseded by a disposable system with integra-
ted amplifier and calibration button. 9. Collecting funnel with valve-controlled effluent 
recycling to reduce foaming. 10. Suction line for the pO2-electrode; venous pO2 can be 
measured continuously and arterial pO2 discontinuously via the arterial bypass (adjustable 
preconstricted bypass line). 11. Water-heated kidney tray. 12. pO2-electrode in tempera-
ture-controlled glass cuvette.ͳ͵ǤȋεεͷȌǤͳͶǤǦ
ȋ	ͶǤͶǤͲͻǤȌǤͳͻͺͲȋʹͶ͸ǡʹ͸ͺȌǤ
͹ͺ
Fig. 5.2.3.: Photograph of the recirculation circuit with membrane oxygenator.The 
recirculation pump is positioned upstream of the membrane oxygenator, supplying the 
oxygenator with an increased circulation volume. Thus, the perfusion pump is always 
supplied with freshly equilibrated perfusate for the kidney. The jacketed reservoir is used in 
mode 2, as well as in mode 3 with dialysis. In mode 3 we use an adjustable measuring rod 
as one electrode, while a stainless steel tube which passes through a double-walled glass 
tube serves as the second. This latter tube returns the venous effluent (and the aliquot 
which is pumped through the oxygen electrode) and provides the contact with the 
perfusate surface necessary for the electronic level control, see Fig. 5.3.2. 
5.3. Recirculation mode with dialyzer for gas equilibration and 
regeneration of the perfusate 
 In this mode, it is necessary to compensate for ultrafiltration by the dialyzer i.e. by an 
automatic recycling of dialysate into the perfusate. We prefer low flux dialyzers (i.e. 
Polysulfon F4/FX5 from FMC) for this purpose. This type of dialyzer can be used either to 
increase the albumin concentration or dilute it with dialysate. The easiest way is to use two 
electronic sensors, one adjustable in height in the reservoir. With a switching module, a 
hose valve (normally closed) is opened as soon as the level of the perfusate drops below 
that of the sensor dipping electrode, causing dialysate* to flow into the perfusate until the 
contact is closed again by the dipping electrode. The presence of surface foam, which 
͹ͻ
cannot be completely avoided with albumin as a colloid, also affects the operation of the 
sensor. The best way to prevent foam is to fill the dialyzer in the correct sequence, i.e. first 
filling the dialysate path (disconnected perfusate path) at a very low flow rate, then filling 
the perfusate path in counter-current mode (from the opposite direction, disconnecting the 
dialysate path), each outflow upwards directed (one switch between). Fig. 5.3.1 depicts the 
set up schematically.  
Fig. 5.3.1.: Recirculation mode using the dialyzer to oxygenate and regenerate the 
colloid-containing perfusate (BSA)Ǥ 1. Reservoir for dialysate (5-liter, see Fig. 5.1.02); 
the tubes to pump 2 and 5 can be driven by one pump head. Pump 6 is controlled by an 
analog feedback signal from the pressure transducer (14). Dialysate is reinfused via tube 
valve 16 to compensate for ultraĮůtrĂƟon by the dialyzer (3) (the sensor electrode in the 
reservoir itself is not shown). The eŋƵent is returned via the collecƟŶŐ funnel (12), which is 
gravity-fed either through a wide-bore tube (our current pracƟce) or via a valve to minimize 
foaming (as indicated in the scheme, and as previously pracƟced), but the ůĂƩer may be not 
necessary. An electromagneƟc Ňow probe (15) is opƟonal. The system was Įrst described in 
1978 (245, 246, 250, 251). My coworker Jörg D. Biela created the above illustrĂƟon 
(unpublished). In the early years in Hannover, a centrifugal pump (Eheim type 1022) was 
used, instead of the peristaůƟc pump (2), to drive the dialysate (about 360 ml/min). The 
magneƟcally coupled rotor was easy to clean. (251).  
* The dialysate for refilling of the perfusate is diverted at a point upstream of the dialyzer,
as a positive pressure is necessary for the correct operation of the magnetic tube valve.
ͺͲ
Fig. 5.3.2.: Jacketed reservoir with magnetic stirrer. The adjustable measuring rod and 
double-walled glass tube for the recycling of perfusion fluid are shown on the right. The 
aliquot for blood gas measurement is pumped via a separately inserted narrow stainless 
steel tube, which also makes contact with the perfusate and serves as the electronic level 
control, which is used for recirculation plus dialysis (see Fig. 5.2.3., which shows the steel 
tube in the inserted position). 
5.4. Reperfusion after anatomical fixation 
 The method originated by chance when fixative leaked from the ureteral catheter 
during the fixation process. The complexity of micropuncture experiments, and the fact 
that the distribution of electric charge is preserved after fixation, prompted us to develop 
this reperfusion model. The technique used for the fixation and reperfusion has been 
described in detail in three doctoral theses and several publications (50-53, 78, 266, 317). 
The following Figures demonstrate the fixation set-up, the storage chamber for the fixed 
kidney including the perfusion cannula, the ureter catheter and the pressure-measuring 
line, as well as the set-up for reperfusing the kidney at normal temperature.  
ͺͳ
Fig. 5.4.1.: Set-up used for perfusion fixation. Fixation is carried out via the arterial 
bypass after blocking off the perfusate supply. A 1.25% solution of monomeric glutaralde-
hyde in PBS buffer with additional colloid (i.e. HAES 6 g%) is used, and a perfusate pressure 
of 150 mmHg has proven to be adequate when reperfusion is planned. Moreover, the 
addition of Verapamil shortly before the onset of fixation is important for sufficiently high 
filtration rates. The procedure was developed in 1985 and published later on (50, 53, 78, 
266, 317).  
For further details, see Chapter 10.4. 
ͺʹ
Fig. 5.4.2.: Schematic diagram of 
the reperfusion apparatus.A plexi-
glass box is used for storage of fixed 
kidneys at 4°C (see Fig. 5.4.4.). For 
reperfusion, the fixed kidney is 
flushed free of residual fixative with 
0.9% NaCl-solution (37°C) at a pres-
sure of 100mmHg. Thereafter, (see 
Fig. 5.4.3.) various test solutions can 
be used sequentially to determine 
glomerular permeability for macro-
molecules (50, 78, 266, 317)Ǥ
Fig. 5.4.3.: Temperature-controlled triple chamber.This allows three different solution 
variants to be used sequentially for recirculation perfusion. Between changes, an aliquot is 
discarded in single-pass mode to avoid a contamination of the following solution. The 
upper ports are connected to the circulation thermostat. The three ports below connect 
the three chambers. 
 The next photo shows the storage box for the perfusion cannula, the kidney, the ureter 
catheter and for the pressure-measuring line plus three-way stopcock.  
ͺ͵
Fig. 5.4.4.:  ȋȌ for fixed kidneys.On the left is the open box, with 
perfusion cannula and pressure measuring line. Fixed kidneys (bathed in fixative) can also 
be stored in the box, which is then sealed with Scotch tape and kept at 4°C until use, days 
or weeks later. 
6. Sterilization and disinfection procedures
All components of the perfusion apparatus that come into contact with perfusate or
dialysate must be thoroughly rinsed, and disinfected or sterilized. In this respect, compro-
mises should be avoided as far as possible, as our early experiences showed. Specifically, 
perfusate and dialysate must be sterilized by filtration through a 0.2 ђm filter immediately 
after preparation, in accordance with the principles of clinical hygiene. In addition, in-line 
filters should be used to avoid contaminating the recirculating medium with tissue frag-
ments inadvertently produced during the surgical procedures. Use of in-line filters is worth-
while even for single-pass perfusion, except when erythrocytes are added. In the latter 
case, large-pore filters (or none at all) may be used. Endre in Oxford used either of two 
different types of filters when red cells were added, one from Pall and a transfusion filter 
made by Fenwall (20-40ђm) (70), Leon L. Miller used white silk of 100-150 standard mesh 
(174). In retrospect, our most stable preparations were those that were done in the 
Medical University in Hannover. When gas sterilization with ethylene oxide was still in 
routine use there, sets of tubing were tightly wrapped in paper/transparency foil for gas 
sterilization, stored until the gas had diffused away completely and then reused.  
ͺͶ
6.1. Disinfection bath 
 At the end of each experiment, tubing and plastic parts, such as three or four-way 
stopcocks, are rinsed with tap water or deionized water, and immersed within a disinfec-
tion bath (10-30 liter volume, Bode Chemie, Hamburg, Germany). We have successfully 
used both sodium hypochlorite (Milton®) and Clearsurf® (quaternary ammonium com-
pounds, Fresenius Medical Care) for this purpose. The plastic material is soaked overnight, 
rinsed with deionized water on the following day, and dried in a drying cabinet at 52°C. 
Longer lengths of tubing may be ventilated with filtered compressed air and dried again.  
6.2. Thermal disinfection 
 Glass and metal parts can also be treated in the disinfection bath, or are rinsed tho-
roughly after the experiment and then heat-treated in a drying cabinet at 132°C. In addi-
tion, plastic screw-caps used for glass connections can be disinfected in this manner, provi-
ded they can withstand the high temperature (see instructions by the manufacturer). To 
avoid the risk of microbial contamination from the water baths, the use of commercial 
additives is obligatory. Clouding of glass parts can usually be remedied with 50% citric acid; 
if this fails, a bath in chromosulfuric acid (available in any glass-blower´s workshop) can 
solve the problem.  
6.3. Sterilization by ethylene oxide 
 When gas sterilization with ethylene oxide was still possible at the Medical University 
in Hannover, sets of tubing were tightly wrapped in paper/transparency foil for gas sterili-
zation, stored to allow the gas to diffuse away completely and then reused. After the switch 
to physical plasma for clinical sterilization in Münster, this was no longer practical.  
6.4. On sterility of the perfusate 
 Fig. 6.1.1 illustrates what happened when we used what was then the standard ap-
proach for the preparation of perfusate (i.e., without any sterilization). The plot clearly 
shows why we decided to use sterile perfusion solutions instead! The Haemaccel-based 
solution was prepared on the day of the experiment by mixing the dry powder with stock 
solutions of electrolytes and metabolic substrates for use in the single-pass perfusion 
mode. Note the drastic rise in perfusion resistance when the same batch of perfusate was 
used in subsequent experiments on the same day. This effect was eliminated only after the 
Haemaccel stock solution had been filtered and autoclaved, then mixed with sterile 
electrolyte stock solutions and substrates and filtered again through an 0.2-ђm membrane 
(257). When a high albumin concentration (e.g. 7g/dl) is used in the recirculation mode, this 
difficulty can be overridden by the extremely high flow rates under these conditions. 
ͺͷ
Fig. 6.4.1.: Time course of the 
flow rate in a single-pass 
perfusion with Haemaccel as 
colloid. The first perfusions be-
gan 1h after preparation of the 
solution. The subsequent ones 
were initiated on average 3,5h 
and 6,5h after perfusate prepa-
ration. Perfusion pressure was 
constant at 100mmHg (257). 
Conclusion: The time-dependent 
increase in resistance correlates 
with the level of bacterial conta-
mination.  
Fig. 6.4.2: Perfusion rate with sterile Haemaccel-solutionǤ In addition to sterilization 
of the perfusate itself, the perfusion lines were subjected to rigorous disinfection and 
sterilization. The fall in the flow rate at 20min is probably due to the filtration of low- 
molecular-weight fractions of filtered Haemaccel, which initially increases the viscosity of 
urine (257) at a time when the volume of filtrate is still low and the reabsorption capacity 
for sodium is still high.  
When H.M. Brink in Nijmegen (Netherlands) used Pluronic F108 as the colloid (43), he 
too observed an increase in viscosity in the fluid in the tubules, based on measurements of 
this colloid in the urine.
ͺ͸
7. Anesthesia
Anesthesia is commonly induced in the rat either with the barbiturate 5-ethyl-5 (1´-
methylpropyl)-2-thiobarbituric acid (Inactin®) administered at 80-150mg/kg BW i.p., or with 
a 1:40 mixture of xylacine (2%) and ketamine (10%). Thiopental (Trapanal®) is a possible 
alternative. In anesthesia, one must avoid hypothermia. To do so, the animal should be 
placed on a heated table (>40°C) and the rectal temperature must be monitored. 
 Barbiturate anesthesia induces slight hypoxia, as revealed by a stimulation of erythro-
poietin synthesis (241, 242). Active ventilation with 25% oxygen inhibits this rise in the rate 
of EPO synthesis during the operation (242). Furthermore, the typical oscillation of nephron 
function disappears under the influence of barbiturate anesthesia, but is still detectable 
after light halothane anesthesia (143, 259). This type of anesthesia (halothane and its suc-
cessor substances) is more complex to administer but easier to manage, and more suppor-
tive of renal function (119, 120). It is scarcely possible to quantify how many physiological 
investigations are carried out on small mammals in a state of hypothermia! Beginners will 
find anesthetization with Inactin easier, because the substance distributes into the fat 
stores, which then serve as a reservoir; in contrast, the combination xylacine/ketamine 
must be replenished frequently (by instillation into the peritoneum).  
 Anesthetization with gas-phase anesthetics such as halothane and its successors is 
more complex, but provides for better oxygenation (120, 143) and better renal function. 
Under these conditions, oscillations in nephron function persist, while they are suppressed 
by the barbiturate (117, 143, 259).  
8. Surgical procedures and perfusion connections
8.1. Selection of surgical instruments 
 Here several variations are possible, depending on the manner of fixation on the ope-
rating table and the surgical technique chosen. The following Fig. shows the set of surgical 
instruments we currently use. The cork inserts lateral to the operating table (temperature-
controlled by water-bath; see Fig. 8.2.01) can be used to secure abdominal-wall hooks.  
ͺ͹
Fig. 8.1.1.1.: Standard set of surgical instruments ȋȌ and a cauterizing 
electrode. Upper panel: Impaled in the cork ring on the left is a selection of home-made 
stainless steel abdominal-wall hooks, together with two additional liver hooks. At the top 
are Sugi suction swabs and cotton buds for atraumatic dissection. On the right various 
forceps, including so-called watchmaker´s forceps (third pair from the right). On the 
extreme right are two differrent-sized Deschamps ligature needles (with eyelet for securing 
thread). Besides the cork ring are scissors. The small spring scissors in the center should be 
handled with care - it is essential for cutting the ureter, as well as the mesenteric artery or 
aorta, for intubation with catheters and cannula respectively. To the right is a small 
vascular clamp and a fixing clamp built by Martin Wensing in the research workshop in 
Münster that prevents the aortic cannula from slipping out if the ligature can be tightened 
only after the start of perfusion. Lower panel: Small, battery-powered cauterizing needle 
electrode (Erbe Elektromedizin GmbH, Tübingen, Germany).  
8.2. Surgical technique and connection procedures 
 After induction of anesthesia, the animal (previously shaved on the ventral side) is 
placed on a temperature-controlled surgical or micro-puncture table. To maintain body 
temperature at 37°C (monitoring of rectal temperature is necessary), the table must be 
preheated to approximately 42-43°C. After opening of the abdominal cavity, a warm-water 
ͺͺ
pillow can be placed on the chest area, because in anesthesia, the body temperature can 
quickly drop below 35°C under anesthesia (feedback-regulated, electrically heated surgical 
tables are now available that monitor and maintain body temperature automatically). We 
have modified the surgical techniques of Weiss (307) and Bahlmann (13, 251, 253). The 
jugular vein can be initially intubated with PE10 tubing to compensate for fluid losses and 
for injection of heparin. Alternatively, heparin may be injected with a thin needle into a 
lobe of the liver immediately prior to the start of perfusion. After making a midline incision 
with scissors along the linea alba from the xiphoid process to the pubic symphysis, the 
gastric intestinal convolution is placed in a wet compress on the left and the abdominal 
cavity is exposed by securing the flaps of the abdominal wall with four appropriately 
positioned wall hooks (inserted into the lateral cork strips). To provide a better overall 
view, one may choose -- after thermal coagulation of the epigastric artery from inside the 
abdominal wall -- to resect the right abdominal wall transversely below the costal arch. 
Fig. 8.2.01.: Small animal operating table. This is a robust version for micropuncture 
experiments. An insert for the operating table, heated by a circulation thermostat, enables 
it to be positioned and removed with the scissors lift. The mobile insert enables a second 
operation to be started at a second operating table while the perfusion set-up is being 
prepared (calibrated etc.) at the first station. For connection of water-jacket tubing see Fig. 
5.1.09. 
ͺͻ
Fig. 8.2.02: Operating table and partial view of the viscera in the abdominal cavity. 
Operating table and view of the abdominal cavity, with the gastrointestinal convolution 
placed to the left and a water pillow on the chest wall to compensate for the heat loss. The 
right abdominal wall has not yet been resected.  
 To prepare the blood vessels for ligation, one should first proceed with blunt cotton 
buds to remove the thin peritoneum, and then extend using blunt tweezers. Figure 8.2.03 
presents a simplified sketch of the disposition of the abdominal vessels. One can adopt 
either a fast or a meticulous strategy. The adrenal artery, which usually sprouts from the 
right renal artery, can be tied off directly. The remaining ligatures are first set in position 
only (for this purpose we use different colored polyester sewing thread, thickness Ne 40/2). 
The fat capsule is dissected away, leaving a rim of fat around the kidney to facilitate 
manipulation of the organ with forceps, and then the connection to the adrenal gland can 
be exposed with a pair of forceps and thermally cut. Here, a flat and broad liver hook 
provides a better overview. Before cannulating the ureter, first cut the surrounding fatty 
tissue away and remove the adventitia with its associated vessels where the incision is 
planned. Close off ligature 1 and tighten the ligature on the ureter slightly (e.g. using a 
small alligator clip or forceps). Cut the ureter halfway through at a point just below the 
level of the distal end of the kidney, widen the lumen with one jaw of a watchmaker´s 
forceps, intubate with the combined catheter (10mm PP10 cut obliquely and extended by 
insertion into PE50, or a glass-catheter with PE50 inserted) and secure it twice by ligature 
(PP10 and PE50) before setting the distal cut. The catheter tip in the ureter should not be 
ͻͲ
rotated or placed too close to the renal pelvis (and certainly not positioned within it). The 
right kidney can then be gently heaved in situ within the kidney tray. This is easier to do if 
the right abdominal wall is cut transversely after having first let the vasa epigastrica of the 
abdominal wall coagulate from the inside, cranial and caudal to the intended site of 
incision. Immediately before the final connection (prior to perfusion) the mesenteric artery 
as well as the left renal artery can be ligated off, following the injection of a small bolus of 
heparin (e.g. 50ђl, 250U) i.v. or into a liver lobe (use a thin hypodermic needle). The distal 
aortic ligature can be tied off and the thread tightened (e.g. by the weight of an attached 
Halsted mosquito-clamp). After placing the vascular clip immediately distal to the origin of 
the right renal artery, the 
aorta can be cut in half. 
Under microscopic control, 
one can dilate the aorta at 
the point of incision with 
watchmaker´s forceps and in-
tubate with the (previously 
flushed) double-barreled can-
nula. The small protruding in-
ner cannula serves as a pio-
neer (the inner cannula is also 
flushed before via the pres-
sure transducer). The cannula 
is advanced to the clip, me-
chanically fixed and then liga-
ted. If the gap is too short, 
the cannula can be ligated af-
ter the start of perfusion, but 
in this case there is a risk that 
it may slip out of the aorta 
(s.a. Fig. 8.1.1.1; fixing clamp 
after Martin Wensing). 
Fig. 8.2.03.: Overall disposiƟon of the renal vasculature a Ğr gross dissecƟon. ModiĮed 
aŌer Ross (224). Tie-oī ligatures are indicated by circles, connecƟŶŐ  ligatures by broken 
circles. This scheme depicts our approach to cannulaƟon of the distal aorta with a double-
barreled cannula. Following the procedure of Bahlmann and Nishiitsutsuji-Uwo the renal 
artery was intubated via mesenteric artery, which is pracƟcal only when larger animals 
(>300 g) are used and requires “ideal” vascular anatomy (13, 185). The point of cannulaƟon 
of the ureter lies closer to the distal end of the kidney, as shown in the schemaƟc drawing. 
However, the catheter ƟƉ should not come into contact with the renal pelvis due to the risk 
of bleeding. 
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 Then connect the suction tube to a suction pump (with collecting vessel or water aspi-
rator). Tie-off the proximal aortic ligature, release the vascular clamp and begin perfusion, 
initially at constant flow (e.g. 8-10ml/min). Transect the aorta (including the associated 
sympathetic nerve on both sides) and the vena cava just below the liver, using active suc-
tion to clear the kidney tray of blood, which will otherwise obstruct your view. Lower the 
operating table together with the animal on the scissors lift. Disconnect the remaining 
connections until the kidney tray and perfusion cannula are free. The operating table is 
then pulled away with the animal, the kidney preparation is rinsed with warm saline to 
remove residual blood and the collecting funnel is swiveled or moved under the kidney 
tray. At this point, the recirculation circuit is closed and perfusion is continued in the 
pressure-constant mode. Mounted at the funnel is a metal catheter for intubation of the 
inferior vena cava, which is swung into position and fixed by ligature. The cava ligature is 
then closed distallyǤ
Fig. 8.2.04.: Position of the kidney in the tray. The kidney lies on the heated kidney tray 
(250). The warming block on the left is a relic of the time when, during single-pass perfu-
sion, tubuli were micropunctured under an oil film, which was warmed up in this way.  
The phenomenon of vasoconstriction after the start of kidney perfusion 
 Sympathetic nerve fibers/tracts run parallel to the aorta on both sides. If these nerves 
are not completely resected prior to the start of the perfusion, rapid and intense vasocon-
striction may occur in parallel with the onset of gasping. Even short-term ischemia will ruin 
the kidney preparation. This was one of the lessons that taught us the meaning of “learning 
by doing” as we systematically “dissected” the problem.  
ͻʹ
 The following Figure shows what happens, when the in-vivo circulation is switched to 
the in-vitro perfusion without first severing all links to the sympathetic nervous system.  
Fig. 8.2.05.: Historic record (1969) of sympathetically induced vasoconstriction in the 
transition phase from in-vivo to in-vitro circulation. Single-pass perfusion with Haemaccel-
Krebs-Henseleit medium. Upper panels: Respiration (monitored via a thermosensor in the 
tracheotomy tube) and blood pressure (measured in the carotid artery). Lower panels: 
Perfusion pressure, i.e. gas pressure (see Fig. 4.1.3.) and electromagnetically registered 
flow rate (arterial inflow). With ligation of the aorta and initiation of in-situ perfusion, 
blood pressure rises and respiration amplitude falls. When the vena cava is resected and 
the aorta is then cut proximally, blood pressure falls precipitously. Two scenarios are shown 
for the period following the vertical arrow: The broken lines depicting perfusion pressure 
and flow demonstrates what ensues when resection of the aorta fails to sever the 
sympathetic nerves on both sides. The solid lines show the result when the nerves are 
successfully cut through (Institut for Clinical Physiology, Steglitz Hospital, FU Berlin (now 
Benjamin Franklin Campus), ca. 1969, unpublished). 
ͻ͵
Fig. 8.2.06.: The heated stainless-steel tray currently used for the right kidney. Note 
the lateral suction tube. The asymmetrical cutout in the front wall is designed to accom-
modate the ureter caudally. The tubing attached to the rear block feeds into a U-shaped 
channel. Also visible is the scissor lift for the operating table.  
Fig. 8.2.07.: Detailed views of the mounting block for the kidney tray. The shaft 
attached to the kidney tray can be inserted into the rear bracket, enabling the kidney to be 
maneuvered obliquely into the tray from above. For details, see Chapter 15, Fig. 15.0.8 
Appendix. 
ͻͶ
Fig. 8.2.08.: Frontal view of 
the double-barreled cannula. 
In the foreground is the double-
barreled cannula with protruding 
inner barrel. Below it is the 
clamped tube for the arterial by-
pass (pO2-measurement), behind 
it the kidney tray connected to 
the water-bath, on the left the 
suction tube attached to the 
kidney tray. To the right of the 
kidney tray is the rectangular 
opening into which the arm of 
the effluent funnel is inserted 
and fixed.
Fig. 8.2.09.: Detailed view of the double-barreled cannula. Note the protruding inner 
(pressure-measuring) cannula, as well as the circumferential groove used to fix the binding 
ligature. The protruding inner cannula acts as a “pioneer” and facilitates intubation of the 
slit-cut aorta. For further details see Technical Appendix. 
ͻͷ
Fig. 8.2.10.: Schematic view of the set-up in Phase 1 after start of perfusion. The 
kidney is isolated and perfused in single-pass mode; the collecting funnel has been swiveled 
into position under the kidney tray (250). The holder can be rotated about a vertical axis. 
This type allows the effluent from the kidney to drain via the funnel directly below the 
kidney tray, separately from that from the cannulated vein. In single pass it is discarded, 
but it is returned to the reservoir in the recirculation mode. Separating the two discharges 
permits one to quantify any leakage that may occur. The block developed later has only one 
funnel. This block is only shifted laterally and no longer pivoted (251).  
ͻ͸
Fig. 8.2.11.: Schematic view of the set-up in Phase 2 after the start of perfusion. The 
collecting funnel is in position, the venous cannula is swung into the vena cava and fixed, 
and the distal ligature of the vena cava is closed, forcing the venous effluent to drain 
completely through the venous cannula. The fixation screw clamps the T-outlet, through 
which an aliquot tapped upstream of the pump can be pumped past the O2-electrode (with 
an open overflow upstream of the pump) to measure venous pO2. The arterial bypass can 
be alternately opened for measurement of arterial pO2. For further details, see Technical 
Appendix.  
ͻ͹
Fig. 8.2.12.: Perfusion with a cell-free medium. The kidney immediately takes on its 
intrinsic color. Compared to the collecting funnel shown schematically in Fig. 8.2.10/11, the 
simplified funnel in this picture is covered with a sieve plate from an online filter (collecting 
funnel made of stainless steel, Research Workshop, Münster University Hospital). Cannula 
within the aorta, the vena cava and the ureter catheter (fixed with red plasticine). The 
yellow plasticine surrounds a steel cannula, which connects the O2-measuring cuvette to 
the atmosphere. On the right in the foreground is the arterial bypass for selective measure-
ment of arterial pO2. The knurled knobs to the right of the funnel-block serve to precon-
strict and limit the flow through the arterial bypass, and fix the venous cannula to its down-
wardly branching T-piece. The venous cannula is connected to a Y-junction, one arm of 
which returns the venous effluent to the sieve plate, while the other provides a sampling 
site (Luer port) that can be used to deliver venous effluate to a blood gas monitor.  
Blood gas measurements on cell-free media may result in incorrect analyses when 
aspirated with a syringe because of the relatively small amount of physically dissolved oxy-
gen (gas) present compared with the total amount of gas in the whole blood. This is parti-
cularly true for arterial samples. Cheung has discussed this issue in connection with studies 
on the isolated perfused rat liver (49). Sampling at a freely draining outlet or the use of 
glass capillaries to which the sample adheres are preferred (see the arterial sample port in 
Fig. 8.2.13).  
ͻͺ
Fig. 8.2.13.:The holder for the perfusion cannula ȋǲǳȌǤThe “gun” is 
water-heated up to the magnetic ball-and-socket joint on which the aortic cannula is 
mounted. On the left arm, warm water flows via a silicon tube from below. In the right arm 
to which the cannula is attached, the inner steel pipe containing the perfusate is externally 
connected to a glass tube in F-form, which functions as a final bubble trap and allows one 
to take samples of arterial perfusate*. The draining tube contains the smaller Tygon tube 
that supplies the perfusate. Between experiments, perfusion cannula and inner tube are 
thoroughly rinsed and then filled with 3% formalin solution and stored until to the next 
experiment.  
* Cheung discussed the analytical problem of measurement of pO2 in cell-free media in
connection with studies in the isolated perfused rat liver (49). In earlier days, glass syringes 
were used for this purpose with smooth-running pistons.  
ͻͻ
Fig. 8.2.14.: Perfusion gun connected to the circulation thermostat. Water-bath ports 
that heat the holder for the perfusion cannula. The inner tube (which is jacketed by the 
outlet tube) contains a perfusate with added erythrocytes. Below left are the tube that 
feeds in fresh perfusate and the one that drains the circulating water. Under the table is 
the peristaltic pump that drives the circuit of the water-heated flow cell of the oxygen 
electrode. The perfusion gun is movably mounted on the shaft above the operating table, 
and can be moved in all three directions and locked into position. This provides for optimal 
positioning and fixation of the aortic cannula.  
9. Measurements: Parameters and methods
9.1. Temperature 
Passive temperature control by means of an air-conditioning system in a closed cabinet 
has many disadvantages, aside from the inherently slow response of the medium. Thus, a 
micropuncture experiment would not be possible under such conditions. Although Bahl-
mann did indeed use such a cabinet, he positioned the perfused kidney outside of it (13). 
Effective temperature control by means of a water-heated circulation system requires the 
use of double-walled, i.e. water-jacketed, vessels and connectors - a double-walled perfu-
sate reservoir, double-walled glass coils and tubes, and provision for heating of the kidney 
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tray, effluent funnel etc.. Temperature measurement is no longer a problem today as 
inexpensive devices for this purpose are readily available from consumer electronics stores. 
Rectal temperature measurement is essential for anesthetized animals (and the operating 
table must be heated) and the temperatures of the water-baths and circulation thermo-
stats must be monitored. Care should be taken to compensate for heat losses on the way 
to the perfused organ, insofar as such losses are unavoidable. See the Technical Appendix 
for details. 
9.2. Perfusion flow rate 
 For pharmacological or physiological studies of the kidney, continuous recording of 
perfusion flow rate and pressure is strongly recommended. The simplest way to do this is 
to equip the roller pump with a speed sensor (tachogenerator) and record the number of 
revolutions of the drive wheel as an analog signal on a potentiometric chart recorder. This 
type of readout promptly reveals that even slight manipulations of the ureteral catheter 
can have a direct impact on the flow rate (under constant-pressure operation) or the 
pressure (in constant-flow mode). This applies to urinary flow rates over 50-ϭϬϬʅůͬŵŝŶ͘ƚ
lower urinary flow rates, e.g. when a higher COP (6.5-7.5 g/dl BSA) is used, such unintended 
changes may otherwise be overlooked. For details of the technique used by us: see chapter 
4.2.3. One disadvantage of the method is that arterial leaks can falsify the measurement. If 
the feedback signal from the perfusion pump’s speed sensor is used to control constant-
pressure perfusion, a preamplifier is required. For our study of vasoactive substances - 
which lead to a change in resistance - we modified an infusion technique first described by 
Joachim Lutz in Würzburg (160), which allows the perfusion rate in constant-pressure mode 
to be controlled in proportion to the flow rate. This ensures that the final concentration of 
the substance under investigation remains constant throughout (see Chapter 5, Figs. 5.1.05 
and 5.1.06).   
 Electromagnetic flow measurement is a more expensive option, and requires appropri-
ate technical systems. Less costly techniques based on differences in the travel time of 
broadband ultrasonic waves are now available which are applicable to pure electrolyte 
solutions (Transonic T106 flowmeter with cannulating flow probe SN22, Transonic, Ithaca, 
NY, USA). Both methods have the advantage that they can also be used to measure the 
venous flow leaving the kidney. (60). 
 Flow measurement with a rotameter (a float in a conical glass cylinder) is a very simple 
technique, but the float must be read visually. Depending on the problem, even this 
technique may be adequate, but has obvious disadvantages compared to continuous 
measurement and continuous recording.  
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Fig. 9.2.1.:   Ǥ ͽǡ ͸Ͷͷͺ ȋ ͼ-channel chart 
ȌǤ The experiment used mode-3 perfusion (recirculation with dialysis, Krebs-
Henseleit-BSA solution with 5% washed human erythrocytes). On the right is the timestamp 
(in minutes). The perfusion pressure is 100mmHg (the pressure chosen is indicated on the 
black bar at the rear (paper output), which is set to 4, zero pressure at 9). The flow rate is 
37.5ml/min (30ml/g kidney); in this case, 0 on the black bar is the 50-ml mark, 10 is the 
zero flow mark. When the arterial bypass is opened the flow rate rises to 40ml/min with no 
change in the perfusion pressure. In the first switching maneuver (front left), the flow is still 
low, and the overshoot in the flux peak when the bypass is opened is compensated for 
manually with the knurled knob (s. Fig. 8.1.2.4.). The oxygen electrode was calibrated with 
pure oxygen and nitrogen; on the black bar the zero point (N2 calibration point) for O2 is 9, 
the O2 calibration point is at 2, corresponding to 699mmHg (the barometric pressure was 
746mmHg, water vapor pressure at 37°C was 47mmHg). The calculated oxygen consump-
tion was somewhat below 9ђmol/min g· kidney.  
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9.3. Oxygen consumption 
 When a membrane-coated Clark electrode is used, geometry and calibration of the 
electrode is somewhat dependent on the hydrostatic pressure acting on the membrane 
(pO2-electrode type MT-1-AC from Eschweiler, Kiel, Germany). For this reason, we normally 
decided not to use one electrode in the venous and a second electrode in the arterial path. 
It is easier to determine the extent of drift between initial and final calibration easily if only 
one electrode is in play. We therefore chose to use the same electrode for both venous and 
arterial measurements. A small roller pump drives an aliquot of the venous effluent past 
the electrode, which is open to the atmosphere on one side. An electropneumatically 
operated valve allows arterial perfusate to enter a pre-constricted bypass to the electrode 
for the determination of the AV difference; a small overflow is allowed in order to avoid 
sucking external air into the line. Under pressure-constant operation the extra flow through 
the bypass is actuated and adjusted automatically (s. Fig 9.1.0.). After completion of the 
calibration at the end of the experiment, the electrode in the chamber should be rinsed 
free of residues. In recirculation mode, the aliquot used for the pO2-measurement is 
recirculated also. Cheung has pointed out that, in the case of cell-free perfusion, drawing 
samples for discrete measurements with a syringe and/or processing them differently can 
easily lead to erroneous results. Sampling for this purpose should therefore be done either 
at a freely draining outlet or using a glass capillary. This problem, which arises because cell-
free perfusate contains only physically solved gases (49) while blood samples have a high 
capacity for blood gases, is negligible with the online-measurement practiced here and can 
be avoided altogether by using added erythrocytes. At venous pO2 values above 100mmHg 
with added red cells, one can calculate the AV-difference directly from the solubility of 
oxygen and the perfusion flow rate per min per g kidney.  
9.4. Urinary flow rate, urinary flow blockage 
 In Christoph Weiss´ lab, the urinary flow rate was sometimes measured at defined 
times with a pipette. We prefer to collect the urine in pre-weighed Eppendorf tubes or 
larger tubes and measure the volume gravimetrically (electronic scale, mg range) at defined 
intervals. In colloid-free single-pass experiments, 10ml test tubes are required (due to the 
high rates of filtration and urinary flow). In experiments with BSA in modes 2 and 3 
(recirculation, and recirculation with dialysis) 1.5- or 2ml Eppendorf tubes are sufficient. In 
pure recirculation mode, urine sampling periods can be kept short and the remaining urine 
can be re-infused, or replaced with an artificial solution that mimics urine, both in its 
constituents and volume. Reinfusing the remaining urine would be an alternative, but Pegg 
has noted that urine may contain particles (e.g., tubular cell aggregates or cell debris) that 
can clog renal capillaries, and he therefore uses a large 0.2-ђm filter upstream of the kidney 
to remove this material (constant sterile filtration). Urine could of course also be passed 
through minifilters before being returned (196-200). In fact, during cell-free perfusion, the 
first tubular cells and cell aggregates appear in the urine sediment after about 30 min, 
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which coincides with the time at which morphologically detectable damage, necrotic TAL 
segments and P3 segments first become manifest (7, 42, 63, 263).  
If the flow of urine is blocked deliberately (e.g. by twisting of the ureter) and the 
perfusion flow rate is being continuously recorded, the drop in the flow rate becomes 
immediately obvious, provided the flow of urine exceeds > 50 ђl/min. When the obstruc-
tion is removed, the flow rate instantaneously rises again. Obviously, such a blockage is far 
more difficult to detect with a simple rotameter - in particular at high COP and low urine 
flow rates. Continuous monitoring is far more sensitive and informative. 
9.5. Glomerular filtration rate (GFR) and its measurement 
9.5.1. Inulin, polyfructosan, sinistrin 
 Inulin was affordable when it was still being used for clinical clearance investigation. 
Meanwhile, sales figures have obviously fallen and the price has correspondingly gone up. In 
addition, either tritium- or (more commonly) 14C-radiolabeled inulin is used by authors in the 
field, especially for the recirculation technique with small volumes of perfusate. We have 
deliberately avoided radioactive markers. In recirculation mode, fluorescence-labelled 
indicator substances can be used, which are based on polyfructosan resp. sinistrin (61, 156). I 
myself have no personal experience with such markers. We used inulin and/or polyfructosan 
for a long time at concentrations of 30-100mg/dl of perfusate, either in single-pass mode or 
in the recirculation/regeneration mode. Glucose was measured enzymatically with the 
hexokinase/glucose-6-phosphate dehydrogenase method and polyfructosan was measured 
with the same assay after acid hydrolysis by incorporating a phosphorhexose isomerase 
reaction into the procedure (239). Alternatively, we used the anthrone method, which has a 
glucose error that can be kept low, as Nagel was able to show (176). In the enzymatic inulin 
analysis, Walter Pfaller´s group used a inulinase for enzymatic cleavage of polyfructosan, a 
technique first described by Kuehnle (133). This approach avoids the time-consuming acid 
hydrolysis step at high temperatures, but urine samples must be appropriately diluted.  
9.5.2. Creatinine 
 These days we make use of the rate of creatinine clearance (kinetics of the Jaffé 
reaction) as a measure of GFR, even though there are no endogenous chromogens in the 
synthetic perfusate and values for male animals are somewhat (10-20%) higher than those 
for inulin clearance, due to secretion. We routinely use creatinine at a dose of 2mg/dl (a 
maximum of 50mg/dl is possible), and add urea where appropriate (6mmol/l). Bowman has 
argued in favor of creatinine as a marker of GFR because it is easy to measure, the lack of 
interacting chromogens in the artificial medium “does not matter” and creatinine secretion 
at high dosage (up to 50mg/dl) can be neglected. Large doses provide a means of depressing 
the sodium concentration in the final urine by displacement, allowing spectacularly high (and 
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largely misleading!) fractional sodium reabsorption levels (at high COP, albumin >6g/dl) to be 
achieved. This high creatinine concentration outstrips the kidney’s secretion capacity. We do 
not use the enzymatic method for creatinine determination (as it yields too many implausible 
results). The method based on the kinetics of the Jaffé reaction gives more trustworthy 
values for perfusate and urine, especially because the otherwise interfering chromogens are 
irrelevant in this setting. However, the method has two drawbacks. First, ketoacids such as 
ŽǆĂůŽĂĐĞƚĂƚĞ͕ƉǇƌƵǀĂƚĞĂŶĚɲ-ketoglutarate can falsify the results (281, 309). Secondly, male 
rats, which we prefer to use because of their more stable hormonal status, secrete creatinine 
at higher rates than females do (100, 308), giving a clearance quotient creatinine/inulin of 
<1.2. For the keto acids listed in Table 4.2. (Recipe R2), creatinine measurement with the 
Jaffé method gives a blanc value of 0.2mg/dl prior to the addition of 2mg/dl creatinine. As 
long as the level of keto acids actually present in the urine is unknown, any correction would 
be an arbitrary one, and dilution of the urine could render it irrelevant. Koene’s group in 
Nijmegen has shown that cimetidine inhibits the secretion of creatinine in humans and, as a 
result, the clearance rate drops to the level measured for inulin (109).  
9.5.3. Other markers for determination of GFR 
 H.M. Brink’s group (also in Nijmegen) has used cyanocobalamin (vitamin B12) together 
with Pluronic F108 as colloid. Interestingly, they measured the level of this pigment in 
perfusate and urine continuously online via flow cells. Comparative measurements with 
14C-inulin were in agreement with the B12 data. Unfortunately, BSA has such a high binding 
capacity for vitamin B12 that the latter cannot be used as a marker for GFR when albumin is 
the colloid (45). Thomas Maack used radioactive Polyethylene Glycol (³H-PEG or 14C-PEG) 
with a molecular weight of 4000 (63, 118). 
9.6. Electrolytes Na, K, Ca, Cl, HCO3 
Flame photometric estimation of sodium and potassium, usually with lithium or cesium 
as standard (for example, Instrumentation Laboratory), remains the gold standard for 
electrolyte assays. Here, one can select the appropriate calibration for the plasma or urine 
standard. When automatic analyzers with ion-selective electrodes are used, one must take 
account of the calibration mode (“protein error”), for these instruments measure the ion 
activity in the protein-free space, whereas in flame photometry, the total volume is fed into 
the flame. Modern blood gas analyzers mostly provide for the measurement such as 
sodium and potassium via ion-selective electrodes, but are not normally calibrated for use 
with urine. In addition, the measurement of ionized calcium is often possible - and 
valuable, in that it is quite amazing how far apart theory (initial weight) and reality (ion 
activity) may be (even when normalized to pH 7.4) in the case of this ion. Chloride, pH and 
HCO3 are usually also measurable or can be calculated. In a study published in 1981, 
Besarab described the very complex interrelationship between total calcium and ionized or 
ultrafiltratable calcium in vitro (26).  
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Fig. 9.6.1.: ȋȌtotal cȀ++. BSA-medium 
was dialyzed against a standard-dialysate of the Krebs-Henseleit type at pH 7.4. In 
recirculation mode with dialysis, the level of ionized calcium in the albumin-containing 
medium remains constant even when the total calcium concentration in the same medium 
is increased in parallel with albumin (g/dl). Albumin was measured both chemically and 
with the Reichert refractometer. Total calcium was measured chemically with an auto-
analyzer and Ca++ ** with the ICA 113 System, the first device marketed by Radiometer 
(Copenhagen, Denmark). The latter values were verified with the ABL 505 device* in 2014. 
On both devices, a conversion to pH 7.4 was possible, resulting in the current analysis in a 
maximum delta of 0.02mmol/l with a range of 0.85 – 1.04mmol/l, at pH fluctuations of 7.36 
to 7.425.  
Note: At physiological concentrations of calcium and phosphate in vivo, the protein fetuin 
acts to dampen fluctuations. Working in vitro means that levels of these ions are always 
close to their solubility limits. It is therefore essential to keep an eye on their concen-
trations, especially when the solution is being prepared (check for the Tyndall-effect). Low 
pH can also guard against exceeding solubility limits (s.a. Chapter 4.1.3.).
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9.7. Osmolality and colloid-osmotic pressure 
Osmolality 
 Freezing point depression (Knaur, Gonotec, Berlin, Germany) or vapor pressure osmo-
metry (Wescor, Logan, UT, USA) are both time-consuming (and technically demanding) 
methods of measurement. Vapor-pressure osmometry requires less material (5-10ђl) than 
the freezing-point method (usually 50 ђl). Calibration is onerous, and automatic instru-
ments offer greater precision. For measurements of freezing-point depression on larger 
numbers of samples, the Osmomat auto (Gonotec, Berlin) provides for automatic pro-
cesssing (after calibration) of a series of 20 samples with surprisingly high precision 
(assessed in duplicate samples). The direct cryoscopy approach (Ramsey cryoscope) pre-
viously used for the analysis of micropuncture samples required only nl sample volumes 
(microcups).  
 Various authors estimate the urine osmolality by calculation (double the sum of UNa 
and UK), which is acceptable as a rough approximation (17, 27). Based on my own expe-
rience, this can underestimate the “true” (directly measured) osmolality by 5-10% (unpub-
lished). If one wants to determine the osmotic clearance, the free water clearance or free 
water reabsorption, one should always measure the osmolality directly. Note that osmo-
lality is based on 1 kg solvent 
(osmole/kg H2O), osmolarity on 
1 liter of solution (osmole/l). 
Fig. 9.7.1.: Apparatus for 
serial measurement of free-
zing-point depression. This 
picture shows the machine 
(Gonotec, Berlin, Germany) 
most recently used in our lab, 
with its (partly concealed) car-
riage for 20 samples (in the 
foreground) in which four test 
tubes are visible. For calibration, 
tube 1 is filled with double-
distilled water, 2 and 3 with cali-
bration solution. All the other 
slots are available for test 
samples. The sliding cover in 
front is retracted stepwise for 
each measurement, thus mini-
mizing losses due to evapora-
tion. 
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Colloid-osmotic pressure (COP) 
 Measurements of COP are very useful when using colloids. One should bear in mind 
that the relationship between colloid in g/l and the COP is nonlinear, because it represents 
the sum of two components, the (nonlinear) Donnan equilibrium and the (linear) Van´t Hoff 
relationship. Fig. 9.7.3 shows the relationship between the concentration of BSA (g/dl) and 
the COP (mmHg). 
Fig. 9.7.2.: Colloid osmometer (Gonotec, Berlin, Germany). Preferably, the 20,000 Dalton 
cut-off membrane is used. For calibration, an initial measurement is performed with the 
waste container on the table, and for the second it is placed on the platform (10 cm 
higher). The pressure can be expressed in three forms: mmHg, cm H2O, and kiloPascal. For 
samples with similar values, serial measurement saves a lot of time, and data protocols can 
be printed out (software available).  
The accuracy of the measurement depends on how closely the test sample resembles 
the reference solution (usually a Ringer-bicarbonate solution) on the other side of the 
separating membrane in terms of composition, temperature etc. 
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Fig. 9.7.3.: Schematic plot of the 
relationship between COP and protein 
concentration. The COP results from the 
total number of particles in the solution 
(which increases linearly with concentra-
tion) and the nonlinear Donnan effect 
exerted by the non-permeable protein (or 
colloid) fraction, and the resulting imba-
lance in the diffusion of the permeable 
particles.  
The Figure is taken from our textbook 
article, Fig. 4.18 (265).  
Fig. 9.7.4.: Colloid os-
motic pressure as a 
function of the albu-
min concentration. The 
colloid-osmotic pressure 
(COP) of bovine serum 
albumin was measured 
with a 20,000-Da cut-off 
membrane at room tem-
perature (Osmomat 50, 
Gonotec GmbH, Berlin, 
Germany). The function is 
not linear, as it reflects 
the contribution of the 
(non-linear) Donnan ef-
fect and the (linear) Van´t 
Hoff relationship. Ac-
cording to the Van´t Hoff 
relationship, the osmotic 
pressure of a solution is proportional to the number of particles. The test series is from 
2014. The measured values are slightly lower, as calculated by the Landis and 
Pappenheimer formula (140) for albumin (2.8c + 0.18c² + 0.012c³, c means the 
concentration of albumin as g/dl).  
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9.8. Colloids, substrates incl. amino acids, protein and glucose 
9.8.1. Albumin 
 The most widely used colloid is bovine serum albumin, which must be dialyzed prior to 
use to remove impurities. In the early years, we simply dissolved the dry powder and dia-
lyzed it at 4°C in cellophane tubing in 10-liter glass containers for 24 hours. Later on, we 
used disposable (low-flux) dialyzers for 4-8 h and have tried to keep the volume (of the 
starting 10% solution) constant, then we filtered the solution to sterilize it and stored it 
frozen in aliquots of 100 ml. Nevertheless, one may still come across batches of albumin 
that depart from the norm (toxic contaminants, active vasoconstrictors?). Our best results 
were achieved with a BSA preparation obtained from Armour in USA, which unfortunately 
is no longer available. A batch purchased from Sigma in 2009 has also proven to be 
satisfactory. Some authors omit the purification by dialysis and use the impurities bound to 
albumin as natural substrates in the recirculation mode. This practice was also sometimes 
followed by Brian D. Ross and his successors in Oxford and Boston. For targeted metabolic 
studies like those done by J.J. Cohen and coworkers, purification of albumin is of course 
essential, because only in this way can the initial conditions be controlled. In experiments 
with fatty acids, Cohen used, in addition to dialysis, activated charcoal to remove bound 
lipids from albumin. In vivo, albumin is constantly being synthesized in the liver and long-
lived, modified albumin molecules are disposed of (203), or go through a recycling process. 
These replenishing and recycling processes are of course not available in vitro. 
 There are blood purification methods (referred to as albumin dialysis) that use albumin 
as a sponge (loading vehicle) in liver disease. In this context, a group in Berlin (MedInnova-
tion GmbH, Berlin-Adlershof, Germany) developed a functional test for albumin. This test 
assesses the albumin molecule in terms of its physiological function as a transport molecule 
by measuring its capacity to load and offload ligands. The binding efficiency (BE in %) 
describes the extent to which the albumin molecule is able to perform its binding function; 
the efficiency of detoxification (DTE in %) indicates how effectively the molecule can off-
load toxins, i.e. deliver bound toxins and metabolites to the liver. Initial analyses of our BSA 
batches give a BE of 65% and a DTE of 61%. These values correspond to the lower end of 
the distribution for human albumin in the normal population. After dissolving the albumin 
powder in dialysate, both of the tested batches had been dialyzed extensively in the cold-
room before 100ml aliquots of 10% BSA were frozen and stored. The samples were then 
transported to MedInnovation in dry ice, and analyzed in the local ESR Lab. A systematic 
study is still pending, which should include analyses of the BSA prior to dialysis, of the 
perfusate with all the substrate additives, and the effects of treatment with activated 
charcoal treatment to free up fatty-acid binding sites. If further work validates the 
technique, this approach could suggest ways of preparing more homogenous batches. 
Extensive and detailed information on albumin can be found in “All about Albumin” by T.J. 
Peters (203).  
ͳͳͲ
Fig. 9.8.1.: Characterization of the functional efficiency of albumin by ESR. The 
binding efficiency (BE in %) quantifies the extent to which the albumin molecule is able to 
bind and transport substrates; the efficiency of detoxification (DTE in %) indicates how 
effectively the molecule can offload toxins and metabolites in the liver. Two of our BSA 
batches were compared with HSA (human serum albumin) from healthy subjects as a 
control standard, HSA as industrial standard, stabilized by the addition of fatty acids (which 
is why its BE and DTE are very low), and the latter HSA after passage through a charcoal 
absorber (HepalbinTM Absorber) to remove fatty acids. Note the marked rise in BE and DTE 
in this last case. 
9.8.2. Other colloids 
9.8.2.1. Dextran 
 In the first report of the perfusion of the rat kidney published by Christoph Weiss et al., 
dextran was used as the colloid (307). However, while this work demonstrated that 
autoregulation of renal blood flow is detectable even in the absence of erythrocytes, 
dextran is not a particularly good choice of colloid for renal perfusion. At a comparable 
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COP, it has a significantly higher viscosity than albumin. Moreover, the anthrone-based 
inulin measurement of GFR must be modified when dextran is present, as the method 
involves acid hydrolysis at elevated temperature. If this step is carried out at too high a 
temperature, dextran will be hydrolyzed to dextrose molecules, which also react with the 
chromogen (176). An alternative approach is to use the enzymatic inulinase method 
described by Kuehnle (133, 311).  
9.8.2.2. Crosslinked gelatin preparations 
 Our initial experiments in Berlin were performed with urea-crosslinked gelatin 
(Haemaccel®, Hoechst). The powder was dissolved in distilled water at a final concentration 
of 46,7g/liter, prefiltered through a glass filter, followed by removal of pyrogens by passage 
through a Seitz filter of EKS grade with porosities of 3 and 1-1.5 ђm in series. The solution 
was stored in 500ml glass bottles at 4°C after autoclaving at 110°C for 30min. This stock 
solution was mixed with sterile salt concentrates and metabolites to obtain the defined 
composition on the day of the experiment, and finally sterilized by passage through 0.2-ђm 
filter (Sartorius flat filter, 142mm diameter). Autoclaving did not increase osmolality. 
Nevertheless, the low-molecular-weight fraction of Haemaccel presents a problem for the 
hydrodynamics in the nephron. At the initially high rates of fractional sodium and water 
reabsorption, the filtered fractions of the colloid increase the viscosity of the tubular fluid. 
This is indicated by the fact that the flow rate reaches a minimum of about 8ml/min· g 
kidney after about 20min of perfusion, and Ptub is increased to the same level in the 
proximal and distal tubule*. This points to an increase in resistance around the lamina 
cribriformis of the papilla due to the increased viscosity, which itself diminishes with time 
as decreasing reabsorption capacity effectively “dilutes” the urine (Fig. 6.4.2., unpublished 
findings). Brink and coworkers in Nijmegen made comparable observations when they used 
Pluronic F108 as colloid (43, 44). The sieving properties were also dependent on the 
filtration rate. At a GFR of 100ђl/ min the sieving coefficient was 0.7, at a GFR of 800-
1000ђl/min it had dropped to 0.3.   
9.8.2.3. Pluronic, HAES 
 Holger Franke had used Pluronic as the colloid in Christoph Weiss’ lab (81). I myself 
have had no direct experience with it. The formation of micelles is one attendant difficulty. 
HAES (hydroxyethyl starch), like other artificial colloids, has the disadvantage of a higher 
viscosity relative to albumin, which makes it impossible to achieve the high flow rates 
attainable with BSA. Several authors have used HAES in combination with albumin. We 
have used HAES for perfusion fixation of kidneys for morphological studies – and the fixed 
organs were then used for reperfusion experiments – our fourth experimental model.  
* See also Fülgraff (84b): micropuncture experiments (furosemide diuresis) in vivo.
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9.8.3. Metabolic substrates 
Glucose 
 We favor a slightly elevated glucose concentration of 8.4mmol/l (compared to the 
standard concentration of 5.5 mmol/l). Earlier studies showed that even higher con-
centration of glucose (for example 20mmol/l) – as the sole substrate added – improved 
rates of sodium transport (55, 57, 226, 227, 256, 264).  
Other metabolic substrates 
 Systematic studies of the IPRK have shown that a significant improvement in sodium 
reabsorption, in parallel with the increase in O2-consumption, is achieved by the addition of 
amino acids (63, 71, 251), Krebs-cycle intermediates (257) and short-chain fatty acids such 
as butyrate. The use of long-chain fatty acids (83) also enhanced sodium transport. 
Whether supplementation with carnitine is beneficial has not yet been investigated syste-
matically. Uptake of butyrate (in contrast to propionate) does not depend on carnitine, and 
butyrate shows the strongest effects (256). Compounds that serve as substrates for gluco-
neogenesis in the kidney can theoretically compete for energy resources with energy-inten-
sive sodium transport (222). A substrate such as succinate, which donates electrons via the 
FAD system to the respiratory chain increases oxygen consumption and reduces rates of 
sodium transport, since it bypasses the first phosphorylation step in the respiratory chain. 
At higher succinate concentrations, CO2 production is so greatly reduced that one has the 
impression that the Krebs Cycle is being starved (256). Several research groups have taken 
a closer look at gluconeogenesis in the kidney. In these studies, the recirculation mode was 
used to enhance the effect (32, 58, 185). Members of F.H. Epstein’s group in Boston – in 
particular Meyer Brezis – have explored the problem of how the level of salt transport in 
the TAL-segments leads to tissue damages due to lack of oxygen, and elucidated its 
substrate dependence (40-42).  
 The following figure shows the effects of butyrate in sodium transport and oxygen 
consumption in comparison with a perfusion solution that is poor in substrates and con-
tains only 5.5mM glucose. In the early 1970s, with the aim of increasing the input of elec-
trons into the respiratory chain, we tried out mixtures of substrates that use the malate-
aspartate shuttle at the mitochondrial membrane to increase sodium transport. This ap-
proach was quite successful in the single pass mode with Haemaccel® as colloid (257) as 
was subsequently confirmed by Brian D. Ross (222). The substrate mixture consisted of 
glutamate, lactate, oxaloacetate and pyruvate, in addition to the obligatory glucose. Later 
on (using albumin as the colloid), 8 amino acids were added according to the recipe of 
Thomas Maack (63), and then the full range of 20 amino acids, as proposed by Franklin H. 
Epstein (71). The use of 5-liters of dialysate in the mode 3 meant that the supply of 
substrate was uncritical compared to a mode 2 with pure recirculation, as had been shown 
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in the case of arginine as NO source (206, 207). On the other hand, the increase in oxygen 
consumption upon substrate stimulation can exacerbate the hypoxic damage incurred 
during cell-free perfusion in the critical interbundle area of the outer medulla (41). In this 
case, the addition of washed erythrocytes alleviates this effect (263).  
Fig. 9.8.2.: Substrate effects on sodium transport and oxygen consumption. The left 
panel shows the effects of additional substrates relative to a control perfusion with 
5.5mmol/l glucose as sole substrate. Addition of butyrate increases sodium transport in 
proportion to oxygen consumption. An even more pronounced effect is seen upon 
supplementation with a mixture of glutamate, lactate, oxaloacetate and pyruvate, while 
the addition of succinate increases the oxygen consumption and reduces sodium transport 
because succinate donates its electrons to the respiratory chain at the level of the FAD 
system, thus bypassing the first phosphorylating step (NAD system). On the right is the time 
course of sodium transport (absolute and %) and oxygen consumption in control 
experiments (5.5mmol/l glucose sole substrate, dotted lines) and with the addition of the 
substrate mixture of glutamate, lactate, oxaloacetate and pyruvate over 3 h. We performed 
the experiments in single pass perfusion mode with Haemaccel as the colloid (130, 246, 
257).  
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10. Kidney perfusion: comparison of results
10.1. Single pass perfusion – recirculation with regeneration of 
perfusate by dialysis 
 All findings made without any colloid, or with a colloid other than albumin, that are 
referred to in this chapter are from single-pass experiments. All other data were obtained 
under mode-3 conditions: recirculation with dialysis and albumin as colloid. With few 
exceptions, albumin was generally not used in single-pass experiments, largely because of 
its cost (233, 234, 280). At flow rates of 15-30ml/min per g (rat) kidney, 900-1800ml of 
perfusate is consumed per hour. A 5-liter batch of medium suffices to perfuse two kidneys 
for 2 hours. When plasma substitutes such as HAES or gelatin derivatives are used, flow 
rates are in the range of 10-15ml/min (257). Specific questions may require perfusion of the 
kidney in the absence of a colloid. In that case, decapsulation of the kidney prior to 
perfusion is recommended and the perfusion pressure can be reduced to 80-90 mmHg. 
Without colloid osmotic pressure, the organs swell and perfusion resistance increases if the 
capsule is intact. On removal of the capsule, flow rates may reach 20-25ml/min·g kidney 
and a GFR of 1.0 up to 1.6ml/min·g kidney - higher than the in-vivo value – can be attained 
(at 90mmHg). The following Figures depict our own data, some of which has already been 
published (250, 251). The diagrams are designed to provide an overview of the functional 
changes that occur in response to variation of the colloid-osmotic pressure (BSA). 
Particularly noteworthy is the significant drop in perfusion resistance with increasing COP 
(albumin concentration), which is apparently induced by the expansion of the vascular bed.  
ͳͳͷ
10.1.1. Dependence of perfusion flow rate, urinary flow rate, GFR and 
 filtration fraction on albumin concentration 
Fig. 10.1.01.:Relationship between perfusion flow rate and albumin concentration 
in the perfusate. Perfusion flow rate in the “steady state” phase between 50-70min is 
plotted against the albumin concentration. Only the colloid-free perfusion was performed 
in single pass mode (250, 251), here with an intact capsule; the perfusion rate is significant-
ly higher without the capsule – equivalent to that with 2-3g/dl BSA. Data points are mean 
values ± SEM (perfusion pressure: colloid-free medium 90mmHg, otherwise 100mmHg). In 
the presence of verapamil (blue) at high BSA concentration, the flow rate is higher. The 
perfusion pressure required to achieve a comparable GFR of 1ml/min ή g kidney (as in 
experiments using 6g albumin at 100mmHg) was 140mmHg. 
ͳͳ͸
Fig. 10.1.02.: Dependence of perfusion flow rate on albumin concentration and 
duration of perfusion.Data points are mean values ± SEM. *Perfusion was initially carried 
out at a constant flow-rate of 8ml/min until the recirculation circuit was closed, then under 
constant pressure at 100mmHg. Perfusions without albumin were carried out in the single-
pass mode with intact capsule at Pa 90mmHg (mean values ± SEM) (250, 251). In perfusions 
without albumin, the flow rates are significantly higher if the renal capsule has been 
removed initially.  
 Perfusion rates increase in proportion to the concentration of albumin but, despite the 
attendant increase in oxygen supply, morphological damage in the interbundle area of the 
outer medulla cannot be fully prevented. Only the addition of erythrocytes as oxygen car-
riers can provide the required amounts of O2 (263). Here, one has to keep in mind the fact 
that, in vivo, although only 8% of the O2-supply is extracted from the blood overall, areas 
such as the outer medulla take up to 80%. In cell-free perfusion, the overall extraction level 
for the whole kidney amounts to about 50% of the physically dissolved O2. Thus, one can 
easily imagine that the level of supply becomes critical in the interbundle area of the outer 
medulla in the absence of erythrocytes. 
ͳͳ͹
Fig. 10.1.03.: Relationship between urinary flow rate andalbumin concentration in 
the perfusate. The volume of urine excreted per minute in the steady state phase 
between 50-70 min is plotted against the BSA concentration. As in Fig. 10.1.0ϭ, the blue 
data point marks the urinary flow rate at elevated perfusion pressure (140 mmHg) 
in the presence of verapamil. The plot is based on data extracted from the tables in 
the 1981 publication (250).  
 The high urinary flow rates attainable in colloid-free perfusion can only be achieved if 
the kidneys are decapsulated and ureteral catheters are used that build up no back-
pressure (see Figs. 4.6.9 - 4.7.1). Parallel filtration rates are higher than in vivo, as one 
would expect on the basis of Starling´s model (287); see Fig. 10.1.04 below. 
ͳͳͺ
Fig. 10.1.04.: Dependence of gȋpȌ
ȋͻͶ-ͽͶȌon the albumin concentration. Data points are 
mean values ± SEM. At high COP (BSA 8g/dl), GFR can be enhanced to the level observed in 
a kidney perfused by 6g/dl BSA by the addition of verapamil and application of a perfusion 
pressure of 140mmHg. There is a clear relationship between GFR and COP (BSA) as 
expected from Starlings concept. The problem of “erratic behavior” has been discussed and 
shown to be an artifact (Chapter 4.6.3, Fig. 4.7.0.). As in Fig. 10.1.01, the blue data point 
marks the value of GFR when perfusion is carried out at elevated pressure (140 mmHg) in 
the presence of verapamil. This is a prerequisite for a valid comparison of performance 
with respect to the absolute and fractional sodium reabsorption between kidneys perfused 
with 6 g% BSA and 8 g% BSA (see Figs. 10.1.12 – 10.1.14). 
ͳͳͻ
Fig.: 10.1.05.: Dependence of the glomerular 
ultrafiltration coefficient on colloid osmotic 
presȋȌǤThe surprising observation that 
glomerular permeability to water is higher at 
higher albumin concentrations (250) under in-
vivo conditions was made very early on (21). 
Although this must be considered in light of the 
fact that filtration conditions in vivo are not as 
easily characterized as they are in the isolated 
perfused kidney with its low filtration fraction 
(see Fig. 10.1.06), a compelling explanation of 
this phenomenon is still lacking. The data shown 
here were obtained in micropuncture experi-
ments that measured early proximal tubular 
free-flow and stop-flow pressures, together with 
an analysis of single-nephron gfr by sampling 
under continuous pressure control (250). The figures in parentheses on the plot indicate 
the numbers of animals used. Micropuncture was performed by Gerd Schwietzer (271), 
who used the Landis technique (141), and later on by Klaus Hinrich Neumann (181) using 
the Berlin technique (154). 
Fig. 10.1.06.: Dependence of the filtration fraction in the steady-ȋͻͶ-70 
Ȍ   ȋȌ  (250). Data points are mean values ± SEM. The 
blue data point indicates the value at high perfusion rates in the presence of verapamil (see 
Fig. 10.1.04).  
ͳʹͲ
10.1.2. Kidney weight – a problematic reference parameter 
Generally, the weight of the unperfused (but decapsulated) left kidney from the same 
animal serves as the reference for quantification of the physiological functions of the perfu-
sed right kidney (which are expressed per g kidney). Control measurements have shown 
that the difference in weight between the two kidneys of a pair is generally negligible, 
which validates the use of this approach. Some authors mention only the average rat 
weight and therefore relate physiological parameters not to kidney weight, but to 
perfusion flow rate (i.e., per ml/min). 
Fig. 10.1.07.: Ratio of the 
weight of the perfused kid-
ney to that of the collateral 
kidney.The concentration of 
albumin in the perfusate is 
plotted against the degree of 
swelling of the perfused kid-
ney or, alternatively, against 
the intratubular and intersti-
tial increase in pressure and 
volume. Data points are 
mean values ± SEM. 
The graph is taken from the 
1981 paper (250, 251) and is 
similar to the data described 
by Little (152). The (colloid-
free) perfused kidneys were not decapsulated prior to perfusion, but immediately before 
weighing, in order to avoid any contribution from the (physiologically irrelevant) lipid 
residues on the capsule and hilum. If the left collateral kidney has been completely ligated 
off (i.e. vein and artery together rather than the left renal artery alone) – which is only 
necessary if, for example, much of the left renal artery is hidden under the vein) – the 
measured weight of the dissected kidney will be about 0.2 g higher. This is probably 
attributable to the pressure drop after ligation of the renal artery alone, which allows fluid 
to leak from tubules and blood to seep from the open veins. 
Comparison of wet weight and dry weight in vivo and in vitro 
 In her 1974 doctoral thesis in Berlin (37), Petra Brandt provided a detailed study of the 
electrolyte content of renal tissue and the ratio of wet and dry weight, and compared these 
data for freshly isolated kidneys with those for Haemaccel-perfused kidneys (256). As 
control samples, she initially used slices of renal cortex obtained from freshly dissected 
ͳʹͳ
kidneys; these were then aliquoted and, after weighing, samples were taken for dry weight 
determination. On average, 100% wet weight was found to correspond of 26.0 ± 0.48 % dry 
weight. This method proved to be unsuitable for isolated perfused kidneys, because they 
contain more fluid and therefore lose more liquid when sliced. Thus, the method described 
by Reinhardt in his Habilitation thesis was to flash-freeze kidneys (within 2 seconds), after 
pinching off hilum, in liquid nitrogen and process tissue samples in the frozen state (216). 
This approach resulted for the in-vivo controls in values of 20.0 ± 0.31% dry weight (relative 
to 100% wet weight). For kidneys perfused in single-pass mode with Haemaccel and a 
standard perfusate with glucose as the sole substrate, the corresponding values were 16.85 
± 0.21% dry weight (based on 100% wet weight). In the context of the simple issue referred 
to at the top of this paragraph, Reinhardt’s procedure appears overelaborate, but its use 
was crucial for the electrolyte analysis in the work of Petra Brandt. Her thesis also 
addresses the issue in the context of comparisons between the blood-perfused kidney in 
vivo and in-vitro perfusion of the organ with cell-free medium (37).     
Fig. 10.1.08.: Ratio of the weight of the left kidney ȋȌ to the total 
weight of the donor rat. This parameter was also used as a reference factor to calculate 
die kidney function/g of the right isolated perfused kidney. Rat strain: Hannover Wistar.  
ͳʹʹ
10.1.3. Autoregulation of renal perfusion flow rate 
 An extensive literature is available on this subject, both for kidneys in vivo and isolated 
perfused kidneys (92, 93). Here, one must distinguish between cell-free solutions such as 
blood plasma and artificial colloid-containing solutions, which can be regarded as New-
tonian fluids on the one hand, and blood as an inhomogeneous suspension of particles on 
the other. For Newtonian solutions, the Hagen-Poiseuille equation applies, which already 
implies that the relationship between pressure and flow is nonlinear (see Fig. 10.1.11). For 
blood, the situation is even more complicated.    
Fig. 10.1.09.: Comparison of autoregulation of perfusion flow rate as a function of 
albumin concentration and COP respectively (250). The measurements were conduc-
ted over a 2-hour period of cell-free perfusion, during which the pressure was raised in 
steps of 20 mmHg [minutes time intervals] at albumin concentrations of 0 g and 7.5 g/dl. 
Autoregulation curves after 60 min and 120 min from a single experiment with 5 g% 
albumin are also shown. Data points are mean values ± SEM. 
ͳʹ͵
 The autoregulation curve obtained in the absence of albumin in the perfusate is very 
flat and is reminiscent of the curve observed when the kidney is replaced by a defined flow 
resistance (see Fig. 10.1.11). During cell-free perfusion, the tubulo-glomerular feedback 
(TGF) that would normally complete the autoregulation loop is not detectable (250).  
Fig. 10.1.10.: Dependence of autoregulation of the perfusion rate on the calcium 
concentration in the perfusate (single experiment). Autoregulation is abrogated by 
verapamil (4.4·10-6 M) (175, 250, 253). The nonlinear form of the curve in the presence of 
verapamil is a reflection of the Hagen-Poiseuille law. The influence of calcium in the 
perfusate is very clear. In 1976 verapamil was found to inhibit tubulo-glomerular feedback 
(175), which plays a role in completing the autoregulation loop. The concentration of 
calcium was calculated from the successive addition (250). At moderate calcium concentra-
tion, addition of angiotensin II enhances the autoregulation to the level seen with 4 mmol/l 
calcium (see Guan et al. (93)). Glucagon abolishes autoregulation of the IPRK completely, as 
Holger Franke has shown (80).   
ͳʹͶ
Fig. 10.1.11.: Pressure-flow diagram for the apparatus without an in-line kidney. 
The pressure-flow diagram follows the Hagen-Poiseuille law and is therefore non-linear. 
The curve is determined experimentally at 37°C with a 4% HAES solution and a compressed 
tube in place of the kidney. The curve observed in the presence of verapamil shown in Fig. 
10.1.10 is comparable to the experimentally determined curve for the system without a 
kidney. 
The Hagen-Poiseuille Law: 
 sȩ = Volumetric rate of flow through a pipe in m3/s 
  r  = Inner radius of the pipe in m 
  l  = Length of the pipe       in m 
ᢡ  = Dynamic viscosity of the flowing fluid in Pa· s 
ȴp  = Pressure difference within the pipe     in Pa 
  z  = Flow direction 
Pa  = Pascal 
ͳʹͷ
Implications for the autoregulation of blood/perfusion flow rate in the isolated 
kidney model 
 The pioneering work of Weiss, Passow and Rothstein in 1959 demonstrated (307) that 
autoregulation requires no red blood cells. Before that, Kinter and Pappenheimer had ar-
gued that autoregulation could be attributed to the phenomenon of “plasma skimming” 
alone (123, 195). Following the demonstration that a cell-free perfusate also exhibits auto-
regulation of renal perfusion, this notion was no longer be sustainable. Both in the in vivo 
kidney and the isolated organ, the Bayliss effect (22) is considered to be the basis for the 
autoregulation phenomena, and this is supplemented by tubulo-glomerular feedback, 
which is not detectable in the cell-free perfused kidney in our hands (unpublished studies 
undertaken together with Hans Ulrich Gutsche and Reinhard Brunkhorst in the Hannover 
Lab). However, Jürgen Schnermann was able to demonstrate a tubulo-glomerular feedback 
in the blood-perfused dog kidney (240). Nevertheless, one should not exclude plasma skim-
ming as a contributory factor; we see it as a third component, but is not relevant for the 
cell-free perfused kidney. Findings made by the group led by Bert Flemming and Erdmann 
Seeliger in Berlin (77, 272) hint at a fourth component. Whether this component plays a 
role in the isolated kidney cannot be decided at present. Our own experience is that hypo-
xia attenuates autoregulation in the IPRK model, but that a combination of angiotensin II 
and an increased calcium concentration improves autoregulation. Indeed, under the latter 
conditions, it is possible to achieve almost perfect autoregulation without any tubulo-glo-
merular feedback (see Chapter 12.3., Fig. 12.3.7.). From incidental observations, we con-
clude that peptide hormones, such as arginine vasopressin (AVP) and – in particular – 
parathyroid hormone (PTH) may also enhance autoregulation. 
10.1.4. Fractional sodium reabsorption and absolute transport rate TNa 
 The rate of sodium transport is a good criterion with which to assess the function of 
the isolated kidney. For comparisons of transport capacity, the choice of kidney weight as 
the reference parameter is just as relevant as in the case of the GFR. A fractional sodium 
reabsorption of >99%, typically found in vivo, is not attainable in vitro with cell-free per-
fusate, and at reduced filtration rates only with the addition of erythrocytes combined with 
other measures, such as supplementation with glutathione and very high levels of creati-
nine (50mg/dl, s. (162, 163)). Thomas Maack has discussed this in detail in two reviews and 
recommends the use of high concentrations of albumin in the perfusate as a means to 
achieve the COP that prevails in the capillary bed of the proximal tubules in vivo, as a 
consequence of the high glomerular filtration fraction. In the isolated kidney preparation, 
this can only be achieved - because of the low filtration fraction - if one accepts a strongly 
reduced filtration rate (GFR, see Fig. 3.0.1.). The following diagrams demonstrate the strong 
dependence of sodium transport on the amount of sodium to be filtered (Na-load). The 
perfusion solutions used here are substrate enriched, as described in 1981 (250, 251).  
ͳʹ͸
Fig. 10.1.12.: Fractional sodium reabsȋͻͶ-ͽͶȌ
plotted against ȋȌǤ In the presence of verapamil, the % Na-
reabsorption at a high COP (7.5 g% albumin) remains at the level observed at COP values 
equivalent to 6g% albumin (at comparable GFR) in its absence. The high fractional sodium 
reabsorption of >98% can be attained in a cell-free isolated perfused kidney only at reduced 
GFR with a hyperoncotic perfusate. Data points are mean values ± SEM (see Fig. 10.ϭ͘ϭϯ). 
Fig. 10.1.13.: Fractional Na-reabsorption and absolute rate of Na-transport TNa in 
    ȋͻͶ-ͽͶȌplotted against   ȋȌǤ
With colloid-free media, only 50% of the filtered sodium is reabsorbed. Data points are 
mean values ± SEM (see Fig. 10.1.14). 
ͳʹ͹
Fig. 10.1.14.: Dependence of fractional sodium reabsorption in the steady state 
 ȋͻͶ-ͽͶȌ on  ȋȌ  
	Ǥ With colloid-free perfusate, the mean Na 
reabsorption is equivalent to 50% of the total Na load and is independent of GFR. Note, 
however, the strong dependence on sodium load at higher COP. Single values (250, 251). 
The reabsorption rate falls significantly during the 2nd -3rd hours. 
10.1.5. Glucose reabsorption 
 Due to the damage induced by hypoxia in proximal tubuli within the interbundle area 
of the outer medulla (S3-segments) in the perfused kidney and the slightly elevated glucose 
concentration in the perfusate (8.4mmol/l), the fractional (%) glucose reabsorption cannot 
attain its normal level. Addition of 5% red blood cells prevents damage to the S3 segments, 
which explains why % glucose reabsorption under these conditions is higher than that seen 
in cell-free perfusions.  
Fig. 10.1.15.: Dependence of 
fractional glucose reabsorp-
tion ȋsteady state phase 50-
ͽͶȌ on albumin concen-
ȋȌǤWith verapamil, 
the % reabsorption at higher 
load is only slightly lower than 
without verapamil. The addition 
of 5% erythrocytes raises glu-
cose reabsorption to >95% even 
at low albumin concentration. 
Mean values ± SEM (250).  
ͳʹͺ
10.1.6. Potassium secretion 
 If one measures the rate of potassium secretion in rats under standard conditions 
(normal diet) in vivo in the metabolic cage, one finds about 20% of the filtered amount of 
potassium in the final/excreted urine, corresponding to a value of 0.2 expressed as 
clearance quotient: K+U/P: Creatinine (Inulin)U/P . In a paper published in 1975, Silva et al. 
reported a clearance ratio of 0.41 for the IPRK (in mode 2) and went on to state that they 
could detect net secretion only in kidneys from animals that had been chronically exposed 
to high levels of potassium in their food (276). The likely explanation for the low values in 
their experiments is as follows: The high concentration of albumin in the perfusate – 6.5-
6.8g/dl, which corresponds to an increased COP – reduces the GFR and leads to low urine 
flow rates (small lumen ureteral catheter PE10). In addition, Silva et al. used a substrate-
poor perfusate in the recirculation mode with only 5mmol/L glucose. Under our conditions, 
the results are quite different. We observe a net potassium secretion in the absence of 
chronic potassium overload, which is dependent both on the urine flow rate and the use of 
a substrate-enriched perfusate. With albumin concentrations of 5 g% and less, we found 
higher urinary flow rates, and this may in part be due to a rheogen effect on secretion. Only 
at very high COP in the perfusate and lower urinary flow rates is potassium secretion 
reduced such that the clearance ratio falls below 1, i.e., no net secretion. In 1979 Silva’s 
group published data for isolated perfused kidneys from adrenalectomized animals. Upon 
substitution of aldosterone, these organs exhibited a rapid increase in kaliuresis after that 
could be inhibited with spironolactone. This effect of aldosterone was only seen if they 
added more exogenous metabolites other than glucose, such as pyruvate, lacƚĂƚĞĂŶĚɲ-
ketoglutarate (ƐǇŶŽŶǇŵɲ-oxoglutarate) (282). The net potassium secretion corresponds to 
the results, published in the initial work of 1975. Potassium secretion reached up to 213% 
of the filtered potassium amount (257) when the perfusate was substrate-enriched. Thus, 
we can conclude that the effect of stimulation with aldosterone persists for the entire 
period of perfusion.    
ͳʹͻ
Fig. 10.1.16.: Potassium secretion during  ȋͻͶ-ͽͶȌ
substrate-enriched perfusate. Potassium secretion [mean values ± SEM (250)] is plotted 
against albumin (BSA) concentration in the perfusate. Net secretion increases up to an 
albumin concentration of 6 g%, but ceases abruptly at 7.5 g% albumin, where GFR and 
urinary flow rate are depressed. The blue data point corresponds to experiments in which 
the GFR was increased by adding verapamil at a higher perfusion pressure, up to the GFR 
level attained with 6g % albumin experiments.  
 The relationship between potassium secretion and the concentration of albumin in the 
perfusate depicted in Fig. 10.1.16 demonstrates that only at the highest albumin 
concentration does net secretion cease. At the high urinary flow rates attained in these 
experiments (using adequate ureteral catheters), the rheogenic-dependent effect on 
potassium secretion is clearly visible. The findings reported by Silva (276), who observed 
net potassium secretion only after dietary stimulation, are probably due to two factors –the 
use of (i) PE10 catheters and (ii) a perfusate containing glucose as sole substrate. In the 
Figs. 10.1.17 and 10.1.18, we take these factors into account. 
ͳ͵Ͳ
Fig. 10.1.17.: Dependence of pȋͻͶ-70 
Ȍon ȋȌǤ Individual values are plotted in relation to 
the urine volume (filled squares), which falls as the concentration of albumin in the perfu-
sate is increased (scale on the right). High secretion rates are a feature of the perfusate en-
riched with metabolic substrates (s. Fig. 10.ϭ.ϭϴ.). In vivo, values are around 0.2. Values 
in this range can be attained in the IPRK only at very high COP values. Most of the 
measured values fall in the shaded area.
ͳ͵ͳ
Fig. 10.1.18.: Dependence of potassium       ȋͻͶ-
ͽͶȌ on the rate of urine output and the presence of substrate additivesǤ
Individual values are plotted against urinary volume (sȩ). Note the difference between 
substrate-poor perfusate (glucose alone) and enriched perfusate (glucose plus glutamate, 
lactate, oxaloacetate, pyruvate and 8 amino acids). The in-vivo clearance ratio based on 
studies in the metabolic cage on rats fed on the standard diet, i.e., at low urinary volumes 
("anti-diuresis") of less thĂŶϭϬʅůͬŵŝŶ͕ŝƐĂďŽƵƚϬ͘Ϯ͘ 
ͳ͵ʹ
10.1.7. Efficiency of sodium transport in relation to oxygen consumption 
 A comparison of rates of sodium transport between the in-vivo kidney and the isolated 
organ raises the question of why the in vivo kidney is able to transport sodium so much 
more efficiently. The calculated in-vivo ratios of TNa to YȩO2 are around 18, i.e., 18 sodium 
molecules are transported per molecule of oxygen consumed. The isolated kidney reaches 
a quotient of 15 – at best. So-called back-leak phenomena are thought to underlie this 
effect, and they may indeed explain the decrease in absolute and fractional sodium 
reabsorption, which is most clearly seen with colloid-free perfusate. An exceptional situa-
tion is described below, in which a value of 18 was reached for a short time. 
Fig. 10.1.19.: Relationship between oxygen consumption and TNa/YȩO2 in the steady- 
state phase ȋ50-ͽͶȌ with substrate-enriched perfusate. YȩO2 and TNa/YȩO2 are 
plotted against the concentration of albumin (BSA). Mean values ± SEM. 
 With the addition of glutathione, cysteine and 5% red blood cells, the in-vivo TNa/YȩO2 
value of 18 can be achieved for a short time (see Table 11.1.6) some 50 min after starting 
perfusion. At 100 min the ratio had fallen to 16.3. The high efficiency obviously declines 
with time, but the reason for this is not clear (shedding of the endothelial surface layer and 
glycocalyx? (204)). 
ͳ͵͵
10.2.Recirculation perfusion 
 With the single-pass perfusions, which we had performed in Berlin using the gelatin 
preparation Haemaccel® as colloid, we experienced initial problems with regard to the sta-
bility of the resistance to perfusion. Switching to sterile perfusion solutions essentially 
solved this problem, and stability could be maintained for 2-4h (257). In our first perfusion 
experiments using bovine serum albumin (BSA) and the recirculation mode in Hannover, 
however, these old problems returned. After 90 minutes, we regularly observed a drop in 
flow rate and in GFR under pressure-constant perfusion conditions. The use of filters with 
8-ђm porosity did not fully resolve the problem, but we retained the inline filtration never-
theless. Reflection on the relative stability of the relatively stable single-pass experiments 
then led to the solution – which would have been obvious to a nephrologist - to regenerate 
the perfusion continuously with the aid of dialysis. In this way, one could aerate the dialy-
sate with a glass frit and replenish the albumin containing perfusate, and achieve greater 
stability. A literature search revealed that the dialysis technique had already been used in 
1967 by Baumung and Peterlik in Vienna (20) on the isolated rat liver to compensate for the 
rapid development of acidosis in their preparation (see Section 10.3. below). 
Table 10.1. Functional parameters of the isolated kidney perfused with 5g 
Ȁand using either a dialyzer circuit ȋȌ and a membrane oxygenator ȋȌǤ
Time course. Mean values ± SEM, n = number of the kidneys, Pa 100 mmHg. 
Perfusion a)  a)  a)  a) 
b) b) b) b) 
Time range (min) 30-50 50-70 70-90 90-110 
Perfusion flow rate (ml/min·g) 22,9±0,9 24,9±1,1 26,2±1,3 27,5±2,1 
26,1±1,9 25,8±1,8 25,3±1,6 * 
Urine flow rate sȩ  (ђl/min·g) 128±21 166±25 201±28 255±33 
111±18 121±19 124±22 * 
GFR Inulin-Clearance (ml/min·g) 0,96±0,04 0,95±0,03 0,96±0,04 0,98±0,06 
0,85±0,05 0,79±0,06 0,66±0,09 * 
TNa (ђmol/min·g) 126±6 116±4 113±5 112±8 
112±7 102±7 82±10 * 
Na-reabsorption % 91,6±1,6 87±2,1 83,3±2,4 81,3±2,5 
90,8±1,7 89,3±1,4 87,3±1,6 * 
Glucose-reabsorption % 94,9±0,3 93,5±0,8 91,9±1,0 90±1,8 
96,9±0,2 95,5±0,5 91,0±1,3 * 
KUP/InulinUP 1,50±0,13 1,47±0,09 1,30±0,08 1,22±0,09 
1,15±0,07 1,04±0,07 0,97±0,07 * 
YȩO2 (ђmol/min·g) 7,93±0,29 8,2±0,3 8,01±0,32 7,90±0,58 
8,78±0,38 8,5±0,4 7,86±0,03 * 
Number of Experiments  n =  14 14 14 9 
13 13 13 * 
ȗThe experiments in recirculation mode 2 with a membrane oxygenator were terminated
after 90 min due to a marked drop in the GFR and a drop in the perfusion flow rate.
ͳ͵Ͷ
 Table 10.1. is taken from the work of 1981 (251). For the sake of comparability, all 
parameters are based on 1g kidney weight. For reference, the unperfused left kidney was 
decapsulated and weighed after the left renal artery had been tied off prior to perfusion. 
Given the typically small difference in weight between the right and left kidney in vivo, this 
is a more reliable reference for the perfused kidney, which almost always gains weight, 
except when perfused with hyperoncotic perfusate (e.g. BSA>7g%), see also chapter 10.1.2. 
Hartwig used verapamil in recirculation experiments with a membrane oxygenator, which 
explains the only slight flow rate and filtrate reduction in comparison (99). 
Perfusion experiments on the endocrine function of the kidney 
To study the role of the kidney for the homeostasis of peptide hormones, we used the 
isolated kidney preparation in the recirculation mode, both as a filtering and non-filtering 
organ (237, 268). This approach enabled us to distinguish metabolic clearance from clea-
rance by filtration, and to quantify both (268). In addition, we were able to show that 
metabolic clearance of homologous rat insulin was more efficient than that of heterologous 
porcine insulin (237). Furthermore, we unexpectedly discovered that peptide hormones 
such as insulin and parathyroid hormone (PTH) are not broken down by the non-filtering 
kidney* (165, 171, 237, 268). However, this is compatible with the fact that an IPRK with a 
normal GFR is a better model for these studies than one with hyperoncotic perfusate and 
reduced filtration rates as used by Rabkin (205). Moreover it is necessary to comply with 
the conditions specified by Johnson and Maack for the non-filtering kidney: a hyperoncotic 
10g% BSA, a lower perfusion pressure (70mmHg) (118) and ligation of the ureter (in con-
trast to Maude, who sought to stop urinary flow only at reduced perfusion pressure (168)). 
By injecting a Lissamine bolus, we have directly confirmed that no filtration occurs under 
these conditions, as Maack had previously reported (162). 
 However, other aspects of the kidney’s function in hormonal homeostasis, such as the 
conversion of cholecalciferol (Vit D) and the metabolism of steroid hormones, could be 
investigated and elucidated (107, 108, 220). In addition to our studies on insulin, C-peptide 
and PTH, we have examined other hormonal processes, such as the conversion of thyroxine 
[T4] to triiodothyronine [T3] and quantified the export of T3 from the kidney to other 
tissues. We were able to demonstrate (99, 314) that an optimized and substrate enriched 
perfusate with added erythrocytes as oxygen carriers supports a much higher conversion 
rate than that reported by Ferguson (75). Earlier, we had investigated the clearance of both 
hormones in the single-pass mode without colloid and those results were published in 1980 
(4). Under such conditions (i.e., in the absence of binding proteins) we found a high, non-
saturable resorption capacity even at non-physiologically high concentrations (100 times 
the normal values). Michael Hartwig used equilibrium-dialysis to recover the free hormone 
fraction from an albumin-containing perfusate (99). 
* This assertion refers to the fact that there is no change when measured by RIA, but a cer- 
tain degree of fragmentation is detectable by column chromatographic methods (171). 
ͳ͵ͷ
 To overcome the increase in resistance that regularly occurred after the first 60-90 min 
of recirculation without replenishment, in the investigations carried out by Hartwig we 
made use of verapamil from the beginning, and were thus able to keep the flow rate stable 
(99). Earlier work had shown that autoregulation and tubulo-glomerular feedback can be 
suppressed also in vivo (175) (see Fig. 10.2.1.). Based on experiments on the isolated rabbit 
kidney, Pegg has pointed out that the return of the urine into the perfusate may facilitate 
blockage of capillaries by debris from the tubule cells. This is detectable by microscopy 
after about 30-40min perfusion with cell-free medium in the urine sediment (218), but can 
be avoided by the addition of 5% erythrocytes, as revealed by the fact that no necrosis 
occurs (218, 263). 
 Using small volumes of substrate-poor perfusate (30 ml/g kidney) Ferguson and 
Jennings measured the amount of T3 formed in kidney tissue, as well as the level of T3 
secreted into the medium (75). Fig. 10.2.1 shows their data for the T3 exported to the 
perfusate. At these relatively low conversion rates, no saturation appears, even at levels up 
to 10 times the physiological concentration of T4. In contrast, the conversion rate measured 
by Gisela Wruck in her doctoral thesis is some 10 times higher than that reported in 
Ferguson´s publication (in the physiological range of T4), but at a T4 concentration of 
ϳϱʅŐͬĚů ĐŽŶǀĞƌƐŝŽŶ it is not linearly enhanced, but only 3 times higher (314). The crucial 
methodological differences here were the following. (i) The perfusate was substrate 
enriched and included glutathione precursor substrates and glutathione; (ii) erythrocytes 
were added to prevent oxygen deficiency damage, and (iii) the ratio of perfusate volume to 
kidney mass was 150ml/g kidney - and thus 5 times higher than in Ferguson´s work. These 
measures ensure that the kidney is supplied with higher levels of metabolically active 
substrates. The correspondingly lower T3 levels were measured with a newly developed 
and highly sensitive RIA (314). 
 In the work of Michael Hartwig the concentration of T4 used was further increased to 
ϭϰϱʅŐͬĚů͘ dŚĞ ƵƐĞ ŽĨ ǀĞƌĂƉĂŵŝů allowed perfusion resistance to be held stable into the 
second hour, and the deliberate restriction of the pO2 to about 400mmHg increased the 
rate of export of T3 furthermore. However, at the highest concentration of T4, the T3 export 
rate fell in the second hour from 79.7±6.5 down to 51.5±4,0 ng/h·g kidney, indicating that a 
saturation threshold had been reached. It follows that a process of model optimization can 
facilitate the approach to in-vivo conditions. Nevertheless, Ferguson had already shown 
that there was no difference in the conversion rate between a filtering and a non-filtering 
kidney. Wruck confirmed this finding, at even higher levels of export. In the physiological 
concentration range of 10ug/dl T4, the filtering kidney exported 5.8±1.2ng/h·g kidney T3 
and the value for the non-filtering kidney was 6.7±0.8ng/h·g kidney. At a T4 concentration 
ŽĨϳϱʅŐͬĚů͕ƚŚĞrate of export was 16.6±2.6 in the filtering and 15.5±1.8ng/h·g kidney in the 
non-filtering kidney. However, Ferguson and Jennings brought filtration to a halt by 
lowering the perfusion pressure to 50-60mmHg (BSA unchanged at 7.5 g/dl) and inter-
preted the cessation of urine flow and the constancy of the T4 concentration as evidence 
for the non-filtering function. In contrast, the non-filtering kidney in Wruck´s work was 
prepared by the method described by Maack, which involves ligation of the ureter, 
ͳ͵͸
elevation of BSA to 10g/dl, reduction of the perfusion pressure to 70mmHg, and the 
demonstration in a pilot experiment that an injected Lissamine-green bolus does not 
appear in collapsed lumina of tubuli. 
Fig. 10.2.1.: Comparison of the rates of ȋ4Ȍ-
ȋ3ȌǤThe diagram shows the amount of T3 exported 
into the medium. Methodological differences account for the major discrepancies between 
the results depicted (s. text). The data from Ferguson (75) were calculated from the plot in 
the original paper. Gisela Wruck’s results (314) are plotted as mean values ± SEM (n = 5, 
and 4 respectively) and Michael Hartwig’s data (99) as mean values ± SD (n = 4). The latter 
data are taken from Hartwig’s doctoral thesis (written in German). They can be accessed 
from the Medical University of Hannover (MHH) and the National Library in Berlin. 
ͳ͵͹
10.3.Recirculation with regeneration of the perfusate by dialysis 
 The functional stability of the isolated perfused kidney is enhanced when a hyperon-
cotic albumin solution is used, but this gain comes at the expense of a reduced GFR. Con-
versely, the use of 5g/dl BSA results in a normal GFR of 1ml/min·g kidney but, 
  , the renal function clearly declines already in the second hour. 
Based on my experience with single-pass perfusion (and Haemaccel® as colloid), which 
provided stable perfusion flow rates over 2-3 hours, I introduced the use of bovine serum 
albumin combined with replenishment by dialysis in Hannover. At first we used an initial 
perfusate volume of 200 ml (150 ml in recirculation) and 2000 ml dialysate. Later on, we 
increased the dialysate volume to 5000 ml and that of the perfusate to 250/200 ml. This 
meant that substrates needed to be weighed out only for the dialysate; the albumin stock 
solution could then be diluted and the perfusate equilibrated by dialysis in preparation for 
the experiment. For details of the preparation of large volumes of dialysate see Chapter 
4.1.3. 
 As mentioned in the previous section (10.2), a literature review showed that Baumung 
and Peterlik in Vienna had already used dialysis technique on the isolated rat liver in 1967 
to compensate for the emergence of acidosis in their preparation (perhaps due to hypoxic 
lactic acidosis or bicarbonate consumption through urea synthesis). Dialyzers in those days 
were made from cellophane tubes (2.8cm in diameter and 160cm in length) in the manner 
of the Kolff-Watschinger coil-type dialyzer. The original publication gives a detailed de-
scription (20). We first obtained a reliable dialyzer in 1976. It had been developed by Josef 
Hoeltzenbein in Münster (112) and Travenol® in Belgium - see Fig. 4.4.11 and 4.4.12 - then 
produced this so-called capillary plate dialyzer (Type M1000) commercially. One outstan-
ding feature of the device was the small filling volume of the blood compartment and the 
optimized diffusion distances. 
 Table 10.1. (Chapter 10.2) presents the comparison of recirculation with oxygenator 
and recirculation with regeneration of the perfusate by passage through this dialyzer. It 
clearly shows the superior performance obtained with the latter technique compared to 
recirculation with an oxygenator. This opened up the possibility of performing micropunc-
ture experiments over 2-3 hours. Early-proximal micropuncture samples could be analyzed 
for albumin, thus allowing the sieving coefficient to be calculated under various experimen-
tal conditions (244, 245, 248, 250, 252, 266, 290-292) after microdisc gradient-gel elec-
trophoresis. In parallel with the introduction of the dialysis method for regeneration of the 
albumin-containing perfusate we used the standard substrates glucose, lactate, pyruvate, 
oxaloacetate and glutamate, and also the mixture of 8 amino acids described by De Mello 
and Maack in 1976 (63). Later, we became aware that the inclusion of arginine in the 
dialysate helped to avoid rapid depletion of this precƵrsor of NO, and we suspected that 
this might have contributed to the improved long-term stability of this preparation. The 
issue was then systematically investigated in cooperation with Jörg Radermacher in our 
ͳ͵ͺ
experimental set-up in Hannover, and our hypothesis was confirmed (206, 207). Owing to 
its swift consumption, arginine deficiency sets in rapidly in the non-replenishing recircula-
tion system, but its effects may be mitigated when perfusion is performed with hyperon-
cotic media. Under these latter conditions, the vascular bed shows the lowest perfusion 
resistance. This is even more obvious at concentrations of albumin of 5 g/dl and below 
(with pure recirculation). Administration of L-NNA (N omega-nitro-L-arginine), an inhibitor 
of nitric oxide synthase, had the same effect as arginine depletion. These findings clearly 
showed why long-term stability was improved by including arginine in the dialysate. On this 
empirical basis, a series of studies with micropuncture techniques was undertaken (181, 
182, 184, 245). The first tubular pressure measurements had been performed in Berlin on 
the single-pass preparation with Haemaccel®. We noted that proximal and distal tubule 
pressures were almost identical in the early phase, during which the flow rate sank to a 
minimum before rising again (see Fig. 6.4.2). We interpreted this drop in perfusion pressure 
as indicating that the filtered gelatin increased the viscosity in the lumen of the tubule at 
this stage, when fractional sodium and fluid resorption rates are still high. These rates fall 
off later on, and the pressure in the distal tubule also decreases. 
 The first measurements of tubular pressure in the albumin-perfused kidney were 
performed by Gerd Schwietzer, who used the Landis technique (141), which was a standard 
method in the laboratory of Karl-Heinz Gertz at that time. In subsequent studies, we were 
able to use the system developed by the Berlin group (154) in the version built by Hampel 
in Frankfurt. Klaus Hinrich Neumann performed the studies with this micropuncture 
technique, having acquired his expertise in the Gertz laboratory in Hanover and in Floyd 
Rector´s group in San Francisco. The dialyzers we have used most recently are low-flux 
dialyzers from FMC, initially the Polysulfone type F4, then the FX5 (Helixone®, Polysulfone 
improved) with a 1-m² surface and a filling volume of 54ml (blood side). So-called high-flux 
dialyzers are unsuitable due to their high permeability for albumin under these experi-
mental conditions. 
10.4.The anatomically fixed kidney as a tool for analyzing the 
glomerular filter 
 The micropuncture experiments used for the characterization of glomerular permeabi-
lity for macromolecules are extremely laborious. This factor motivated a search for a 
simpler method, which resulted in the fixation technique and the published material 
summarized in Chapter 12.4.  
10.4.1. Perfusion fixation of the isolated kidney for reperfusion 
 We preperfused the kidneys initially by the standard method at 100 mmHg with a 
substrate-enriched Krebs-Henseleit solution containing 5% BSA over 15 min in mode-3 
recirculation with dialysis and in the presence of verapamil (4.4 · 10-6 mol/l). The perfusion 
ͳ͵ͻ
pressure was then raised to 150 mm Hg just before the fixation, and the kidney was 
perfused with the warmed fixation solution at the same pressure over 5-9min.
Fig. 10.4.1.: Set up for anatomical fixation.The arterial bypass serves as an inflow for 
the fixation solution, which is warmed up to 37°C and as driving force we used compressed 
air. Compressed air fills a reservoir as driving force, near the set or a pressure-controlled 
peristaltic pump replace what is lost. To start fixation seamlessly we clamp the inflow of 
standard perfusate and open the influx of fixation solution. We record the perfusion 
pressure during fixation. 
ͳͶͲ
10.4.2. Fixation solution for reperfusion experiments 
 The starting material was a 6g% HAES solution in 0.9% NaCl (FMC), which was concen-
trated by ultrafiltration to half the volume to yield a 12g% solution. In addition, we used an 
8% solution of monomeric glutaraldehyde, diluted with phosphate buffer (7.1 pH) and 
mixed 1:1 with the HES solution to give a final concentration of 1.25% glutaraldehyde. The 
rational for the use of HAES is the following: If one uses colloid-free fixing solution, a 
dramatic increase of perfusion resistance occurs immediately after the transition to the 
perfusion fixation. This can be avoided by using a non-proteinaceous colloid-solution, which 
in turn permits better and more homogeneous fixation of kidney tissue, based on morpho-
logical criteria as assessed by light and transmission electron microscopy (s. Chapter 12.2.). 
Fig. 10.4.2.: Pressure recording in the fixation phase.The recorder protocol shows the 
transient oscillation of the perfusion pressure (black line) following the abrupt rise on the 
transition to fixation. The initial pressure is 90mmHg; at the onset of the transition, there is 
a brief drop in pressure, which then rises to just over 90 mmHg before settling down to the 
preset fixation pressure (here 80 mmHg). The train of pulses coincides with the restart of 
the aerating peristaltic pump to keep the pressure in the gas reservoir near the set 
perfusion pressure of 80 mmHg. In this case, the fixation was carried out specifically for 
morphological studies. For fixation of kidneys for use in reperfusion experiments an 
effective pressure of 150 mmHg is used.
ͳͶͳ
11. Tabellarium
Abbreviations used in the following Tables and in Chapter 13. 
Parameter  Dimensions Meaning 
ffp   (Pff) ° mmHg free flow pressure early proximal 
sfp   (Psf) ° mmHg stop flow pressure early proximal 
efp  (Puf) ° mmHg effective filtration pressure  
gcp mmHg glomerular capillary pressure 
Kf * nl/s·mmHg glomerular ultrafiltration coefficient 
k nl/s·mmHg·cm² effective hydraulic permeability  
K ђl/min·mmHg coefficient of hydraulic conductance of the whole kidney 
TF/PInulin ratio of inulin to tubular fluid/perfusate  
gfr, SNGFR nl/min single nephron filtration rate  
Yȩ** nl/min perfusion rate of single nephron 
GFR ml/g·min glomerular filtration rate (Inulin) of the whole kidney 
RPF ml/g·min renal perfusion flow of the whole kidney 
FF % filtration fraction GFR/RPF  
TNa ђmol/g·min absolute sodium reabsorption rate 
YȩO2 ђmol/g·min oxygen consumption rate 
sȩ ђl/g·min urinary volume per minute 
COP/ʋ  mmHg colloid-osmotic (oncotic) pressure of perfusate 
KU/P/InulinU/P    clearance ratio of potassium 
* Calculated from Kf of the whole kidney/3൉104 nephrons in a rat kidney (approximate
number)
** Calculated from total perfusion rate/3·104 nephrons of a rat kidney 
ͳͶʹ
Table 11.1.1.: Effects of increasing concentrations of ȋȌ
on functional parameters of the  ȋmeasured 50-70min after the start of 
ȌǤ Albumin (bovine serum albumin BSA) was the sole colloid. The COP was cal-
culated with the Landis and Pappenheimer (L & P) formula: 2,8c + 0,18c2 + 0,012c3 where c 
is the albumin concentration in g/dl. The measured COP values were read off from a cali-
bration curve obtained experimentally with a 20000-Da membrane. The data for colloid-
free perfused kidneys are from single-pass (mode 1) perfusions, the others from mode 3 
(recirculation with regeneration of the perfusate by dialysis). The effective perfusion pres-
sure Pa in colloid-free perfusate was at 90mmHg and otherwise at 100mmHg. In order to 
achieve a GFR at high COP comparable/equivalent to that observed at "normal" COP, it was 
necessary to increase the effective perfusion pressure from 100 to 140 mmHg and add 
verapamil (4.4 · 10-6 mol/l); this is listed in the last column. Single nephron flow rate and 
single nephron gfr was calculated based on 3·104 nephrons / kidney. The material in this 
Table was first published in 1981 (250, 251). n = number of the animals, mean ± SEM.  
Verapamil 
Albumin (g/100ml) 0 2,82±0,26 4,66±0,09 5,72±0,1 7,59±0,14 7,86±0,16 
ʋ COP L&P-formula 
(mmHg)
0 9,6±0,89 18,2±0,35 24,2±0,42 36,9±0,68 39,0±0,79 
ʋKW measured (mmHg) 0 7,5 15,3 20,8 32,3 34 
Perfusion rate 
(ml/min·g) 15,6±1,3 24,1±1,8 30,5±1,9 32,0±1,6 36,4±1,4 43,7±2,1 
Urine flow rate sȩ
(ђl/min·g) 683±122 421±61 226±71 140±17 30,6±8,8 132±22,1 
GFR Inulin-Clearance
(ml/min·g)
1,38±0,15 1,15±0,06 0,96±0,08 0,94±0,06 0,56±0,05 0,96±0,11 
TNa (ђmol/min·g) 96,8±15,5 109,1±7,8 108±7 126±7 77,7±7,1 119±16 
Na-Reabsorption % 51,3±5,5 69,8±3,4 82,6±6,2 91,6±1,3 97,1±1,0 90,7±1,2 
TGlucose (ђmol/min·g) 9,17±1 8,71±0,62 7,48±0,63 7,73±0,65 4,32±0,29 8,72±1,44 
Glucose-
Reabsorption % 78,5±3,5 90,8±1,4 91,6±2,2 94,6±0,6 94,5±0,7 93,8±1,5 
KUP/InulinUP 1,18±0,03 1,55±0,14 1,61±0,14 1,69±0,18 0,78±0,22 0,83±0,11 
YȩO2 (ђmol/min·g) 7,77±0,9 8,4±0,51 8,89±0,79 9,0±0,48 7,15±0,14 n.m. 
TNaͬYȩO2 12,2±1,03 13,0±0,86 12,3±1,8 14,1±1,0 10,8±0,9 n.c. 
Filtration-fraction % 8,83±0,55 4,84±0,32 3,14±0,15 2,99±0,25 1,57±0,17 2,20±0,19 
Single nephron flow rate 
(nl/min) 532±45 821±60 1140±71 1034±51 1117±43 1310±63 
Single nephron gfr
(nl/min) 47,0±5,2 39±2,0 35,7±2,8 30,2±2,0 17,0±1,5 28,9±3,2 
Number              n = 4 7 3 12 7 5 
The colloid-free perfused kidneys in this group were not systematically decapsulated before 
the start of perfusion (although spontaneous decapsulation often occurred during the 
course of perfusion). Hence the perfusion rates are significantly lower than for perfusions 
that were initiated only after removal of the renal capsule.
ͳͶ͵
Table 11.1.2.: Albumin free perfused rat kidney.Effects of perfusion with and without 
ureteral back pressure on overall renal function and nephron hydrodynamics. Data are 
means ± SEM. n = number of tubules (in parentheses, the number of animals). Pa = 
100mmHg. The single nephron-gfr and Kf are calculated on the assumption that the rat 
kidney comprises 3·104 nephrons. Functional parameters were measured at 50-70 min 
(whole kidney) and at 30-115 min (single nephrons). For colloid free perfusate the stop flow 
pressure (sfp) = the glomerular capillary pressure (gcp). The ureter of the control kidney 
was cannulated with a short glass cannula extended with a PE50 tubing, the ureteral 
backpressure was applied via a PP10 catheter (10cm length) inserted in the ureter, s.a. Fig. 
4.7.0. The data displayed in this Table was first published in 1981 (250) (251). 
with ureteral 
control back pressure 
Parameter   IPRK       Number   n = n = 32 (4) n = 21 (4) 
Perfusion flow rate (ml/min·g) 15,6±1,3 15,0±1,1 
Urine flow rate sȩ(ђl/min·g) 683±122 279±30 
GFR Inulin-Clearance (ml/min·g) 1,34±0,05 0,54±0,01 
TNa (ђmol/min·g) 96,8±15,5 37,7±3,9 
Na-Reabsorption % 51,3±5,5 49,6±3,9 
TGlucose (ђmol/min·g) 9,17±1 3,32±0,3 
Glucose-Reabsorption % 78,5±3,5 84,2±1,2 
KUP/InulinUP 1,18±0,03 1,21±0,15 
ǚ O2 (ђmol/min·g) 7,77±0,9 7,23±0,32 
*TNa/ǚ O2 12,2±1,0 5,23±0,54 
Filtration-fraction % 8,83±0,55 3,33±0,25 
Single nephron data 
Free flow pressure ffp (mmHg) 55,4±1,6 47,7±1,8 
Stop flow pressure sfp (mmHg) 73,8±1,3 68,9±1,4 
Effective filtration pressure efp 18,4±0,6 21,2±1,1 
Single nephron flow rate (nl/min) 520 500 
Single nephron gfr (nl/min) 46,1±1,5 19,4±0,3 
UltraĮůtraƟon-coeĸcient Kf (nl/s mmHg) 0,0426±0,0015 0,0161±0,0011 
The pressure drop along the thin PP 10 catheter was set to about 22mmHg at a urine flow 
ƌĂƚĞŽĨϮϳϵʅůͬŵŝŶ;Ɛ͘Ă͘&ŝŐ͗͘ϰ͘ϰ͘ϯ͘Ϳ͘ 
*Note the slight difference in oxygen consumption relative to the amount of sodium
transported, TNa. The TNa/YȩO2   ratio falls from 12.5 to 5.2. This could be due to backleak
phenomena in the proximal tubule. 
ͳͶͶ
Table 11.1.3.: Comparison of functional parameters of the isolated rat kidney 
ȌȌͽȀ in mode 
3 ȋȌ at various phases of the experiment.
Values are means ± SEM. n = number of kidneys. Pa = 100mmHg.  
Note that the capsule was not systematically removed prior to colloid-free perfusion. The 
material in this Table was first published in 1981 (250, 251). 
Perfusion   a) a) a) a) a) 
Perfusion  b) b) b) b) b) 
Period (min) 30-50 50-70 70-90 90-110 
Perfusion flow rate (ml/min·g) 14,5±1,0 16,8±1,4 19,4±1,7 21,0±1,7 
33,1±2,1 35,4±1,4 35,0±1,8 34,6±1,8 
Urine flow rate sȩ(ђl/min·g) 556±80 703±59 718±61 778±97 
15±2,7 26,8±5,7 33,3±7,6 28,2±6,8 
GFR Inulin-Clearance (ml/min·g) 1,18±0,13 1,40±0,07 1,37±0,07 1,40±0,1 
0,58±0,09 0,63±0,04 0,58±0,06 0,49±0,08 
TNa (ђmol/min·g) 87,3±9,6 97,4±5,4 89,2±5,2 86,6±3,1 
84,1±12,8 89,6±7,6 82,7±8,3 69,7±10,6 
Na-Reabsorption % 54,7±3,2 50,9±2,3 47,8±2,3 45,6±3,1 
99,1±0,2 98,4±0,4 97,1±0,7 94,4±1,1 
Glucose-Reabsorption % 86,6±2,2 83,4±2,3 82,4±3,8 79,1±5,0 
95,9±0,4 95,8±0,3 95,4±0,3 94,4±1,1 
KUP/InulinUP 1,15±0,05 1,09±0,06 1,08±0,07 1,05±0,09 
0,43±0,07 0,67±0,13 0,67±0,13 0,77±0,12 
ǚ O2 (ђmol/min·g) 7,26±0,45 7,29±0,36 7,43±0,45 7,58±0,60 
7,12±0,20 7,33±0,2 7,44±0,21 7,42±0,17 
TNa/ǚ O2 12,02 13,36 12,01 11,42 
11,81 12,22 11,12 9,39 
Number of Experiments  n =    10   10    8    7 
6 6 6 6 
 The fact that oxygen consumption does not differ significantly between the colloid-free 
and BSA-perfused kidneys during the first 90 minutes is reflected in the amount of sodium 
transported, TNa. Only during the latest phase of the experiment does the ratio TNa/YȩO2
in colloid-free perfused kidneys fall off significantly. Note also that no ureteral backpressure 
was applied (see Table 11.1.2). 
ͳͶͷ
Table 11.1.4.: Hydrodynamics of superficially accessible nephrons (early proximal 
tubules) and functional parameters of the whole kidney with increasing concentration of 
albumin (BSA) from 0 to 4.9 g / dl. Pa = 100 mmHg, n = number of tubules, in parentheses 
the number of animals. The material in this Table was first published in 1981 (250). 
Period  50-70 min 
Albumin BSA (g/100ml) 0 2,82±0,26 4,66±0,09 
ʋ COP L & P (mmHg) 0 9,60±0,89 18,17±0,35 
Perfusion flow rate (ml/min·g) 15,6±1,3 24,1±1,8 30,5±1,9 
Urine flow rate sȩ(ђl/min·g) 683±122 421±61 226±71 
GFR Inulin-Clearance (ml/min·g) 1,38±0,15 1,15±0,06 0,95±0,08 
TNa (ђmol/min·g) 96,8±15,5 109±7,8 108±7,3 
Na-Reabsorption % 51,3±5,5 69,8±3,4 82,6±6,2 
Glucose-Reabsorption % 78,5±3,5 90,8±1,4 91,6±2,2 
KUP/InulinUP 1,18±0,03 1,55±0,14 1,61±0,14 
YȩO2 (ђmol/min·g) 7,77±0,90 8,40±0,51* 8,46±1,19 
TNaͬYȩO2 12,2±0,90 13,0±0,86* 13,6±2,0 
Filtration-fraction % 8,83±0,55 4,84±0,32 3,14±0,15 
Filtration coefficient whole kidney
(ђl/min·mmHg) 76,6±2,8 82,3±2,0 127,4±8,5 
Number              n = 4 7 (5*) 3 
Period 30-107 min 
Albumin BSA (g/100ml) 0 2,76±0,08 4,9±0,08 
ʋ COP L&P (mmHg) 0 9,35±0,23 19,5±0,4 
ʋKW measured (mmHg) 0 7,4 16,5 
Free flow pressure ffp (mmHg) 55,4±1,6 35,4±0,4 29,8±1,1 
Stop flow pressure sfp (mmHg) 73,8±1,3 49,5±0,5 39,2±1,5 
glomerular capillary pressure gcp (mmHg) 73,8±1,4 59,0±0,6 58,7±1,5 
Filtration pressure  ȴp (gcp - ffp) 18,4±0,6 23,6±0,49 28,8±0,7 
Effective filtration pressure efp 18,4±0,7 14,0±0,3 9,4±0,6 
Ultrafiltration coefficient Kf (nl/s mmHg) 0,0426±0,0015 0,0458±0,0011 0,0708±0,0047 
Single nephron flow rate Yȩ  (nl/min) 535±44 810±59 1136±70 
Single nephron gfr (nl/min) 46,1±1,5 37,8±0,7 36,7±1,3 
Number              n = 32 (4) 46 (7) 27 (3) 
Yȩ , gfr und Kf were calculated on the basis of 3·104 nephrons / kidney  
ʋ COP L & P (mmHg) was calculated using the Landis and Pappenheimer formula (see 
Section 9.7.1, Fig. 9.7.4)   
ͳͶ͸
Fig. 11.1.1.: Comparison of SNGFR with the GFR of the whole kidney ȋʹͷͲȌǤThe SNGFR 
was measured directly by micropuncture. The calculation is based on an average number of 
30000 nephrons per rat kidney. The single-nephron filtration rate (SNGFR) was measured at 
subcortical nephrons under constant pressure control (181). Measured and calculated values 
are in good agreement as long as the colloid osmotic pressure of the perfusate is within the 
physiological range. At hyperoncotic perfusate, the SNGFR determined by micropuncture of 
nephrons is significantly lower than the SNGFR calculated from the total GFR. Here, the 
higher SNGFR of juxtamedullary glomeruli may have an impact. The GFR was measured as 
the rate of polyfructosan clearance, using the double-enzymatic method (macro- and 
microversions) according to Schmidt, (181, 182, 184, 239, 250, 251). 
Table 11.1.5.: Data plotted in Fig. 11.1. The colloid-osmotic pressure calculated from 
the albumin concentration using the Landis & Pappenheimer formula (250). 
Albumin 
concentration
(g/100ml)  
COP 
(mmHg) 
SNGFR 
 (nl/min) 
SNGFR 
 (nl/min) 
Number of 
nephrons 
(kidneys) 
Kidney- 
weight (g) 
Measured Calculated (GFR/30000) 
0 n.m. 46,1±1,5 32 (4) 1,02±0,08 
2,79±0,07 9,5 43,2±3,4 42,3±2,4 11 (4) 0,93±0,07 
5,64±0,12 23,7 29,0±2,6 27,4±2,0 14 (5) 0,92±0,05 
7,67±0,04 37,5 15,3±1,3 20,1±1,1 10 (3) 0,96±0,05 
ͳͶ͹
Table 11.1.5.: Hydrodynamics of superficially accessible nephronsȋ
ȌǤ These data are for kidneys with ureteral backpressure (due to the use of narrow-
bore ureteral catheters; see Table 11.1.1.) perfused with the indicated concentrations of 
albumin (BSA). Pa = 100 mmHg. n = number of tubules (in parentheses, the number of 
animals). The data are taken from the Habilitation thesis of 1981 (250), s.a. Fig. 4.7.0. 
Period 50-70 min 
Albumin BSA (g/100ml) 0 2,54±0,16 4,85±0,17 
ʋ COP L&P (mmHg) 0 8,47±0,53 19,18±0,67 
Perfusion rate (ml/min·g) 15,0±1,1 19,8±1,4 24,8±0,6 
Urine flow rate sȩ(ђl/min·g) 279±30 350±40 208±33 
GFR Inulin-Clearance (ml/min·g) 0,50±0,03 0,88±0,04 0,90±0,05 
TNa (ђmol/min·g) 37,7±3,9 84,7±5,1 106,4±7,0 
Na-Reabsorption % 49,6±3,9 67,6±2,7 82,6±3,7 
Glucose-Reabsorption % 84,2±1,2 92,5±0,6 90,3±2,0 
KUP/InulinUP 1,21±0,15 1,18±0,08 1,49±0,21 
YȩO2 (ђmol/min·g) 7,23±0,23 8,02±0,66 8,50±0,58 
TNaͬYȩO2 5,32±0,54 10,3±0,6 12.6±1,1 
Filtration-fraction % 3,49±0,55 4,46±0,53 3,64±0,19 
Filtration coefficient whole kidney
(ђl/min·mmHg) 28,9±1,8 70,7±3,2 91,5±1,9 
Number              n = (4) (3) (4) 
Period 37-115 min 
Albumin BSA (g/100ml) 0 2,67±0,03 4,9±0,08 
ʋ COP L&P (mmHg) 0 8,99±0,14 19,5±0,2 
ʋKW (20000 Dalton membrane) (mmHg) 0 7,1 16,5 
Free flow pressure ffp (mmHg) 47,7±1,8 52,0±0,5 36,4±0,9 
Stop flow pressure sfp (mmHg) 68,9±1,4 66,1±0,5 46,7±0,9 
Glomerular capillary pressure  gcp
(mmHg) 68,9±1,5 75,2±0,5 66,3±0,9 
Filtration pressure ȴp (gcp - ffp) 21,2±1,1 23,2±0,6 29,9±0,8 
Effektive filtration pressure  efp 21,2±1,1 14,1±0,6 10,3±0,24 
Ultrafiltration coefficient Kf (nl/s mmHg) 0,0161±0,0011 0,0393±0,0018 0,0508±0,001 
Single nephron flow rate Q (nl/min) 540±68 731±50 856±33,2 
Single nephron gfr (nl/min) 19,4±0,3 32,2±0,7 31,9±0,6 
Number              n = 22 (4) 21 (3) 21 (4) 
Yȩ , gfr und Kf were calculated on the basis of 3·104 nephrons / kidney 
ʋ COP L&P (mmHg) was calculated using the Landis and Pappenheimer formula (see 
Section 9.7.1, Figure 9.7.4) 
ͳͶͺ
Fig. 11.1.2.: Effect of inadequate ureteral catheterization on the single nephron gfr.
The strongest impact on the single nephron gfr is observed under colloid-free perfusion and 
ureteral backpressure due to the use of a ureteral catheter that is too narrow. This pheno-
menon, which was described as "erratic behavior of GFR" by two research groups (34, 152), 
was subsequently shown to be a consequence of inadequate ureteral catheterization (250, 
251). Tables 11.1.3 and 11.1.5 present the basic data. The findings imply that under 
perfusion with a colloid-free medium, perturbation of post-renal outflow leads to a drastic 
reduction in hydraulic conductivity at an otherwise adequate effective filtration pressure. 
See Fig. 10.1.05, which shows that at a COP of between 10 and 20mmHg the ultrafiltration 
coefficient increases significantly; i.e. the hydraulic conductivity of the glomerular capilla-
ries increases significantly (250). 
ͳͶͻ
Table 11.1.6.: Effects of enriched perfusate on functional parameters of the 
isolated perfused rat kidney after 50 and 100 minutes.After the addition of the indi-
cated additives (glutathione, cysteine and washed human erythrocytes (5% hematocrit)) for 
perfusate. Perfusion in mode 3 with regeneration of the perfusate by dialysis, 5g / dl BSA, 
basic formula R1 (Table 4.2.) and R2 (Table 4.3). The perfusion pressure was 100mmHg in 
groups 1-3, 90mmHg in the 4th group in order to obtain comparable glomerular filtrates.  
* Significance compared to the control (unpaired t-test Student), from (263).
Group 1 
Control 
n = 8 
Group 2 
Glutathione + Cysteine 
n = 3  
Group 3  
Erythrocytes 
n = 5  
Group 4 
As Gr 2 + Erythrocytes 
n= 5 Parameter 
50min 100min 50min 100min 50min 100min 50min 100min 
Perfusion flow rate 
(ml/min·g) 25±2 28±2 25±2 26±2 21±2 22±3 21±1 23±1 
Urine flow rate sȩ
(ђl/min·g) 142±20 225±33 153±13 198±46 77±29* 115±27* 80±12* 134±19* 
 Inulin-Clearance 
(ml/min·g) 0,96±0,04 0,98±0,07 0,91±0,09 0,81±0,02 0,76±0,09 0,77±0,08 1,04±0,05 0,94±0,07 
TNa
(ђmol/min·g) 
123±7 112±8 116±11 96±5 99±10 95±9 143±7 119±8 
Na-Reabsorption % 90±2 81±2 90±1 83±3 94±2 89±3 95±1 88±2* 
Glucose- 
Reabsorption % 95±1 90±2 96±1 92±1 96±1 95±1* 96±1 96±1* 
KUP/InulinUP 1,59±0,07 1,22±0,09 1,62±0,012 1,35±0,01 1,12±0,007 1,04±0,008 1,17±0,023 1,49±0,008
YȩO2
(ђmol/min·g) 
8,2±0,4 7,9±0,6 6,7±0,5 6,3±0,3 7,6±0,5 7,3±0,4 7,8±0,2 7,3±0,5 
TNa/ YȩO2 17,3 14,2 17,3 15,2 13,0 13,0 18,3 16,3 
In control kidneys, unlike IPRKs under pure recirculation, GFR remains stable (see Table 
10.1.). Addition of glutathione and cysteine had no effect on GFR but was associated with a 
striking reduction in oxygen consumption. Addition of erythrocytes increased sodium and 
water reabsorption, resulting in constant fractional glucose reabsorption, perhaps because 
red blood cells prevent morphological damage to proximal S3-segments and TAL-segments 
(263). Another surprising finding in Group 4 is the quotient TNa/YȩO2   of 18 in the first hour
after the start of perfusion, which is comparable to the value under in-vivo conditions. The 
Table is from the 1985 publication (263). 
ͳͷͲ
12. Annex
12.1. Biochemical studies on the energy metabolism of the IPRK 
 In the early single-pass experiments with Haemaccel® (urea-crosslinked polygelatin) as 
colloid, we perfused control kidneys, and kidneys that had been subjected to short-term 
“pre-perfusion” with basic medium, with perfusates containing various substrate additives. 
We then analyzed various metabolites after flash-freezing with the Wollenberger technique 
(313), modified to exclude the renal hilum and the papilla. 
Fig. 12.1.: 	   ȋjaws 
of copȌ rs (253) (after 
Wollenberger, modified). The kidney is 
supported on a plexiglass mount with 
a molded spacer; the cut-outs at the 
base of the tongs are designed to ex-
clude the papilla and the renal hilum. 
We modified the freeze tongs descri-
bed by Wollenberger (313) so that the 
metal spacer enabled us to obtain 
tissue slices of defined thickness from 
the perpendicularly oriented kidney, 
while excluding the papilla and hilum. 
Before clamping, the fat capsule is 
removed, the cranially located adrenal 
gland is dissected away, and the 
kidney is oriented on the Plexiglas 
mount. In this way, flash-freezing 
could be performed in situ under nor-
mal circulation conditions, or on the 
isolated perfused kidney oriented on 
its kidney support. 
Thereby, we could exclude papilla and 
hilum. 
 When comparing the in-vivo data with the data for the IPRK one must consider that, 
after a short period of perfusion, the wet weight of the isolated kidney is greater (by 16.8 
to 24.4%) than that of the in-vivo control. Thus, for example, the decrease in the ATP 
concentration is only 33% of the in vivo value. If we take into account the ATP content of 
blood as our in-vivo situation, the relative decrease compared to the blood-free perfusate 
(free of ATP) is still modest, and is comparable to the values measured in kidneys under 
micropuncture conditions in vivo (Roland Kirsten, personal communication, FU Berlin). 
ͳͷͳ
Table 12.1.: Metabolite concentrations in flash-frozen kidney tissue (256) The data 
are expressed in units of 10-9 mol / g wet weight. The results for succinate were later 
extended by Ingrid Krause in her dissertation (s. Tab. 12.2.). 
in vivo in vitro 
Substrate Control Blood Control Oxaloacetate Succinate 
1mmol/l 10mmol/l 
G6P 58,3 ± 2,3 34,0 ± 11,2 32,1 ±3,1 17,8 ± 4,05 
F6P 16,1 ± 0,2 13,5 ± 4,0 9,5 ± 1,7 
2-P-Glycerate 7,2 ± 2,1 8,1 ± 5,7 25,0 ± 7,2 
3-P-Glycerate 78,7 ± 4,8 58,6 ± 3,4 112,0 ± 20,2 
PEP 29,0 ± 2,2 27,8 ± 10,4 120,0 ± 37,3 
Pyruvate 88,5 ± 5,3 74,8 43,5 ± 10,1 208,0 ± 3,6 35,9 ± 11,3 
Lactate 828,0 ± 82,8 1728,0 523,5 ± 66,8 580,0 ± 45,7 410,4 ± 47,1 
L/P 9,4 23,1 12,0 2,8 11,4 
ATP 1734,0 ± 34,1 972,8 ± 50,7 734,0 ± 64,6 475,2 ± 85,4 
Citrate 209,0 ± 13,7 42,0 ± 6,6 94,2 ±10,7 45,0 ± 11,2 
Malate 123,8 ± 16,9 78,1 ± 10,9 
MW ± SEM n = 6 n = 6 n = 6 n = 4 n = 6 
Table 12.2.: Effect of increasing concentrations of succinate in the perfusateon the 
metabolite content of flash-frozen tissue (130). The data are expressed in units of 10-9 
mol / g wet weight.  n = 6. 
Control Succinate Succinate Succinate 
Substrate 1mmol/l 4mmol/l 10mmol/l 
ATP 806 ± 67 1025 ± 23* 754 ± 83** 507 ± 38*** 
ADP 590 ± 29 467 ± 17 455 ± 35 553 ± 38 
AMP 414 ± 42 299 ± 28 313 ± 26 1145 ± 226**** 
ATP/ADP 1,37 2,19 1,66 0,92 
єĚĞŶŝŶe nucleotides 1810 1790 1522 2205 
2-PG 71 ± 6 405 ± 30 78 ± 4 50 ± 5 
PEP 162 ± 13 177 ± 18 189 ± 15 84 ± 15 
Pyruvate 27 ± 3 50 ± 6 55 ± 2 37 ± 5 
Lactate 907 ± 111 838 ± 205 632 ± 107 870 ± 95 
L/P 33,6 16,8 11,5 23,5 
Malate 122 ± 8 148 ± 119 357 ± 25 415 ± 44 
MW ± SEM n = 6 n = 5 n = 5 n = 6 
*p<0,025 **p<0,02 ***p<0,005 
****p<0,0025 
 The metabolite content in flash-frozen tissue is expressed relative to the wet weight of 
the organ. As discussed above, values relative to dry weight differ less from those of the in-
vivo controls, as we know from the electrolyte analysis carried out by Petra Brandt on in-
ͳͷʹ
vivo kidneys and isolated perfused kidneys (37). The mean dry weight of in-vivo kidneys 
was 20.0 ± 0.31% of their wet weight. The corresponding figure for isolated perfused 
kidneys was 16.85 ± 0.21%, which gives a conversion factor of 1.187. Applying this 
conversion factor yields a value for the ATP concentration in the in-vitro controls of 
1155·10-9mol/g wet weight instead of 973·10-9mol/g wet weight. This, however, ignores the 
fact that the vascular beds in the isolated and cell-free perfused kidney are devoid of cells. 
In vivo, the erythrocytes, leukocytes and thrombocytes all contain ATP. 
Functional and morphological evidence of an oxygen deficit in the 
cell-free perfused rat kidney. 
Weiss and his group in Hamburg and Kiel (142, 306) and Ochwadt`s team in Göƫngen 
(67) have presented strong evidence for a relaƟve lack of oxygen in the cell-free perfused 
kidney. Based on micropuncture studies, in 1976 De Mello and Maack deĮŶed a funcƟonal 
defect in the isolated kidney (63), which they localized to the TAL-segments. In 1978, 
Venkatachalam ĂƩributed morphological damage in speciĮc areas in the medullary rays of 
the cortex and outer medulla to a shortage of O2 (300). Three years later, Alcorn described 
similar changes in the isolated, cell-free perfused rat kidney (7). We studied this topic in 
parallel with Franklin Epstein´s group in Boston (38-42) and were able to develop our own 
ideas based on comparisons with in-vivo studies on the exposed kidney (117, 243, 250, 259 -
261, 263). In cooperĂƟon with Wilhelm Kriz in Heidelberg, we were able to place morpholo-
gically deĮned Ɵssue damage in a funcƟonal context (263) and these Įndings sƟmulated 
further invesƟŐĂƟons. A conversĂƟon with ChrisƟĂŶ Bauer during a stroll along the Vltava 
River in Prague in 1982 raised the quesƟon of whether glomeruli are actually exposed to 
arterial blood, as was the general view in those days. With the support of Horst Baumgärtl 
and Dietrich W. Lübbers at the MPI in Dortmund, we were able to establish a technique for 
measuring pO2 in superĮcial glomeruli and tubules in our laboratory in Hannover. In addi-
Ɵon to the půĂƟŶƵm microelectrodes encased in glass provided by Horst Baumgärtl, we also 
adapted the gold mƵůƟǁŝre electrode technique of Herrmann Metzger in Hannover. This 
then led to several studies (117, 259-261) which demonstrated the existence of preglo-
merular oxygen sŚƵŶƚĚŝīƵsion. Two students, Uwe Jost and Harald Bertram, contributed 
sŝŐŶŝĮcantly to this work. Harald Bertram completed his disserƚĂƟon thesis on the topic 
(eŶƟƚůed “The sŝŐŶŝĮcance of preglomerular sŚƵŶƚĚŝīƵsion of blood gases in the renal 
cortex for the intrarenal localizaƟon of erythropoieƟŶ synthesis: A comparison of experi-
mental results on the rat kidney with a mathemĂƟcal model of shuntdiīusion”) in 1991 at 
the Hannover Medical School (Medizinische Hochschule). Both students were among the 
authors of the resƵůƟŶŐ publicĂƟons (260, 261). The following micrographs, which were 
taken in Wilhelm Kriz’s laboratory in Heidelberg, were obtained from kidneys perfused in 
mode 3 (recirculaƟon with aeraƟon and regenerĂƟon by dialysis) in Hannover and then 
anatomically Įxed, and are taken from the 1985 paper (263). 
ͳͷ͵
12.2. Morphological studies of the isolated kidney, perfused either 
cell-free or with erythrocyte-containing medium (250, 263) 
Wilhelm Kriz (263) performed the mor-
phological analysis and prepared the 
Figures. One micrograph was contributed 
by Karlwilhelm Kuehn (Figure 12.2.08). 
The data shown come from four experi-
mental groups: 
Group 1: Control group, kidneys perfused 
(cell-free) with the basic medium supple-
mented with glucose, oxaloacetate, pyru-
vate, lactate, glutamate and the 8 amino 
acids from the protocol of DeMello and 
Maack and 10mU AVP (Pitressin®) (see 
R2 Table 4.3.).  
Group 2: Protocol as for group 1, with 
the addition of reduced glutathione 
(0.2mmol/l) and cysteine (0.5mmol/l) to 
perfusate and dialysate.  
Group 3: protocol as group 1, plus 5% 
washed human erythrocytes without in-
line filter.  
Group 4: protocol as group 2, plus 5% 
washed human erythrocytes. Perfusion 
pressure was reduced (90mmHg) to ob-
tain a comparable GFR (see Table 11.1.6). 
Fig. 12.2.01.: Longitudinal section 
through the  ȋȌ the outer 
ȋȌ of the outer medulla. 
Group 2, cell-free perfusion with addition 
of glutathione. Within the cortex, glome-
ruli, tubules and vessels are structurally 
intact. In the outer stripe, necrotic P3 seg-
ments are arranged in columns (dotted 
line), beginning in the basal portion of 
the medullary rays and extending to the 
border between outer and inner stripes. 
For further details, see Fig. 12.2.02. Epon 
section, 1ђm thick, stained with methy-
lene blue and azure II; Light micrograph 
(LM), magnification 100x.  
Only at higher magnification does the 
true extent of the damage to the P3 seg-
ments become clear (see Fig. 12.2.03.). 
ͳͷͶ
Fig. 12.2.02.: Cross sections 
through the outer stripe of the 
outer medulla.
Group 1, cell-free standard perfu-
sion over 2h. 
a. Distribution of areas containing
degenerated P3 segments (dotted 
lines), which are consistently loca-
ted farthest from vascular bund-
les (V). Damaged epithelia are 
characterized by their dark, con-
densed appearance. Epon section, 
1ђm thick. Magnification 100x 
(LM). 
b. Damaged P3 profiles around
the vascular bundle (V) often 
exhibit a split between a degene-
rated and an intact half. The latter 
(arrows) generally face the vascu-
lar bundle. Epon section, 1ђm 
thick; magnification 160x (LM). 
Radial diffusion of oxygen from 
the vascular bundles helps to sup-
ply the tubules. As a consequence 
of the low oxygen-carrying capa-
city of the cell-free perfusate, the 
vascular bundles in the more re-
mote areas are underserved. The 
characteristic feature of necrosis 
in the P3-segments is coagulation 
necrosis. As water loss from the 
cells causes shrinkage of the cyto-
plasm and nucleus, the microvilli 
condense and become narrower, 
before being shed into the lumen. 
Different stages of the processes 
can be observed in one and the 
same tubule, where cells on one 
side may be intact while the op-
posite side shows defects.  
(See the following Figs.).
ͳͷͷ
Fig. 12.2.03.: Electron micro-
graphs of structural damage.  
Group 1 (a and b) and Group 2 (c). 
Cell-free standard perfusion for 2 h 
(a, b), with addition of glutathione 
(c). 
a) The micrograph shows a group of
four damaged P3 segments (P). 
Damaged cells are shrunken and ex-
hibit coagulation necrosis. Borders 
between damaged and intact cells 
are sharp (arrows). 
Magnification: 1200x (EM). 
b) Detailed view of the interface
between an intact and a damaged 
(early phase) P3 cell. All components 
of the cell, including the microvilli, 
are electron dense and appear dark, 
and shedding of the microvilli has 
begun.  
Magnification: 5000x (EM). 
c) Center of the damaged area in the
outer stripe. Among necrotic P3 seg-
ments (P) one can find thick ascen-
ding limb profiles (TAL) of loops of 
Henle, which contain degenerated 
cells sharply separated from intact 
cells (arrows).  
Magnification: 2000x (EM). 
 ͳͷ͸

Fig. 12.2.04.: Cross section of the outer stripe of the outer medulla.
Note the coagulation necrosis of proximal P3 segments. On the right is a tubule with very 
darkly stained cells directly adjacent to somewhat less condensed cells. Many of the 
microvilli that make up the cells’ brush borders have already been shed into the lumen. 
Magnification: 3575x (EM).  
ͳͷ͹
The following Fig. 12.2.05. – 12.2.08 show intact structures. 
Fig. 12.2.05.: longitudinal section of a proximal tubule (S1, S2 segments).  
The ultrastructure is intact after 120min of perfusion with 5g% albumin in standard 
perfusate (corresponding to group 1). Perfusion fixation, magnification: 28125x (EM). 
ͳͷͺ
Fig. 12.2.06.: Longitudinal section of a distal tubule.
Ultrastructure is intact. Magnification: 28125x (EM). 
ͳͷͻ
Fig. 12.2.07.: Distal tubule, macula densa cells.
Note the typical perinuclear vacuoles, which disappear when transport is inhibited with 
loop diuretics. Magnification: 11875x (EM). 
ͳ͸Ͳ
Fig. 12.2.08. Detailed image of a glomerular capillary.
Perfusion fixation after 2 hours of perfusion. Ultrastructure is intact. The characteristic ring 
structure seen at the lower margin of the image is an assembly line for the production of 
basement membrane. The micrograph was taken by Karlwilhelm Kuehn. Magnification: 
24000x (EM). 
ͳ͸ͳ
Fig. 12.2.09.: Cross-sections 
through the innermost one-
third of the inner stripe.  
Group 2, perfused for 2 hours with 
cell-free standard medium supple-
mented with glutathione.  
a) The regular pattern of damage
around the vascular bundles (V) is 
obvious. Thick ascending limbs 
situated immediately around the 
bundles are structurally intact 
(Ai), while those farthest from the 
bundles are necrotic (An). All 
other tubular segments are intact.  
Magnification: 100x (LM). 
b) Vascular bundle with surroun-
ding thick ascending limb profiles 
(asterisks), which are intact on the 
side facing the bundles and dama-
ged on the opposite side. Collec-
ting ducts (CD) and descending 
thin limbs of loops of Henle are 
structurally intact.  
Magnification: 300x (LM). 
ͳ͸ʹ
Fig. 12.2.10.: Electron micro-
graphs of cell damage in the 
inner stripe of the outer 
medulla.  
Group 2, perfused for 2 hours 
with cell-free standard medium 
supplemented with glutathione. 
a) Thick ascending limbs in the
vicinity of vascular bundles (V) 
are intact (Ai), while those 
farthest from V are necrotic 
(An). In between these same 
thick ascending limbs (asterisk) 
is one that exhibits a damaged 
and an intact half. The type of 
necrosis seen here is a hydropic 
degeneration with extensive 
cytoplasmic and mitochondrial 
swelling; the nuclei are pyknotic. 
In the most severely damaged 
tubules, the circumferential out-
line of the tubule is maintained 
only by the basement mem-
brane (arrow). Collecting ducts 
(CD) and descending thin limbs 
(D) are intact. 
Magnification: 750x (EM). 
b) Thick ascending limb profile
with an intact and a necrotic half 
(border indicated by arrows). 
Note the swollen mitochondria 
and the pyknotic nucleus. 
Magnification: 2300x (EM). 
ͳ͸͵
Fig. 12.2.11.: Electron micrographs depicting details of defective TAL-segments.
Swollen mitochondria fill almost the whole cell; only small wisps of cytoplasm remain. Note 
the nuclei in various stages of pyknosis. Collecting ducts on the left and right are intact. 
Magnification: 6875x (EM). 
ͳ͸Ͷ
Fig. 12.2.12.: Cross-section of 
the inner medulla.
Group 1, perfused with cell-free 
standard medium for 2 hours.  
a. Survey light micrograph.
Collecting ducts (CD) are struc-
turally intact. 
Magnification: 170x (LM). 
b. Detailed view. All tubules
and collecting ducts are structu-
rally intact. ATL, ascending thin 
limb; DTL, descending thin limb. 
Magnification: 1600x (EM). 
ͳ͸ͷ
Fig. 12.2.13.: Cross-section 
through the outer stripe 
ȋȌ    ȋȌ 
the outer medulla.  
Group 4, perfused for 2 hours 
with the addition of 5% ery-
throcytes.  
a. Outer stripe. Unlike the
case in cell-free perfused kid-
neys, no necrosis is visible.  
Magnification: 75x (LM). 
b. Inner stripe. All tubules
appear structurally intact. V, 
vascular bundle.  
Magnification: 60x (LM). 
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Fig. 12.2.14.: Schematic diagram to 
demonstrate distribution of damaged 
ȋȌǤTwo 
vascular bundles are depicted at the top, 
beginning at their glomeruli in the cortex 
(C), traversing the outer stripe (OS) and 
the inner stripe (IS) and penetrating the 
inner medulla (IM). Areas containing da-
maged tubules (indicated by shading) ex-
tend from the border between outer and 
inner medulla up into the basal portions 
of the medullary rays of the cortex, and 
are always located farthest from the vas-
cular bundles. The distribution of dama-
ged areas in a cross-sectional plane of the 
outer stripe (middle) differs from that in 
the inner stripe (bottom); circles repre-
sent the cross-sectional vascular bundles 
and damaged areas are again shaded. In 
the outer stripe, the damaged P3 seg-
ments are confined to the centers of the 
interbundle regions, whereas in the inner 
stripe the damaged TAL-segments form a 
confluent area. In addition, the top panel 
indicates the course of descending and 
ascending vasa recta responsible for the 
supply of blood (resp. perfusate) to the 
inner medulla and inner stripe. 
Pathway 1 represents the inner medul-
lary circulation, with the ascending vasa 
recta rising within the vascular bundles, 
and spreads out from the bundles within 
the outer stripe. 
Pathway 2 represents the inner medul-
lary circulation, in which the oxygen 
depleted ascending vasa recta mostly 
ascend individually between the vascular 
bundles to the corticomedullary border. 
The traversing ascending vasa recta [see 
references (131, 132)] mainly supply 
blood to the tubules in the outer stripe. 
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12.3. Hypothesis to account for oxygen deficiency in the cell-free 
perfused kidney 
 The assumption that perfusion without oxygen carriers, i.e., with cell-free perfusate, 
does not provide an organ such as the kidney with sufficient oxygen goes back to the idea 
that there are regions in the kidney, such as the outer medulla, which even under normal 
conditions in vivo consume up to 80% of the available oxygen (39, 56). One striking feature 
of this region is that the TAL-segments have a very high density of mitochondria, and levels 
of glycolytic enzymes are ten times higher than in the cells of the proximal tubules (18). 
This high capacity of glycolysis can only be explained if there are phases of oxygen deficien-
cy which lead to gene activation by (as is now known) HIFϭɲ (hypoxia-inducible factor-ϭɲͿ
(273-275), which is also responsible for the activation of the erythropoietin gene. The mor-
phological damage described in section 12.2 can be explained by the fact that, in the cell-
free perfused rat kidney, the tubuloglomerular feedback (TGF) loop is not operative (un-
published data from Ulrich Gutsche and Reinhard Brunkhorst in my laboratory in Hanover 
in June 1979). In contrast, Schnermann demonstrated that the TGF is present in the blood 
perfused dog kidney (240). In vivo, the TGF acts to reduce the SNGFR when oxygen levels in 
the TAL segment become critical and the cells must draw on anaerobic glycolysis for ener-
gy. Reabsorption of NaCl becomes insufficient and consequently the NaCl concentration at 
the macula densa increases. One indication of this switch from aerobic to anaerobic energy 
production are oscillations in tubular pressures, first described by Paul Leyssac in 1983 
(143) and followed up by Holstein-Rathlou (113, 114). Using a microconductivity probe (95) 
Hans-Ulrich Gutsche detected oscillations of equal frequency in the NaCl concentration in 
the tubular fluid of the distal convoluted tubule, which were, however, phase-shifted with 
respect to the oscillations in tubular pressures. The oscillations were observed only under 
light halothane anesthesia (94, 119, 120), when barbiturate was used they were not 
detectable (94). We found furthermore that the oscillations in tubule pressure and distal 
sodium concentrations are also reflected in measurements of oxygen pressure in 
superficially located tubules and glomeruli, as shown in Fig. 12.3.1. 
 Perfusion of the renal medulla, proceeding via the vascular bundles of descending and 
ascending vasa recta, is postglomerular, which is a prerequisite for the development of 
osmotic gradients through the shunt diffusion of solutes such as urea. Shunt diffusion of 
blood gases also occurs, with a continuous drop in the pO2 between the cortico-medullary 
border and the papilla, and a concomitant increase in pCO2 (trapping). The vascular bundles 
are linked by alternately meshed, individual capillary networks, which are supplied with 
more or less depleted pO2. In a remarkable piece of work, Bastin has uncovered a clear 
distinction between the proximal tubule and the TAL-segment with respect to the relation-
ship between levels of ATP on the one hand, and the levels of glucose seconds after 
ischemia / hypoxia on the other. The proximal tubule loses its stock of ATP very quickly, 
while the glucose level remains stable for much longer (18). 
ͳ͸ͺ
Fig. 12.3.1.: Original recording of the oscillations in the free-flow pressure in the 
proximal tubule and the NaCl concentration in the fluid of the early distal tubule
(measured as electrical conductivity) (95). The red trace at the top corresponds to the 
blood pressure registered in the carotid artery, the green line to the pressure in the 
proximal tubule (8-16mmHg), the blue trace to the conductivity as NaCl equivalent (30-
75mmol/l). Hans Ulrich Gutsche provided the image personally. The finding emerged from 
a collaboration with Paul Leyssac´s laboratory in Copenhagen (94).  
 The TAL segment consumes its stock of glucose via anaerobic glycolysis within 2 
minutes, which allows it to maintain its ATP level for almost 60 seconds. I have extracted 
the graph shown in Fig. 12.3.2. from the Tables in this work (18).
ͳ͸ͻ
Fig. 12.3.2.: Comparison of ATP ȋȌ   ȋȌ levels following the onset of 
hypoxia in the proximal tubule and TAL segment. The proximal tubule (PCT) quickly 
loses its energy reserves in the form of ATP, without a correspondingly dramatic change in 
its glucose stock. However, under hypoxia the TAL segment consumes its glucose by glycol-
lysis within 2 minutes, so that its pool of ATP can be maintained for nearly 60 seconds. This 
reflects the high potential of TAL-segments for glycolysis, in contrast to the proximal tubule 
(the plot is based on Bastin´s data (18)). 
 This temporal profile is compatible with the generation of the oscillation frequency in 
those nephrons whose amount of filtrate exceeds the reabsorption capacity of the associa-
ted TAL-segment. Thus, the TGF protects the proximal tubule from damage that would 
otherwise be induced by oxygen deficiency. Shunt diffusion of blood gases is not only pre-
sent in the renal medulla but also in the renal cortex, as had long been suspected but was 
first definitively confirmed by measurements on superficial glomeruli of Munich-Wistar-
Froemter rats (260). This is compatible with the finding that a significant portion of the 
renal cortex is not as well supplied with oxygen as the high venous pO2 values suggested by 
the rather bright red color of renal venous blood. This was the starting point for our 
subsequent in-vivo studies on the pO2 at the kidney surface using multiwire gold microelec-
trodes, which revealed oscillations of the oxygen pressure in a subset of nephrons. As with 
Leyssac´s observations, this was detectable only under light halothane anesthesia. The 
following Figures show recordings of glomerular and tubular pO2 pressures at the renal 
surface in Munich-Wistar-Froemter rats. 
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Fig. 12.3.3.: Original recording of pO2 
at the kidney surface in a Munich-
tar-Froemter rat in-vivo and in-
situ. The systemic arterial pO2 of 130 
mmHg was measured with an O2
macroelectrode (bottom) inline of a 
femoro-femoral arterio-venous shunt 
under continuous blood flow (driven by 
the rat´s heart) and  under ventilation 
with 25% O2 . 
Wires 1 & 2 of the multiwire (8) gold 
microelectrode were positioned directly 
above the glomerulus (ochre and red 
traces), wires 3 and 4 (blue/green) above 
the proximal tubules. The mean frequen-
cy of oscillation was 2 cycles per min or 
33mHz. The pO2 pressures above glome-
ruli and tubules are clearly distinguishable in height. This Figure, like the following, is taken 
from the thesis by Oliver Johns (117, 259). The traces run from right to left 
(Schreibrichtung). 
Fig. 12.3.4. Sketch of the 
temperature-controlled ca-
libration chamȋͷǡ͸ȌǤ  
The calibration gas is passed 
through the frit (5) in vent 3/4 
and causes the calibration fluid 
to rotate as in an Ussing 
chamber, without allowing gas 
bubbles to enter the calibration 
funnel. The figure shows the 
calibration of all 8 gold wires 
from an original calibration.  
For more details, see original 
publication (117, 259).
ͳ͹ͳ
Raumluft = room 
air 
ȴĞŝƚсȴƚŝŵĞ͕
due to Pen  
offset 
Schreibrichtung = 
Recording-  
direction 
Fig. 12.3.5.: Original recordings of all 8 wires of gold electrode during the transi-
tion from air to 95% O2 and back. The geometric disposition of the detection wires of 
the electrode in relation to the glomerulus is depicted at the top left. K4 and K5 are directly 
above the glomerulus. The starting point of the recording is on the right-hand side. At first 
only weak oscillations are seen, but strong pressure oscillations set in immediately after 
switching to 95% O2 and reach a maximum of 130mmHg. The corresponding systemic 
arterial pO2 reached 600mmHg under ventilation (261). K3 and K6 are implaced in a 
tubuloglomerular intermediate region, K1, K2 and K7, K8 are supratubular records. Since 
the compensation recorder had only 4 channels, we switched this recording from the first 4 
on to the next 4 wires in the middle. For further details see original publication (117, 259). 
 The oscillations are observed in only a small portion of the nephrons under "normal 
conditions". Most nephrons operate at a constant level. A physiological perturbation like 
that shown in Fig. 12.3.5 or its converse - hypoxia - induces more nephrons to oscillate. 
Cortical, subcortical and midcortical nephrons, whose TAL-segments are further away from 
the vascular bundles of the renal medulla are more susceptible to oscillations than juxta-
medullary nephrons. The TAL-segments of the latter benefit from the radial diffusion of 
oxygen because they directly surround the vascular bundles. This allows these groups of 
nephrons to adjust their SNGFR over a much wider range. Holstein-Rathlou has presented 
evidence that nephrons that are associated with an interlobular artery can oscillate 
synchronously as a group (113). 
ͳ͹ʹ
Fig. 12.3.6.: Synopsis of an oscillating nephron.Oscillations of equal frequency can be 
detected in (proximal) tubular pressure, and (phase shifted) in the sodium concentration 
(conductivity) in distal tubules and the oxygen pressure at both supraglomerular and supra-
tubular positions on the renal surface. Consequently, the amount of sodium will oscillate 
with the same frequency (at the entrance to TAL segment) as the tubular flow rate, and the 
cells of the TAL segment convert the flow signal into a change in the concentration of 
sodium if their metabolism switches from aerobic to anaerobic ATP production. The oscilla-
ting sodium concentration at the macula densa can use the TGF to adapt the tubular 
transport to the oxygen supply, making it the driver and the source of this regulatory 
oscillation phenomenon (259). The pacemaker nephron then takes over the synchroniza-
tion of the whole group of nephrons around a pair of interlobular vessels (113). 
ͳ͹͵
Summary of the components of the hypothesis 
 In vivo, only 8% of the oxygen that passes through the mammalian kidney is consumed 
by the organ. Nevertheless, some areas of the kidney are constantly on the brink of oxygen 
deficiency. This may be one reason why evolution has relocated the site of erythropoietin 
synthesis from the liver in the fetus to the kidney in the adult organism. Here, reductions in 
both the oxygen carrying-capacity of the blood (for example, due to blood loss) and the 
ambient oxygen pressure such as at high altitude (above sea level) can be readily detected. 
Another reason may be that efficiency of renal function is essentially proportional to the 
overall level of metabolism and thus more or less directly reflects the magnitude of the 
latter (see for example, performance adjustment of the kidneys in pregnancy). 
1. In vitro studies of the normothermic perfused rat kidney reveal an uptake of 40-50%
of the oxygen available in a cell-free perfusate that has been equilibrated with 95%
oxygen. Under these conditions, there are physiological signs of functional insuffici-
ency of S3 segments of the proximal tubule and of TAL segments, which manifest
morphologically in the form of necrosis due to oxygen deficiency. Under cell-free
perfusion, radial diffusion of oxygen from the vascular bundles of the medulla
cannot meet the demands of the affected structures. In vivo, the particular
architecture of the vessels of the renal medulla indeed allows the kidney to set up
concentration gradients down to the papilla, thus maintaining their concentrating
ability by shunt diffusion of solutes in the vascular bundles. However, this inevitably
involves the shunt diffusion of blood gases, which leads to a greatly reduced pO2
and elevated CO2 (“trapping") in the renal medulla. In vivo, the kidney can cope with
the consequences, but not when perfused with cell-free medium lacking oxygen
carriers.
2. In vivo studies on MWF rats that have a large number of glomeruli in superficial
locations show that half the oxygen disappears on the way from the renal artery to
the superficial glomerulus due to highly efficient shunt diffusion within the renal
cortex, specifically via the vasa interlobulares. This implies that, in spite of high
circulation rates, there are also areas of oxygen deficiency in the renal cortex.
3. In vivo studies under light halothane anesthesia have detected oscillations in the
hydrostatic pressure of the proximal tubule which are reflected in - phase shifted –
oscillations in the sodium concentration in the early distal tubule and in the oxygen
pressure in superficial glomeruli and tubules. These findings indicate that nephron
efficiency oscillates as a function of its transport capacity. The critical factor here is
the transport capacity of the TAL-segments, which depends on oxygen availability.
When the TAL-segment is forced to shift from aerobic to anaerobic energy genera-
tion, this serves not so much as an emergency reserve but as a metabolic switch
that triggers an oscillatory adjustment to the functional transport capacity of the
ͳ͹Ͷ
nephron. The tubulo-glomerular feedback thus has a vital function in inhibiting 
necrosis not only in TAL-segments. In addition, it protects the proximal tubule 
(which has a weak capacity for glycolysis) against oxygen deficiency by reducing and 
adjusting the single-nephron filtration rate. Persson and coworkers have shown that 
the oncotic pressure substantially affects the feedback response, i.e. that a high 
colloid osmotic pressure (COP) – which is associated with a high filtration fraction - 
ensures a high feedback response rate in the efferent arteriole, and conversely a 
lower COP leads to a significant weakening of the feedback response (201, 202). In 
the cell-free perfused kidney, the filtration fraction is always below 10%, which may 
explain why the lack of feedback does not further depress the filtration rate – in 
response to the limiting O2 supply - and thus enables damage due to O2 deficiency. 
An observation made by Zoltan Endre (70) and coworkers is interesting in this 
context: they found that an isolated kidney perfused with 2% added erythrocytes, 
and thus under slight hypoxia, shows damage to proximal tubules but not to TAL-
segments. This may mean that the added erythrocytes specifically protect TAL-
segments, but that simply shifts the problem to the proximal tubules, which suffer 
from overloading due to defective tubuloglomerular feedback. Thus, when confron-
ted with a high sodium load proximal tubules - with their weak glycolytic capacity - 
cannot handle oxygen deficiency. 
Fig. 12.3.7.: Hypothetical relationship between filtration fraction and feedback 
response in the IPRK . The filtration fraction of the IPRK ranges between 1.5 and 8% while 
the mean for the rat kidney in vivo is 30%.  
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Summary: 
 The balancing act between concentrating ability, adequate oxygen supply and erythro-
poietin secretion, which the kidney performs so well in vivo, is beyond the capacity of the 
isolated cell-free perfused kidney. The latter´s concentrating ability is severely limited by 
the high perfusion of the medulla; hence, the necessary concentration gradient along the 
corticomedullary axis cannot be established or maintained.  
 The oscillations in oxygen pressure detectable in glomeruli and tubules at the surface 
of the kidney in vivo, together with the associated pressure fluctuations in proximal tubules 
and conductivity fluctuations in distal tubules, point to an oscillating functional state of the 
nephron in relation to its transport capacity. The crucial factor is the transport capacity of 
the thick ascending limb of the loop of Henle (TAL-segment) under oxygen-deficiency con-
ditions: It is not surprising that the cells in this TAL segment contain large numbers of 
mitochondria and display a high capacity for glycolytic activity. As a result, this segment can 
react to oxygen deficiency by flipping a metabolic toggle switch which triggers an oscillatory 
adjustment of the affected nephron to the level of available oxygen (by means of its shift 
kinetics). 
 In the isolated cell-free perfused kidney (IPRK), oxygen capacity is insufficient - despite 
the high partial pressures employed – to meet the demands of the interbundle area of the 
outer medulla which, even under in vivo conditions, takes up no less than 80% of the 
oxygen supplied. Since the TGF in the cell-free perfused kidney is too insensitive and does 
not work, the GFR cannot be adapted to the reduced transport capacity of TAL segments 
and proximal tubuli. This results in morphological damage to the vulnerable structures of 
the interbundle area, such as the S3 segments of the proximal tubule and the TAL segments. 
In contrast, structures nearer the vascular bundle profit from radial diffusion of oxygen and 
therefore remain morphologically intact. 
 In vivo, the fact that nephrons operate at the brink of oxygen deficiency enables them 
to sensitively monitor the supply of, and demand for oxygen, and to control the synthesis 
of erythropoietin. Although the IPRK can synthesize erythropoietin, it is unable to 
accomplish the required balance between concentrating ability, oxygen sufficiency and 
adaptation of the rate of erythropoietin synthesis. 
 The key to the lack of long-term stability of the isolated kidney and the resulting loss of 
function of isolated kidneys lies in the fact that the integrity of the endothelium is lost 
during artificial perfusion. The complexity of circulating whole blood and its permanent 
reconditioning is a crucial prerequisite for the integrity of the endothelial barrier and its 
glycocalyx. The glycocalyx builds up an endothelial surface layer whose components are 
drawn from the bloodstream, and this layer defines the integrity and local permeability of 
the endothelium under in vivo conditions (97, 204). Another significant factor may be the 
ͳ͹͸
unfavorably narrow margin between oxygen deficiency and oxygen intoxication in the 
isolated kidney. In order to remain within the optimal range, one must mimic the condi-
tions that prevail in vivo, which provide for a high oxygen capacity at low (i.e. normal) 
oxygen pressure (i.e. lower perfusion flow rates). For the isolated liver, this principle was 
established a long time ago with the result that, for example, the oxygen consumption was 
higher than at reduced hemoglobin levels and high pO2 partial pressures (1, 2, 169). In 
addition, lysosomes remain intact for much longer (up to 8 hours) than in the case of the 
conventional perfusion (low Hb, high O2 partial pressure) technique. 
 Another approach would be to improve the stability of albumin function. In vivo, 
albumin has a limited half-life and is constantly replenished. In vivo, aged and defective 
albumin is removed by mechanisms which are not available in vitro. Siliconization of the 
interior surfaces of the perfusion apparatus would be worthwhile, as would measures to 
minimize contact of the perfusate with air and avoid foaming as far as possible. With the 
latter aim in view, we used a sensor in the draining funnel which controlled a tube valve, 
thus allowing perfusate to flow back as a column of liquid with no air bubbles in between. 
This can reduce an unnecessary denaturation. In the laboratory in Muenster we had aban-
doned this principle for the sake of simplicity, which was perhaps a mistake. Whether these 
scruples are realistic may be another field of research.  
ͳ͹͹
12.4. Overview of the contributions of our group to the four 
different techniques of renal perfusion 
1 Single pass perfusion ȋȀǡǤǤ̺Ȍ
2 RecirculationȋȌǡȀ
3 Recirculation with dialysisǡȀ
4 Reperfusion of the perfusion-fixed kidney 
1a Single pass perfusion with Haemaccel® as colloid 
Sodium transport and metabolism ȋ	Ȍ
ͳͻ͹Ͳ ǦǤǦȋʹ͸ͶȌ
ͳͻ͹ͳ ǦʹǦȋʹͷͷȌ
ͳͻ͹ʹ ȋǡǡȌ
ȋʹͷ͸ȌǤ
ͳͻ͹ͷ Ǧ
ȋʹͷ͹Ȍ
ͳͻ͹ͷ  Ǧ
 ȋʹͷͶȌǤ
ͳͻ͹͸ 
ȋʹͷ͵ȌǤ
ͳͻ͹͸ ǣǦ
Ǧȋͳ͹ͷǡ
ʹͷ͵ȌǤ
ͳͻͺͶ Ǧ
ǡȋͳ͵ͲȌʹͷ͸ȌǤ
1b Single pass perfusion without colloid ȋȌ
The effect of albumin on the function of the IPRK compared to “colloid-
free  perfusion” 
ͳͻͺͳ ȋʹͷͳȌǤ
The renal clearance of thyroid hormones by the IPRK 
ͳͻ͹ͺȀ ȋͶȌǤ
ͳͻͺͲ
The effects of AVP and dDAVP on free-water reabsorption in the IPRK 
ʹͲͳͳ Ǧʹȋʹ͸ʹȌǤȋ
òȌ
ʹͲͳͷ ǣȋ͵ʹͲȌ
ͳ͹ͺ
2 Recirculation with bovine serum albumin, BSA (with/without red cells) 
Conversion of thyroxine to tri-iodothyronine in the IPRK (with red cells) 
ͳͻͺ͸ ȋ͵ͳͶȌǤ
ͳͻͺͺ Ͷ
ȋͻͻȌǤ
Renal metabolism of peptide hormones and uremic middle molecules 
ͳͻ͹ͻ ȋǡǦǡǦȌ
ȋʹ͸ͺȌǤ
ͳͻͺͲ ȋʹ͵͸ǡʹ͵͹ȌǤ
ͳͻͺͲ ȋͳͷͺǡʹ͵͵ǡʹ͵ͶǡʹͻͲȌǤ
Renal metabolism of leukotrienes 
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3 Recirculation with BSA, regeneration and aeration of perfusate by dialysis 
Glomerular permeability for albumin in the IPRK, functional characteriza-
tion. Mikropuncture studies are indicated in bold italics  
ͳͻ͹͹ Direct assessment of the glomerular sieving coefficient for albumin in the rat 
kidney ȋʹͻͲȌǤ
ͳͻ͹ͺ Micropuncture experiments on albuminuria in the IPRK ȋʹͷʹȌǤ 
ͳͻ͹ͻ A comparison of micropuncture studies in the IPRK with the in vivo 
experimental conditions (292)Ǥ 
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ȋʹͶ͹ȌǤ
ͳͻͺͶ Glomerular albumin leakage and morphology after neutralization of 
polyanions I ȋͳʹǡʹͺͶȌ. 
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ͳͻͺ͸ The „repaired defect“ hypothesis of the glomerular capillary wall. Analysis 
in the  IPRK ȋʹͶͶȌ. 
ͳͻͻʹ The physiological and pathophysiological basis of glomerular permeability 
for plasma proteins ȋʹ͸͸Ȍ. 
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Various aspects of renal function which were studied in the IPRK 
Micropuncture studies are indicated in bold italics  
ͳͻͺͳ ȋʹͷͳȌǤ
The micro-puncture data raised in parallel have been published only in the 
habilitation workȋʹͷͲȌǤ
1984 Single nephron function after unilateral nephrectomy in rats treated with 
Cyc A ȋʹ͸͹ȌǤ
1984 Studies on the pathophysiology of glomerular water permeability ȋͳͺͳȌǤ 
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1986 Effective hydraulic permeability of the glomerular capillary wall in rats 
after unilateral nephrectomy ȋͳͺͶȌǤ 
1986 Influence of Cyc A on adaptive hypertrophy after unilateral nephrectomy in 
the rat ȋͳͳ͸Ȍ ȋʹ͸͹ȌǤ  
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2004 Age-dependent thickening of glomerular basement membrane has no major 
effect on glomerular hydraulic conductivity ȋͳͺʹȌǤ
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4 The reperfusion model of a perfusion-fixed rat kidney 
Studies on the importance of the electric charges of the glomerular 
filtration barrier 
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Klaus Hinrich Neumann 
13. Special aspects of micropuncture experiments on the
IPRK
13.1.Studies on the isolated perfused rat kidneys 
 Micropuncture techniques permit one to investigate tubular and glomerular functions 
of surface nephrons in the IPRK under conditions similar to those that prevail in vivo. 
However, they require certain modifications of the experimental set up normally used in 
studies on the IPRK and some special aspects must be considered. The placement of the 
experimental kidney in the temperature controlled kidney tray is similar to that employed 
for the in-vivo preparation. One major advantage for micropuncture experiments lies in the 
absence of the renal movements associated with respiration, which inevitably complicate 
the puncturing of superficial cortical nephrons in situ. On the other hand, as a consequence 
of perfusion with cell-free medium, peritubular capillaries are less clearly defined, which 
hampers precise placement of puncturing glass capillaries under stereomicroscopic control.  
Fig. 13.1.1.: Set-up for micropuncture experiments in the IPRK. Micromanipulators 
are positioned on both sides of the kidney tray, which are used to estimate single nephron 
gfr, to measure tubular pressures and for indirect determination of glomerular capillary 
pressure by means of the stop-flow technique described by Gertz (86). The holder for the 
glass pipette for collection of tubular fluid is mounted on the left micromanipulator. The 
micromanipulator on the right is used to direct the pipette mounted on the microperfusion 
pump with the micropressure transducer. The stereomicroscope in the center is a Leitz 
model, equipped with episcopic illumination, a 4x objective and 10x eyepieces. 
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 achieve the highest possible contrast for 
visualization of cortical tubules, the surface of 
the isolated kidney is illuminated tangentially 
by cold light sources. When viewed with ver-
tically directed incident light the level of con-
trast at the surface of the cell-free perfused 
kidney is extremely low. 
Fig. 13.1.2.: Schematic view of the positio-
ning of micropuncture pipettes. The upper 
panel shows the disposition used for collection 
of tubular fluid (top), the lower panel depicts 
the arrangement used for measurement of tu-
bular free flow (PFF) and stop flow (PSF) pres-
sure (bottom). The latter enable one to mea-
sure the single nephron GFR (SNGFR) and cal-
culate the effective filtration pressure (181).  
 Proximal convoluted tubules of surface nephrons are punctured with sharpened glass 
pipettes (tip size 8-10 ђm) filled with isotonic sodium chloride solution containing 0.1% 
Lissamine green (Serva, Heidelberg, Germany) for better visualization. For measurements 
of pressure and tubular perfusion the pipettes are mounted on the lucite pipette holder of 
the microperfusion pump (W. Hampel, Frankfurt, Germany) which is filled with silicon oil 
(AH35 Wacker Chemie, Munich) and connected via a side-arm to a micropressure trans-
ducer (type Epi-080-25, Entran Devices, Little Falls, NJ, USA). The transducer signal is 
recorded by a chart recorder (Linseis Messgeräte, Selb, Germany). The microperfusion 
pump including the pressure transducer [this system was developed in Berlin (154)] is 
mounted on a micromanipulator (Leitz, Wetzlar, Germany). The pipette tip is placed in a 
proximal tubule (under stereomicroscopic control). Then the free flow pressure (PFF) is 
recorded and the tubule is perfused for a short period of time with the colored solution. If 
an early proximal tubule has been punctured, as indicated by the number of colored loops 
visible downstream (at least 4, range 4-7, mean 5.3), the pressure pipette is left in place. 
Since the number of proximal surface loops in Wistar rats has been reported to be 5.2 on 
average, it can be assumed that the pressure pipette is located in the earliest accessible 
part of the proximal tubule. The last proximal surface loop is then punctured with a second 
pipette filled with colored paraffin oil and, after the introduction of a small droplet of oil 
into the lumen of the tubule, fluid is collected for specific period (5-8 min). The collection 
rate is adjusted so that the continuously recorded tubular pressure is held at the initial PFF 
level and the oil droplet is kept distal to the collection pipette. When collection is complete, 
the pipette is withdrawn and the tubule distal to the pressure pipette is blocked with 
paraffin oil using another pipette. The stop flow pressure (PSF) is then recorded and the 
position of the tubule is noted for later identification (181). Since the tubulo-glomerular 
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feedback mechanism is not operative in this isolated perfused kidney preparation, any 
possible influence of proximal collection of tubular fluid on hydraulic pressure in the 
glomerular capillary can be disregarded. At the end of the experiment, the kidney is 
perfused at the original perfusion pressure with a 1.25% glutaraldehyde solution in 
phosphate buffer containing 6g% hydroxyethyl starch as the colloid. The tubules previously 
studied are then gently injected in the retrograde direction with Microfil (Canton Biomedi-
cal Products, Boulder Co, USA) so that the marked glomeruli can subsequently be identified 
in histological sections, based on the presence of small particles of Microfil in Bowman´s 
capsule. 
Fig. 13.1.3.:Schematic diagram of continuous tubular pressure registration during 
pressure controlled collection of tubular ϔluidǤ The pressure pipeƩe is located in the 
earliest accessible loop of the proximal tubule and the free Ňow pressure (PFF) is registered. 
The last proximal surface loop is then punctured with a second pipeƩe Įůůed with colored 
parĂĸŶ oil, and a Ɵmed collecƟon (5-8 min) of tubular ŇƵŝĚ is begun ĂŌer inserƟon of a 
small droplet of oil into the tubular lumen (arrow 1). The collecƟon rate is adjusted so that 
the coŶƟŶƵously recorded pressure is held at the original PFF and the oil droplet is kept 
ĚŝƐƚĂůƚŽƚŚĞĐŽůůĞĐƟŽŶƉŝƉĞƩĞ͘ŌĞƌĐŽůůĞĐƟŽŶŝƐĐŽŵƉůĞƚĞĚ͕ƚŚĞƉŝƉĞƩĞŝƐǁŝƚŚĚƌĂǁŶĂŶĚ
ƚŚĞƚƵďƵůĞĚŝƐƚĂůƚŽƚŚĞƉƌĞƐƐƵƌĞƉŝƉĞƩĞŝƐďůŽĐŬĞĚďǇŝŶũĞĐƟŶŐƉĂƌĂĸŶŽŝůĨƌŽŵĂŶŽƚŚĞƌ
pipeƩe. Then the stop Ňow pressure (PSF) is recorded (see arrow 2), (181). 
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Calculations: The volume of tubular fluid (V) obtained in timed collections is estimated 
from the length of the fluid column in a calibrated constant bore capillary glass tube 
measured with an eye-piece micrometer. The inulin concentration in microsamples of 
tubular fluid (TF) and perfusion fluid (P) is measured with a downscaled adaptation of the 
macro-analytical technique.  
SNGFR = ǚ  (TF/P) Inulin PUF  = PSF - PFF
Under the conditions prevailing in the isolated perfused rat kidney the glomerular ultrafil-
tration pressure (PUF) can be calculated as the difference between the stop flow pressure 
and the free flow pressure (PFF): 
Derivation: 
(1) PUF  =  (PGC – PFF) – ;ʋGC - ʋTF),  ʋTF  = 0 
(2) PSF  =   PGC - ʋGC                                       PGC = PSF нʋGC
Hence PUF  =  PSF  + ʋGC – PFF  - ʋGC 
PUF   =  PSF - PFF
PUF : glomerular ultrafiltration pressure PFF : tubular free flow pressure 
PGC : hydrostatic pressure in glomerular capillary  PSF : tubular stop flow pressure 
ʋGC : colloid osmotic pressure in glomerular capillary͕ĂŶĚŽĨƚƵďƵůĂƌĨůƵŝĚ͗ʋTF 
Fig. 13.1.4.: Schematic depiction of glomerular pressure profiles in vivo:The panel 
on the left shows how “filtration pressure equilibrium” (PUF = 0) along the glomerular 
capillary is achieved under hydropenic conditions. The panel on the right depicts the 
“filtration pressure disequilibrium” observed under euvolemic conditions with positive PUF 
at the end of the glomerular capillary length. The shaded area represents the effective 
filtration pressure. ȴP represents the hydrostatic pressure difference, which falls slightly 
along the length of the ĐĂƉŝůůĂƌǇ͕ ȴʋ ƐƚĂŶĚƐ ĨŽƌ ƚŚĞ ĐŽůůŽŝĚ-osmotic pressure difference, 
which increases along the capillary during the filtration process (181).  
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Fig. 13.1.5.: Schematic depiction of glo-
merular pressure profiles in the IPRK:
Due to the high perfusion rates at “normal” 
GFR, the filtration fraction is low (2 - 8%). 
The colloid-osmotic pressure consequently 
rises only minimally, thus providing almost 
constant filtration conditions along the glo-
merular capillary. Therefore, the effective 
glomerular filtration pressure can be easily 
and unequivocally calculated in this model 
(181). If the colloid-osmotic pressure is high 
(e.g. when a perfusion solution with 7g/ 
100ml albumin is used), the filtration frac-
tion can be as low as 2%, whereas it can rise 
up to 8% with a colloid-free perfusion 
solution due to the very high filtration rates 
(up to 1.6ml/g·min). 
Estimation of the glomerular hydraulic conductivity 
 Due to its unique features the IPRK is well suited as an experimental model in which to 
quantify the determinants of glomerular ultrafiltration and calculate the glomerular ultra-
filtration coefficient Kf.  Since Kf is the product of the hydraulic conductivity of the glomeru-
lar capillary wall (k) and the glomerular capillary surface area (S), in order to calculate k 
from Kf (k = Kf /S), it is necessary to measure the glomerular surface area. The actual anato-
mical site of the glomerular hydraulic resistance has not been clearly defined. Therefore, 
the effective hydraulic conductivity k is usually calculated from the total area of the inner 
surface of the glomerular capillaries for the purpose of comparability.  
This method was applied in the context of the following issues: 
x Dependence of the effective hydraulic permeability on age (122, 181)
x Adaptation hypertrophy after unilateral nephrectomy (122, 184) and
x Suppression of adaptation hypertrophy under the influence of cyclosporine A (116, 267)
13.2.Glomerular morphometry 
 Glomerular capillary surface area is measured using the technique described by Aei-
kens (5, 6). After perfusion fixation of the kidney, wedges of tissue - each containing the 
nephron that had been investigated and marked by particles of synthetic colored silicone 
rubber (Microfil) - are dehydrated and embedded in Araldite (Serva, Heidelberg, Germany). 
Beginning at the kidney surface, 400 – 600 serial sections (0.9 ђm thickness) of which about 
150 include the marked glomerulus, are cut on an ultramicrotome (MT-22-B Serval DuPont 
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Instruments, Miami, FL, USA). The thickness of sections is monitored interferometrically. 
The sections are stained with methylene blue and covered with a coverslip. 
Fig. 13.2.1.: Light micrograph of a glomerulus from an isolated perfused kidney of 
a 2-month-old rat. Particles of Microfil are present in Bowman´s capsule and in the 
proximal tubule [methylene blue, from (181)].  
 Morphometry of glomerular structures is interactively performed on serial light micro-
scopic sections using an ASM Leitz image analysis system (Leitz, Wetzlar, Germany). The 
system consists of a digitizer linked to a computer (LSI11, Digital Equipment, Maynard, Ma, 
USA; see Fig. 13.2.1). The movement of an electronic pencil with a diode at the tip over an 
induction table is projected onto the light microscopic image of the structure under investi-
gation via a system of prisms. The inner surfaces of the glomerular capillaries are outlined 
with an electronic pencil and their circumferences are calculated by the computer program. 
The computed sum of the capillary circumferences is then multiplied by the thickness of the 
sections to obtain the total capillary surface area. Aeikens (6) has shown that when 
measuring a microscopic structure of the size of a glomerulus a magnification factor of 
1:680 results in an error of less than 1% (S.D.). For the histomorphometric measurements, 
the changes in size due to fixation and embedding of the material must be taken into 
account. According to Aeikens (5, 6), perfusion fixation results in a 6% enlargement of area 
and embedding causes a reduction in area of 9% relative to measurements on frozen 
sections. These changes are taken into account in the calculations. 
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Fig. 13.2.2.: Schematic represen-
tation of the morphometric ana-
lysis system for the determina-
tion of the capillary surface from 
serial sections. The movement of 
the light pen on the induction table 
is projected via a system of prisms 
onto the microscopic image and 
processed by the PDP8 computer. 
The microprocessor was attached to 
the ASM image analyzer and the 
drawing tube of the microscope 
(181). 
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14. The isolated perfused mouse kidney
 After isolated perfused kidneys of different species - especially rats - had been used in 
medical research for over half a century, adaptation of the model to mouse kidneys 
became desirable early in the new millennium. With the establishment and dissemination 
of the transgene and knockout technology in mouse, detailed investigation of specific gene 
products became possible. For instance, the function of transport proteins or ion channels 
for which no specific pharmacological tools are available could now be investigated in vivo 
by genetic manipulation of the respective gene. Apart from the other problems encoun-
tered in the analysis of genetically manipulated mice, the significance of any direct effect 
on kidney function in such experiments is often limited by the systemic phenotype, which 
can potentially influence kidney function as well. For example, mice with global genetic 
deletion of the endothelial NO-synthase (eNOS) or of the receptor for the cardiac natriu-
retic peptides ANP and BNP (guanylyl cyclase-A, GC-A) each exhibit arterial hypertension 
because eNOS and GC-A both play important roles in the cardiovascular system (48, 65, 87, 
155). Since this systemic phenotype has a major impact on kidney function, a detailed 
analysis of the direct effects of eNOS or GC-A on kidney function is not possible in vivo. This 
sort of scenario presents an ideal opportunity for the isolated perfused kidney model, 
which, as has been discussed in detail in the preceding chapters, allows the investigation of 
kidney function ex situ under controlled conditions, and therefore without the confounding 
influences of the systemic phenotype of the mice. Of course, systemic effects of the genetic 
manipulation and the resulting systemic phenotype might result indirectly in functional 
(e.g., changes in receptor expression levels, vessel contractility, etc.) or structural (e.g., 
fibrosis) changes in the kidney, which could influence kidney function even in the isolated 
perfused organ. Obviously, such eventualities should be carefully considered when inter-
preting the results of such experiments.  
14.1.Perfusion techniques 
 All the perfusion techniques that have been employed in published experiments using 
isolated perfused mouse kidneys so far are based on the methods used for kidneys from 
other mammals. The technique was described in detail in a recent Video Article (62). The 
perfusion medium consists of a modified Krebs-Henseleit buffer, which is continuously 
aerated with a mixture of 95% O2 and 5% CO2 (209, 270, 289). Some studies have used 
perfusion medium that contained neither albumin nor erythrocytes (288, 289, 303), while 
both bovine serum albumin (BSA) and erythrocytes were included in the perfusate in other 
cases (48, 209, 270). The effects of BSA and erythrocytes on the function and integrity of 
isolated perfused mouse kidneys has been addressed in only one published study so far 
(209). It was shown that reduction of the BSA concentration in the perfusate resulted in a 
marked increase in urine excretion (at 4% BSA: ca. 40 ђl / min per g kidney weight, 
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equivalent to more than 10 times the rate of diuresis in vivo) and in the fractional excretion 
of sodium (FENa at 4% BSA: 11.6%), as was already known from the IPRK (251). Moreover, 
the glomerular filtration rate was markedly attenuated compared with the in vivo situation. 
In that study, a BSA concentration of 6.7% resulted in the reduction of urine excretion to 
such small volumes that the collection of sufficient urine over reasonable time periods was 
impossible. Hence, a concentration of 5.5% of BSA was chosen as a compromise between 
preservation of kidney function and the production of sufficient volumes of urine for 
analysis. With this concentration of BSA almost physiological values for urine volume (22 ђl 
/min per g kidney weight), GFR (400 ђl/min per g kidney weight) and FENa (1.5%) were 
observed. While the addition of rat erythrocytes (hematocrit 1%) to the 5.5% BSA perfusate 
did not significantly alter GFR or diuresis, the fractional excretion of sodium was further 
reduced to 0.3% and therefore to physiological values. This study very clearly underlines 
the high-energy demand of tubular transport and the resulting need to use a perfusate 
containing erythrocytes at least in studies focusing on tubular transport. This conclusion is 
further corroborated by the fact that the use of a perfusate without erythrocytes results in 
markedly pronounced damage to tubular cells in the inner stripe of the outer medulla (209, 
263). However, since some structural tubular damage was also detected when a hematocrit 
of 1% was used, the addition of higher concentrations of erythrocytes to the perfusate 
would seem advisable. Importantly, none of the tested perfusates resulted in reasonably 
physiological renal vascular resistance (209), which can most probably be attributed to the 
lack of vasoconstrictor hormones in the perfusate.  
 The diameters of human and rat erythrocytes are quite similar (ca. 7.5 ђm) so that the 
use of human erythrocytes for the perfusion of rat kidneys should not induce marked 
mechanical alterations of the renal vasculature. Since mouse erythrocytes are significantly 
smaller (mean diameter 5.6 ђm), human or rat erythrocytes might well be too large for the 
glomerular capillaries in mouse kidneys. Their use for the perfusion of mouse kidneys could 
perhaps be expected to cause perturbations in renal perfusion, glomerular filtration and 
therefore renal function. However, Rahgozar and colleagues demonstrated in pilot experi-
ments that the use of erythrocytes from rats, mice or sheep (mean diameter 4ђm) had no 
detectable impact on renal perfusion (209). These results are in good agreement with 
unpublished studies from our group, which addressed the effect of the size and source of 
erythrocytes (mouse vs. human) on renal vascular resistance and renal endothelial function. 
 In light of the above-mentioned studies, which demonstrated that: (i) the presence of 
erythrocytes in the perfusion medium is essential for nearly physiological renal function; (ii) 
a hematocrit of 1 % is not sufficient to preserve the integrity of the kidney for a perfusion 
time of 1 hour, and (iii) the use of larger erythrocytes from a different species does not 
appear to have major effects on renal hemodynamics or renal function, we chose to use a 
perfusion medium containing human erythrocytes at a hematocrit of 7 – 10%. Due to the 
relatively large numbers of erythrocytes necessary for kidney perfusion, the use of mouse 
blood as a source is neither feasible nor ethically justifiable.  
ͳͺͻ
 As with the perfusion of kidneys from other species, mouse kidneys can be perfused at 
either a constant flow rate (289) or a constant perfusion pressure (270). In contrast to the 
perfusion of kidneys from larger species, which require high rates of perfusion with a com-
plex and expensive perfusate and therefore necessitate its recirculation, perfusion of 
mouse kidneys can be performed in single-pass mode due to the low flow rates (see 
Chapter 2).  
Use of the isolated perfused mouse kidney for the investigation of renal renin 
release and renal vascular resistance 
 In the Institute for Physiology and the Collaborative Renal Research Center 699 on 
Structural, Physiological and Molecular Determinants of Kidney Function at the University 
of Regensburg, Germany, several groups are working on the regulation of renin secretion 
and the control of renal perfusion. Since, as indicated above, genetically manipulated mice 
allow new and detailed insights into these topics, the technique used for the perfusion of 
isolated rat kidneys, which was described in detail in the preceding chapters, was adapted 
to mouse kidneys. They have since been used successfully in the investigation of renin 
release and renal perfusion (8, 65, 91, 101, 111, 137, 138, 167, 192, 238, 269, 270, 304). 
Although determination of the glomerular filtration rate and of the tubular function can be 
successfully performed using this technique, our approach to these tasks (cannulation of 
the ureter using a glass capillary micropipette, usage of FITC-labeled sinistrin for the 
determination of the GFR) is not yet fully mature, so that a detailed description of the 
method would not be appropriate at this stage. Instead, the interested reader is referred to 
the publication by Rahgozar (209) in which a different method of urine collection is 
described. Alternatively, the author of this chapter can contacted directly.  
14.2.Perfusion medium 
 A modified Krebs-Henseleit buffer (see Table 4.1) serves as the basic perfusion medi-
um, which is supplemented with substrates according to formula R2, table 4.2. A com-
mercially available solution (Aminoplasmal AS10, Braun AG, Melsungen, see table 4.3.) is 
used as the source of amino acids. Butyrate is not used in our perfusate. A 5-liter batch of 
perfusate is freshly prepared on the day of the experiment and sterile filtered (see figure 
4.5.1, 4.5.2). Bovine serum albumin is then dissolved in this sterile medium (6 g BSA per 
100mL) using a magnetic stirring bar and the resulting albumin solution is subsequently 
sterile filtered. In order to remove bound substances such as hormones from the albumin 
solution, dialysis can be performed, but we do not use this step for routine experiments.  
 To ensure an adequate supply of oxygen to the kidney, the albumin solution is supple-
mented with human erythrocytes at a hematocrit of 7-10%. As source of erythrocytes, 
packed red blood cells, which are just past their expiry date, are purchased from the local 
blood bank. Red blood cells are repeatedly washed with sterile modified Krebs-Henseleit 
ͳͻͲ
buffer without albumin (see above) at least three times or until the supernatant after 
centrifugation is clear (see chapter 4.1.6.3). For an experiment of 2 hours duration and 
perfusion in single-pass mode, approximately 250 ml of perfusate is needed.  
14.3.Perfusion apparatus 
 Perfusion of mouse kidneys is carried out at a constant pressure of 90 or 100 mmHg in 
the single-pass mode. In order to avoid alterations in the composition of the perfusate 
(modified Krebs-Henseleit-buffer + BSA + human erythrocytes) during the perfusion period 
(owing to the release of potassium from erythrocytes as a result of hemolysis, for instance) 
and to ensure adequate oxygenation of the perfusate, continuous dialysis of the perfusate 
is performed (see Chapter 4.4.5., the dialyzer as the “kidney´s lung”). As dialysate, the 
modified Krebs-Henseleit buffer without albumin and erythrocytes is used. The dialysate is 
continuously aerated with a mixture of 95% O2 and 5% CO2.  
Fig. 14.3.1.: Apparatus for the perfusion of mouse kidneys at constant perfusion 
pressure in the single-pass mode: Complete setup (Fig. 14.3.0) and detailed view of the 
dialysate and perfusate circuits (Fig. 14.3.1). 
 The perfusion pump (7), electronic control unit (9) and perfusion chamber (5 in Fig. 
14.3.3) shown in Figs. 14.3.1 – 14.3.3 were purchased from Hugo Sachs Electronic – Harvard 
Apparatus GmbH, Germany. 
ͳͻͳ
Fig. 14.3.2.: Detailed view of the dialysate and perfusate circuits. 
The numbers in the Figures refer to the following components: 
1. Temperature-controlled perfusate reservoir
2. Temperature-controlled dialysate reservoir
3. Dialyzer for solute and gas exchange between perfusate and dialysate
4. Roller pump for the circulation of the perfusate
5. Centrifugal pump of the dialysate circuit
6. Variable clamp for the adjustment of the hydrostatic pressure in the perfusate circuit
7. Roller pump for perfusion of the kidney, which can be pressure dependently regulated
by the attached electronic control unit (9).
8. T-junction for the withdrawal of perfusate for kidney perfusion
9. Electronic control unit for pressure-dependent regulation of perfusion pump (7). The
temperature-controlled perfusion chamber and the pressure transducer are shown on
the right in Fig. 14.3.1 (and in greater detail in Fig. 14.3.3).
 The perfusate and dialysate reservoirs are enclosed in water-jacketed containers ([1] 
and [2] in Figs. 14.3.1 and 14.3.2) and the perfusate is heated immediately before entering 
the kidney and the (temperature-controlled) perfusion chamber (see below), ensuring that, 
when it leaves the perfusion cannula, the perfusate temperature is 37°C. Perfusate (250 ml) 
and dialysate (3.5 l) circuits are connected via a dialyzer ([3] in Figs. 14.3.1 & 14.3.2) and are 
driven by a roller pump (perfusate, [4] in Figs. 14.3.1 & 14.3.2) and a centrifugal pump 
(dialysate, [5] in Figs. 14.3.1 & 14.3.2) respectively. After filling the respective fluid circuits 
with perfusate and dialysate, and before beginning the experiment, the pressure within the 
perfusate circuit must be adjusted, either by changing the flow rate of the roller pump ([4] 
in Figs. 14.3.1 & 14.3.2) or by altering the setting of the variable pressure clamp ([6] in Figs. 
14.3.1 & 14.3.2), so that fluid transfer between perfusate and dialysate is avoided. 
ͳͻʹ
Fig. 14.3.3.: Set-up used for the perfusion of mouse kidneys at constant pressure in 
single-pass mode. 1. Roller pump for perfusion of the kidney, pressure dependently regu-
lated by the attached electronic control unit. 2. T-junction for the withdrawal of perfusate 
for the kidney perfusion. 3. Temperature-controlled helical tube. 4. T-junction for the 
determination of perfusion pressure. 5. Temperature-controlled perfusion chamber with 
kidney (shown in greater detail and without lid in Fig. 14.4.1). 6. Pressure transducer for the 
determination of perfusion pressure. 
 The perfusion of the kidney is driven by a roller pump (4-channel, 8 rollers; [7] in Figs. 
14.3.1 & 14.3.2; [1] in Fig. 14.3.3), which withdraws the necessary amount of perfusate 
from the perfusate circuit via a T-junction ([8] in Figs. 14.3.1 & 14.3.2; [2] in Fig. 14.3.3). On 
its way to the kidney, the perfusate, which has been prewarmed in its storage container, 
passes through a thermostated helical tube ([3] in Fig. 14.3.3) and reaches the 
thermostated perfusion chamber ([5] in Fig. 14.3.3) via a further T-junction ([4] in Fig. 
14.3.3). This one provides for determination of the hydrostatic pressure in the perfusate 
circuit by a pressure transducer ([6] in Fig. 14.3.3). The pressure serves as the feedback 
signal for the electronic control unit ([9] in Figs. 14.3.1 & 14.3.2) of the perfusate pump to 
maintain a constant perfusion pressure. Note here that, due to the rather narrow inner 
diameter of the perfusion cannula, a pressure is built up in the perfusate tube, so that the 
pressure determined by the pressure transducer in the perfusate circuit is higher than the 
actual pressure in the renal artery. In accordance with the Hagen-Poiseuille law, this 
systematic error increases disproportionately with decreasing inner diameter of the 
perfusion cannula. Accordingly, a cannula with the highest possible diameter should be 
used. Moreover, the pressure build-up in the perfusate tube has to be determined for each 
cannula and must be taken into account when the perfusion pressure is adjusted via the 
electronic control unit of the roller pump.  
ͳͻ͵
14.4.Surgical preparation and cannulation of the renal artery 
 Basically, the preparation of the mouse kidney follows the procedure described for rats 
in Chapter 8.2. For the operation, the anesthetized mouse is placed in the thermostated 
perfusion chamber. Anesthesia is performed using a combination of ketamine and xylazine. 
After abdominal midline incision, the aorta is dissected and is clamped distal to the right 
renal artery, so that perfusion of the right kidney is not disturbed during the subsequent 
insertion of the perfusion cannula into the abdominal aorta distal to the clamp. The mesen-
teric artery is ligated, and a metal perfusion cannula (outer diameter 0.6 – 0.9 mm) is inser-
ted into the abdominal aorta. After removing the aortic clamp, perfusion is started imme-
diately at a low flow rate (100 ђl/min) to prevent clotting in the cannula. Subsequently, the 
cannula is advanced to the origin of the right renal artery and fixed in this position. The 
aorta is ligated proximal to the right renal artery and the perfusion rate is increased until a 
perfusion pressure of 90 – 100 mmHg is achieved. Alternatively, perfusion mode can be 
switched to “constant pressure” at this time point. Use of the cannulation technique men-
tioned above avoids any significant ischemia of the right kidney. Finally, the right kidney is 
excised, placed in the humid and thermostated chamber, and perfusion at constant pres-
sure (100 mmHg) is established. In order to facilitate the subsequent cannulation of the V. 
cava superior, a part of the liver, which partially encircles the V. cava, should be excised to-
gether with the kidney en bloc. Finally, the V. cava is cannulated proximally (polypropylene 
catheter, approximately 1.5 mm outer diameter, the largest possible diameter should be 
used) and distally ligated. The venous effluent is drained outside the moistened perfusion 
chamber and collected for determination of renin activity and venous blood flow. 
 The perfusate flow rate can be determined from the speed (rpm) of the perfusate 
pump and the renal vascular resistance can be calculated if the pump has been calibrated. 
Note that the perfusate flow rate will be markedly overestimated if any leakage should 
occur in the arterial limb (e.g., if a side branch of the aorta has not been properly ligated). 
An alternative way to determine the renal perfusion rate is to measure venous blood flow. 
This can be done either by using electronic flowmeters, which can be easily integrated into 
the venous outflow tubing, or by the sampling of the venous effluate over a certain time 
interval and determination of its volume. The disadvantage of the latter method is that the 
renal blood flow will be underestimated in the event of a venous leakage. However, with 
this method one can be certain that all of the sampled blood has in fact passed through the 
kidney, which is eminently important if the experiment focuses on the secretion of a 
certain hormone or substance. Since our experiments on the regulation of renin secretion 
require the sampling of the venous blood in any case, we routinely use the latter method 
for the determination of renal blood flow (see Fig. 14.4.1). In addition to the renin activity 
in the venous effluate of isolated perfused mouse kidneys, we have determined the 
concentration and renal secretion of the cyclic nucleotides cAMP and cGMP, and of 
adenosine and ATP. 
ͳͻͶ
Fig. 14.4.1.: Perfusion chamber with open lid. Kidney with perfusion cannula (right, 
black plastic wing of cannula visible) and venous catheter (left) for the drainage of the 
perfusate out of the perfusion chamber. The venous catheter is attached to the perfusion 
chamber by plasticine. 
ͳͻͷ
Ad 14.2 Appendix 
Sheep erythrocytes as O2 carriers during perfusion of the isolated 
mouse kidney.   Jan Czogallaǡ   ǡ
ǡǤ
Raw material: Defibrinated sheep whole blood obtained from EOlabs (Burnhouse, 
Bonnybridge, UK) is used. The donor sheep are kept in quarantine (under veterinary 
supervision) and supplied with food, and water ad libitum (ISO 17025:2005). The blood is 
withdrawn in cycles, thus guaranteeing a constant animal hematocrit above 35%. The blood 
is withdrawn into gamma-irradiated blood collecting bags under sterile conditions from the 
jugular vein, and subsequently agitated at 4°C until full defibrination is achieved. It is then 
stored at 4°C under sterile conditions (ISO Grade 5/GMP Grade B) and dispatched within 48 
hours. Quality control: (ISO9001:2008): Columbia-Agar is inoculated with the blood and 
plates are monitored for the growth of microorganisms for 14 days. The cost of 3 liters of 
blood prepared in this fashion is 99 GBP (136€). 
Shipment: Blood is packed in units of 3x1 liter in Styrofoam boxes. Two cooling bags (0°C) 
are included, separated from the blood by a Styrofoam panel. The order is sent by 
International Priority via FedEx and reaches Zurich within 20h, at which point the 
temperature is approximately 8°C. The cost of shipment is 78€. 
Storage and stability: Erythrocytes are stored at 4°C. The shelf life stated by the supplier 
side is 1 month. Functional tests with the isolated perfused kidney with 1-month-old 
erythrocytes were successful (flow, pressure, gfr and urinary output were the same as with 
3-day-old blood).  
Protocol: On the day of the perfusion, three times the final erythrocyte volume needed is 
withdrawn under sterile conditions. The blood is then centrifuged in 12-ml Falcon tubes for 
8 min at 3000g. Blood plasma and the upper 0.5cm of the erythrocyte layer are removed 
and replaced by the dialysis buffer used for kidney perfusion. This step is then repeated 
three times. After the last step, the clear supernatant is removed and the erythrocytes are 
filtered (Machery-Nagel MN 615 paper filter, 4-12ђm pore size) and added to the final 
perfusion buffer (final hematocrit approximately 10%). For two mouse kidneys, 700ml of 
perfusion buffer is used. 
ͳͻ͸
Fig. 14.2.1.: Sheep Erythrocytes from EOlabs in smear, diluted.  
Left: Erythrocytes after 2 hours of continuous dialysis.  
Right: Erythrocytes after 2 hours of continuous dialysis and passage through the isolated 
kidney, taken from the renal vein. Scale bar: 10ђm. 
H.J. Schurek´s P.s.: 
There is an interesting new way – not yet used in the IPRK - to enhance oxygen capacity by 
using the extracellular macro-hemoglobin of the marine annelid worm Arenicola marina. 
This path has been developed by the French biologist Dr. Franck Zal and his company´s 
name is Hemarina. One may expect that this macro-hemoglobin will not be filtered at the 
glomerular capillaries and its large size may not contribute to the colloid-osmotic pressure 
(296b).  
ͳͻ͹
15. Technical appendix
Fig. 15.0.1.: Ensemble for humidification and heating of gases. Gases are pre-warmed 
in the water-jacketed glass coil at the top, humidified by passage through the ground-glass frit 
into distilled water in the Erlenmeyer flask which is placed in a water bath (see Fig. 5.1.01). Gas 
is reheated by passage through the glass coils in the lower panel, thus avoiding transfer of 
condensate into the perfusate. The 4-fold coil was originally designed for studies (in the single-
pass mode) of the effects of different substrates on sodium transport. Up to 4 Woulff bottles, 
each filled with 2 liters of a different perfusate, could be connected in series (256, 257). 
ͳͻͺ
Fig. 15.0.2.: Mount for the collecting funnel, with venous cannula holder and valve 
block. Upper panel: The current collecting funnel, made of stainless steel, is positioned 
below the kidney tray and is equipped with a threaded hose adapter (for perfusate 
outflow). On the left are connections for water circulation (temperature control). The two 
apertures at the front serve to accommodate the arterial bypass and the tube used to tap 
the venous cannula via a T-junction. Lower panel: The bar inserted below the screws 
controls two clamping pins, which are driven by compressed air via a solenoid valve, and 
alternately direct or block the arterial or venous inflow to the O2 electrode. The com-
pressed air cylinder connects to the bracket on the right. The collecting funnel originally 
used in Hannover was made of nickel-plated brass. The later versions employed in 
Hannover and Münster were constructed of stainless steel in the research workshop, and 
provided for adequate temperature control. The dark color resulted from an attempt to 
create a diamond-like surface by exposing the unit to a physical plasma (with acetylene) in 
vacuum. The plate on the right is used to mount the block.
ͳͻͻ
Fig. 15.0.3.: The venous cannula. The cannula is fitted with a stepped T-junction that 
connects the bypass to the O2 measuring cell. On the right is a Luer connector for spot-
check measurements and venous sampling. 
 The reluctance of experimenters to cannulate the renal vein is understandable. 
However the method we used gives us enough time to monitor the success of the maneu-
ver under continuous flow control on the recorder after the start of perfusion. When the 
funnel has been positioned and perfusion at constant pressure is underway, the venous 
cannula in the mounting block can be brought close to the vena cava inferior from the 
cranial side (right) and the vein is then slipped over the cannula with the aid of two 
watchmaker’s forceps, and the upper cava ligature is fixed. The lower cava ligature can 
then be fixed so that the perfusate drains quantitatively via the cannula. This procedure is 
quite simple, because the cannula is rotatable about the axis of the lower T-arm and can be 
firmly arrested with the fixing screw, while monitoring flow on the recorder. 
Choice of plastic tubing. 
Pegg et al. published an analysis of different plastic tubes concerning gas permeability and 
adsorption of fatty acids which should make the selection easier. At that time Tygon was 
not available. 
Pegg et al.: Cryobiology 9, 569-571 (1972)
ʹͲͲ
Fig. 15.0.4.: Linkage of the venous cannula and arterial bypass, and outlet to the 
oxygen-measuring cell. The Tygon® tube connects the venous cannula to a 4-way 
manifold, to which the tube for the arterial bypass, with the outlet to the O2 measuring cell 
(on the right) and the open overflow, which is recycled into the funnel. 
Fig. 15.0.5.: Disposition of the tubing on the mounting block (seen from above). The 
tubing system is prepared for installation.
ʹͲͳ
Fig. 15.0.6.: Final assembly (seen from above). The venous cannula is positioned and 
temporarily fixed. It is rotatable about the axis of the T-outlet and is pivoted into the 
inferior vena cava from the cranial side with opening directed toward the renal vein. The 
tube for the arterial bypass must still be threaded from below through the front hole. 
Fig. 15.0.7.: Final assem-
bly (seen from below). The 
4-way manifold is screwed 
to the bottom of the block, 
and the tube for arterial 
bypass is pushed through 
and is clamped off by the 
valve bar by spring pres-
sure. The plate (bottom 
right) is used to position the 
funnel under the operating 
table. The effluent tube is 
attached to the large-bore 
nozzle, and leads to the 
reservoir or (in single-pass 
mode) a waste receptacle. 
For sensor-controlled recyc-
ling of the effluent via a valve for foam reduction (which allows effluent to be recycled 
without intervening air segments) a smaller nozzle is sufficient (and more effective). 
ʹͲʹ
Fig. 15.0.8.: Views of kidney tray last used, with its mounting block. The two-part 
mounting block is made of brass, the tray is stainless steel. The heated water is circulated 
via a U-shaped channel within the inclined back-plate of the tray, which connects the inlet 
and outlet ports. The suction tube* is laser-welded to one side of the tray, opens forward 
and, when in use, this end should be underlain with a wide silicone half-tube in order to 
prevent aspiration of fat globules. Dimensions of tray: width 28 mm, height of the front 
wall 15mm, total height 29mm, depth 20,5mm, connectors 6 / 4mm, suction tube 3mm. 
Mounting rod 10 mm diameter, 90 mm long. Dimensions of mounting block: width 30mm, 
height 35mm, depth 20mm, the inner part is 16mm wide and has a horizontal groove on 
the right to accommodatefixing screw. 
ȗAfter the start of perfusion, when the aorta and vena cava have been severed, this tube is
used to suck the blood into a suitable container (e.g., an Erlenmeyer flask with a ground 
glass neck). In Berlin we used a water-jet pump for this; nowadays, the inlet nozzle of a 
small compressor is connected to the Erlenmeyer flask. 
ʹͲ͵
Fig. 15.0.9.: Conditioning in preparation for mode-3 perfusion before addition of 
erythrocytes.is the bottle containingͷǡ
  ȋ	ͷȌǡ which is driven by the two-way pump behind it. The inlet for 
dialysate is on the top left, that for perfusate on the top right, behind the feedback-
controlled perfusion pump and the reservoir for perfusate. 
Fig. 15.1.0.: Detailed view of the complete assembly. On the left is the tube valve 
(normally closed), which is opened to add dialysate to the perfusate when the level of liquid 
in the perfusate reservoir drops below that of the scanning probe; the control volume is 
equivalent to about 1% of the filling volume (i.e., 2ml). Suitable electronic water switches 
(e.g. Kemo M158) are available from specialized retailers. The blue clamp on the right cuts off 
the connection to the kidney, while the bypass (to the left of the clamp) is open.
ʹͲͶ
Fig. 15.1.1.: After erythrocyte addition and initiation of ȋͷͿth ȌǤA 
hematocrit of 5% is sufficient to prevent morphologically visible damage indicative of 
oxygen deficiency (253). In the perfusate reservoir, a magnetic stirring bar (coupled to a 
stirrer placed below the reservoir) prevents settling of the erythrocytes. 
Fig. 15.1.2.: Close-up view of part of the assembly. The thin tubing between the two 
ports of the perfusion pump (black arrow) leads directly to the reservoir. This tube is used 
to supply dialysate to offset losses of perfusate as urine and during ultrafiltration in the 
dialyzer. Volume losses due to withdrawal of perfusate samples are compensated for by 
lowering the sensing probe. During perfusion, the bypass from the glass coil to the 
reservoir is closed (blue clamp). 
ʹͲͷ
Fig. 15.1.3.: Detailed view of perfusate reser-
voir with level control. The sensing probe on the 
left is adjustable in height, and serves as one of the 
electrodes for the refill control to compensate for 
losses during ultrafiltration of the dialyzer and 
withdrawal of urine samples. The thin stainless steel 
tube on the right serves both as a second electrode 
and as the return path for aliquots used for oxygen 
pressure measurements. See Fig. 5.3.2. 
 Fig. 15.1.4.: Mobile double-barreled aortic can-
nula attached to a magnetic ball joint. The ball 
moves freely in the pan. The perfusion cannula 
itself is screwed firmly to the rod axis (IBS Magnet, 
Berlin; ibsmagnet.de). 
The detailed view of the 
cannula (below left) shows 
the extended inner cannu-
la used for pressure trans-
mission to the pressure 
transducer. The outer can-
nula has a frontal notch to 
secure the fixing thread. 
The exact dimensions of 
the cannula are given in 
Fig. 4.6.4. 
ʹͲ͸
Fig. 15.1.5.: Perfused kidney with cannulas in aorta and vena cava and ureteral 
catheter. The venous effluent is drained via the sieve-plate under the kidney tray. The tray 
itself is covered with Parafilm, and the ureteral catheter is fixed with plasticine. The 
ureteral catheter on the left leads to the collecting vial. In front, the bypass for arterial pO2 
measurement, on the right the Tygon tube leads to the measuring cell. The black cylinder 
on the right is the compressor inlet that pneumatically activates the switch bar for venous 
or arterial pO2 measurement. 
Fig. 15.1.6.: Detailed view of the pO2 ȋType MT-1-ǡǡȌ its 
cuvette. A multiple cuvette for measurement of pO2, pCO2 and pH can also be used, but 
calibration requires considerable effort. Such measurements show that fluctuations in pH 
and pCO2 are significantly greater in cell-free perfusate. 
ʹͲ͹
Fig. 15.1.7.a/b.: Set-up used for reperfusion of anatomically fixed kidneys.A water-
jacketed glass container supplies three separate reservoirs, allowing for recirculation and 
variation of perfusate composition. For rinsing purposes, we use warm NaCl solution 
delivered via the glass coil on the left.
ʹͲͺ
16. Appendix on the history of renal perfusion 1849–1908
Chronology of the development of perfusion equipment modified by BD Ross from the 
work of K. Skutul from the Pharmacology Laboratory of the St. Vladimir University of Kiev 
(277): Über Durchströmungsapparate. Pflügers Arch 123: 249-273, 1908 
1849 Carl Eduard Loebell: De conditionibus quibus secretiones in glandulis. 
Doctoral dissertation ȋin LatinȌ, Marburg University (153). Loebell describes his 
initial attempts to perfuse the isolated porcine kidney with defibrinated blood and 
measure urine output, so-called pass-through tests. Particularly noteworthy is his 
observation that when the bright red arterial blood emerged from the renal vein, it 
was darker in color and contained more solids, while a completely clear liquid came 
out of the ureter, which contained considerable amounts of protein (see Ernst 
Bidder´s commentary on Loebell´s work for remarks on the quality of the Latin). 
1862 Ernst Bidderǣ   ȋ 
Ȍ, Imperial University of 
Dorpat ȋ-day Tartu in EstoniaȌ (29). Bidder is quite critical of the work of 
Loebell, but cites the above observation as an important result. Interestingly, Bidder 
himself noted that at very low urinary flow rates more protein was excreted than at 
higher flow rates. 
1869 Alex Schmidt: In Carl Ludwig´s laboratory in Leipzig. Beginning in 1867, 
Schmidt improved methodology by heating the defibrinated blood to 36-40°C and by 
achieving continuous flow through the kidney (Annual Report of the Physiological 
Institute in Leipzig 1869, p.99). 
1877 G. Bunge and O. Schmiedeberg (47). These authors reported the synthesis of 
hippuric acid, based on ‘pass-through’ experiments on the isolated canine kidney. 
1885 Frey and Gruber constructed an apparatus equipped with an oxygenator (artificial 
lung) and a pulsatile pump for the circulation of blood. 
1890  C. Jacobj introduces his so-called "Haematisator” in Strasbourg. Designed by 
Jacobj, this machine used a water-driven two-valve pump and provided for 
oxygenation of the blood, thus more closely approximating natural circulation. 
1892  Ǥ    Ǥ  make use of a biological lung as oxygenator, 
thus avoiding direct contact of the blood with ambient air. Skutul refers to this set-
up as a "double Haematisator". Pulsatile perfusion as above. 
1895  O. Langendorff in Rostock develops the first successful perfusion apparatus 
for the heart, the principle of which has hardly changed since. He studied the 
function of the beating heart and was able to record the contractions.Asa pressure 
source he used a 17.5-liter glass bottle filled with water, and kept the pressure 
constant by steadily replenishing the water (the gasometer principle). 
ʹͲͻ
1903  T. G. Brodie in London described a recirculation apparatus with variable pump 
and adjustable constant perfusion pressure, and a small recirculation volume. With 
increasing experience, he later installed filters in the venous and arterial legs of the 
system, which were retained in the arterial branch (or were "re-discovered”) up to 
modern times. The perfusion of surviving organs. J Physiol 29: 266-275, 1903 
1904  Sakusow in St. Petersburg described in his dissertation thesis (in Russian) an 
improved temperature control with a water-filled glass coil heated in a water bath. 
1904  A. Siewert in Kiev (work published in German) perfused isolated hearts with a 
modified Langendorff apparatus with a temperature-controlled glass coil placed 
immediately before the heart, enabling him to preheat the perfusate so that the 
organ reached normothermia. Pflügers Archiv 102: 364-372, 1904. 
1908  K. Skutul in Kiev carried out a survey of existing equipment (with the 
exception of Brodie´s work). After careful study of the defects and deficiencies of his 
predecessors’ designs, he went on to develop his own apparatus. (277) (Publication 
in German). 
Selection of historic graphs, photos 
Fig. 16.0.1.: The apparatus used by Ernst Bidder. The illustration is taken from the 
dissertation (in German) he submitted in 1862 to the Imperial University of Dorpat, now 
Tartu in Estonia (29). 
ʹͳͲ
Jacobj C:XXIII Work from the Laboratory of Experimental Pharmacology at Strasbourg. 78. 
Apparat zur Durchblutung isolirter Organe.Archiv f. experimentelle Pathologie u. Pharma-
kologie Volume XXVI: pp 388-400, 1890.The journal is now published by Springer Science 
Publishing as Naunyn-Schmiedeberg's Archives of Pharmacology, and is accessible in digital 
form (115). Copyright permission of Springer. 
Fig. 16.0.2: Diagram of the historical apparatus used for perfusion of the canine 
kidney by Jacobj at the Pharmacology Institute of the University of Strasbourg. It 
consists of three subsystems for (1) arterial blood, (2) venous blood, and (3) air or oxygen 
circulation for “arterialization” of blood. On the right is the "artificial heart" (A) a bellows 
pump with two valves, driven in pulsatile fashion by a rocker powered by a water motor. 
The total volume of defibrinated blood in reservoir B and the main circuit was 300 ml, and 
it was compressed and aerated by the oxygen gasometer D. The shunting circuit could be 
closed at S, and acted as a buffer on the output of the pump. Oxygen, derived from CO2 by 
passage through potassium hydroxide solution, was added at I. Temperature control was 
achieved with the aid of a glass spiral immersed in a water bath (K) which was heated by 
Bunsen burners, and temperature was monitored at N. Jacobj used the calibrated chamber 
P to measure the venous flow rate, and mercury-filled U-tubes for pressure measurement. 
The input oxygen pressure was measured in the cylinder D. The oxygen in the gasometer D 
was displaced in portions by the inflow of water into E and expelled via a mercury return-
valve into the reservoir for arterial blood where it mixed with CO2. Pure oxygen was mixed 
with the blood at I, and thus arterialized (F had a defoaming function). The protocols in the 
study show that the flow rates per minute were quite low at 10-33ml for a dog kidney of 28 
g of wet weight. On the other hand, swine kidneys that were obtained directly from the 
slaughterhouse and had been devoid of perfusion for only 45 min showed significantly 
higher values, but they exhibited high levels of oxygen consumption, indicating a perfusion 
deficiency (see Nizet in the 20th century (186)). Two years later, Jacobj, together with von 
Sobieranski, used a biological lung in the second circuit to overcome the drawbacks of the 
system described in the 1890 publication.  
ʹͳͳ
Jacobj C and v. Sobieranski W: II Scientific work from the Laboratory of Experimental 
Pharmacology at Strasbourg. 89. Ueber das Functionsvermögen der künstlich durchblute-
ten Niere. Archiv für experimentelle Pathologie und Pharmakologie 29: 25-40, 1891. 
(today: Naunyn-Schmiedeberg´s Archives of Pharmacology) 
In this work the authors complain about the difficulties caused by fluctuations in urban 
water pressure, and consider how one might overcome this problem. 
Fig. 16.0.3.: C. Jacobj´s 1890 apparatus. This picture, taken by a court photographer 
from the neighboring town of Kehl, shows the elaborate mechanical rocker (on the right) 
with which the rubber ball (substituting for a ventricle) is compressed via the camshaft. The 
system was powered by a water-driven motor like those used in many washing machines 
(which were then cheaper than electrical machines) up to the 1950s. One can also see the 
two Bunsen burners under the organ chamber (on the left) and the water bath for the glass 
coil (in the middle). The U-shaped mercury manometers at venous output and arterial 
inflow can also be seen. 
ʹͳʹ
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An organ such as the kidney naturally functions best in a healthy orga-
nism. Once a kidney has been removed from its normal context, it is 
FUXFLDOWRïQGWKHRSWLPDOFRPSURPLVHEHWZHHQWKHGHPDQGVRIWKH
SUREOHPDWLVVXHDQGWKHH[SHULPHQWDOPRGHOWREHDGRSWHG$QLVROD-
ted kidney is, in effect, a “dying kidney”, although it may continue to 
IXQFWLRQIRUEHWZHHQDQGKRXUVGHSHQGLQJRQRQHÚVGHïQLWLRQRI
QRUPDO7KHEDVLFUHDVRQIRUWKHSURJUHVVLYHGHWHULRUDWLRQLQIXQFWLRQ
FDQEHIRXQGLQWKHVWUHVVHVVHWXSE\WKHWUDQVLWLRQIURPSHUIXVLRQE\
ZKROHEORRGWRWKHXVHRIDPRUHRUOHVVDUWLïFLDOSHUIXVLQJPHGLXP
,QGHHGEORRG LVDÝOLTXLGRUJDQÞDKLJKO\FRPSOH[FRFNWDLO WKDW LV
steadily being reconditioned by the actions of other organs, and this 
FRPSOH[LW\H[SODLQVZK\DOOHIIRUWVWRPDLQWDLQNLGQH\IXQFWLRQLQLVR-
ODWLRQDUHXOWLPDWHO\GRRPHGWRIDLOXUH,IZHZDQWWRDSSURDFKLWVIDQ-
WDVWLFSURSHUWLHVWKHQZHVKRXOGOHDYHDQRUJDQDVWKHNLGQH\ZLWKLQ
WKHERG\$V0HSKLVWRUHPDUNVLQ*RHWKHÚVGUDPDÝ)DXVWÞ6WXGLHU-
]LPPHU,,Ý%OXWLVWHLQJDQ]EHVRQGUHU6DIWÞÝEORRGLVDTXLWHVSHFLDO
juice”.
